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SYNTHESIS AND PHOTOPHYSICAL STUDIES OF NITROGEN HETEROCYCLES
CONTAINING BENZOTHIAZINE, BENZOTHIAZOLE, INDOLE AND QUINOLINE
By Ealin Patel
Dissertation Advisor: Dr. Matthew Brichacek
An Abstract of the Dissertation Presented
in Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
(in Chemistry)
May 2021
Nitrogen heterocycles such as quinolines, benzothiazines, benzothiazoles, and indoles are widely
found in nature and these compounds have significance in organic and medicinal chemistry,
biochemistry as well as materials science. Monomeric units of eumelanin (brominated 5,6dimethoxyindolecarboxylate derivatives) were synthesized and regioselectively functionalized to
form three monobrominated, three dibrominated, and a tribrominated variant using thermally
induced nitrene insertions. After deprotection, three monobrominated 5,6-dihydroxyindole
carboxylate (DHICA) derivatives were synthesized, and their UV-Vis absorbance was compared
to DHICA. Bominated DHICA derivatives showed similar λmax as DHICA (~330 nm) but did not
show aerial oxidation as evident by absence of chromophore absorbance at 550 nm. Monomeric
synthetic analogues of pheomelanin subunit benzothiazole (six variants) and benzothiazine (four
variants) were synthesized with CO2Et and CH2CN sidechain via Sandmeyer reaction, and Cu (II)catalyzed thiolation-Ullmann coupling, respectively. This monomeric pheomelanoid synthesis
was the first successful unified strategy to access this class of molecules. Utilizing these melanin
building blocks, synthesis of mixed melanoids was done using Miyaura borylation and Suzukicoupling. Preliminary photophysical studies of synthesized mixed melanoids showed red shifted
UV absorbance (from ~280 nm to 360 nm) due to extended conjugation and these compounds
exhibited fluorescence properties as organic chromophores. With a goal of developing material for
optical memory, gold-heli viologen was synthesized and characterized successfully via Pd (0)catalyzed Stille coupling route, or Hiyama-Heck coupling from 3-bromoquionoline as the key step.
Temperature variable photoluminescence and quenching experiments were performed to study the
photophysical behavior which showed quenching of gold luminescence by heli-viologen involving
an electron transfer.
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1 INTRODUCTION
1.1
Nitrogen heterocycles
Nitrogen heterocycles (N-heterocycles) are one of the most significant chemical class of organic
molecules, as they are widely found in natural products and active pharmaceuticals.1 Nheteocycles are present in building blocks of life- DNA, RNA, ribosomes and conenzymes.2
Over 75% of pharmaceuticals approved by the FDA contain nitrogen-heterocycles.3 Most
common structural classes of five and six membered nitrogen heterocycles present in
pharmaceuticals have been shown in Figure 1-1.4

Figure 1-1- Pharmaceuticals containing nitrogen Heterocycles4 (Adapted with permission from
Njardson et al.).
Four membered β-lactams are of importance due to their activity in antibiotics (e.g. Penicillin)
among other bioactive heterocycles.3 Five membered N-heterocycles-indole, thiazole, and
imidazole, and six membered N-heterocycles-quinoline, pyridine, and thiazine have been of
interest in organic, medicinal and materials chemistry. N-heterocycles exhibit hydrogen bonding,
dipole-dipoe interactions, π-π stacking interactions in addition to electron acceptor and donor
properties, which are important in biological functions as well as materials development.1,3,4 Nheterocycles can be synthesized via biosynthesis and chemoenzymatic synthesis, or chemical
synthesis methods such as transition metal catalysis, cycloaddition, photocatalysis, nitrene
1

insertion and other radical reactions. Subclasses of N-heterocycles such as indole, thiazole,
thiazine and quinoline (Figure 1-2) are of interest to the research discussed in this work. Indole
compounds are most commonly synthesized by intramolecular reaction of two ortho-substituents
on an aromatic ring or by internal cyclization of a single substituent onto the aromatic ring.
Thiazoles are synthesized by metal catalyzed thiocyanation. Quinolines are generally synthesized
by Skraup synthesis or Michael type reactions.5 Our interest in these particular heterocycles stem
from their presence and role in biological systems as well as potential material applications of
these conjugated systems.

Figure 1-2 N-heterocycles of interest.
Indoles, thiazoles and thiazines are widely present in melanin which are natural biopolymers
found in skin, hair pigments and brain of humans and other animals. They exhibit interesting
photoprotective and phototoxic behavior due to their unique photophysical properties. Pyridines
and quinolones are present in viologens (diquaternary salts of Bipyridine), which have
applications in optical memory storage and electrochromic devices. Detailed background on
melanins and viologens is discussed in the following sections.
1.2
Melanin
Melanin pigments are one of the most widely present biological molecules in the animal kingdom
as well as fungi, plants and bacteria.6,7 These compounds are involved in multiple biological
functions such as thermoregulation, virulence factor where it protects organism from host immune
response.8 They also possess interesting material, photophysical and chemical properties such as
broadband radiation absorption (UV-Vis and Infrared), metal chelation, and free radical
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scavenging.9 There are a few different types of melanin: eumelanin, pheomelanin, neuromelanin
and allomelanin. Allomelanin is the only type of melanin which does not contain nitrogen or sulfur
in the heterocycle as they are derived by polymerization of catechol and dihydroxynapthalene type
monomers.9 Two of the most commonly found melanin in nature are Eumelanin and Pheomelanin.
Eumelanin is an insoluble brown to black pigment, whereas pheomelanin is a red to yellow
pigment as shown in Figure 1-3.10 The arrows in the chemical structure indicate branching points
or chain proliferation sites of these bio-polymers.

Figure 1-3 Melanin pigments responsible for hair color.
Both of these melanins are derived from dopaquinone which is formed from oxidation of amino
acid L-tyrosine by the enzyme tyrosinase.11 The structural difference between the two is the
presence of sulfur it in pheomelanin due to the role of cysteine in formation of pheomelanin.9,12
Neuromelanin is a dark polymer pigment present in substantia nigra and locus coereleus of the
brain, and it is composed of mixed melanins (conjugated eumelanins and pheomelanins), metals,
3

and proteins.13 In order to understand the structure and the function of these biomolecules,
discussion of melanogenesis is crucial.
1.2.1 Melanogenesis
1.2.1.1 Rapor-Mason-Prota pathway of Melanogenesis:
Basic understanding of melanogenesis (Figure 1-4) was derived by Ito in 2003 from the works of
Raper14 who isolated dopa, 5,6-dihydroxyindole (DHI), 5,6-dihydroxyindole carboxylic acid
(DHICA) from tyrosine oxidation by tyrosinase; Mason15, who spectroscopically characterized
dopachrome; and Prota16 who proved cysteinyldopa as a pheomelanin precursor leading to the
understanding of late stage melanogenesis.17 As mentioned above both types of melanins found in
animals, eumelanin and pheomelanin are formed from dopaquinone, which is highly reactive. It
was believed previously that DOPA (3,4-dihydroxyphenylalanine) is formed from L-tyrosine
which then oxidizes to dopaquinone. However, it was proved by Cooksey et al.18 using N,Ndimethyldopamine as a substrate for tyrosinase enzyme that dopaquinone is formed directly from
tyrosine during the initial stage of melanogenesis.18–20 In the absence of cysteine (sulfuryl
compound), dopaquinone, due to its high reactivity undergoes intramolecular amine addition by
the L-dopa sidechain amine group forming cyclodopa (leucodopachrome). Redox exchange
between dopaquinone and cyclodopa results in formation of dopachrome and dopa. As described
in Figure 1-4, dopa can convert back to dopaquinone by tyrosinase-catalyzed oxidation.
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Figure 1-4 Rapor-Mason-Prota pathway of Mixed melanogenesis.17
Dopachrome is a red-orange intermediate undergoes intramolecular rearrangement to form natural
eumelanoid monomers, 5,6-dihydroxyindole-2-carboxylic acid (DHICA) and 5,6-dihydroxyindole
(DHI) if it decarboxylates during rearrangement.14,17,20 These eumelanoid monomers further
oxidize and polymerize to form the brown-black insoluble polymer pigment, eumelanin. When
sulfuryl compounds such as cysteine are present, it converts dopaquinone to one of the two
isomers: 5-S-cysteinyldopa (5-S-CD) and 2-S-cysteinyldopa (2-S-CD), among which 5-S-CD is
the major isomer.21 Redox exchange between dopaquinone and cysteinyldopa leads to formation
of cysteinyldopaquinones (CD-quinones) and DOPA. CD-quinones further oxidize to form
benzothiazine intermediates, which can convert to benzothiazoles via rearrangement.
Benzothiazines and benzothiazoles are the natural pheomelanoid monomers. These small
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molecules further oxidize and polymerize to form pheomelanin pigment.17,20,21 Several enzymes
are involved in melanogenesis regulation. Tyrosinase, a class of proteins containing copper with
ability to bind dioxygen, regulates formation of dopaquinones.22 Dopachrome tautaomerase (Dct),
a melanogenic Tyrosinase-related protein-2 (Tyrp-2) catalyzes the tautomerization of dopachrome
to DHICA.19,23,24 This isomerization involving hydrogen shift is also facilitated by divalent metal
ions.25 DHI oxidative polymerization was previously attributed to tyrosinase activity, but it was
proved through pulse radiolysis study that this process can be facilitated by oxidation of
dopaquinone to DOPA.26,27 DHICA oxidative polymerization is catalyzed by Tyrosinase-related
protein-1 (Tyrp-1).17
1.2.1.2 Kinetics of melanogenesis
Dopaquinone is a type of orthoquinone, which are very reactive and unstable compounds. Due to
their low stability, to study kinetics of orthoquinone, pulse radiolysis is used. In this technique,
pulsed ionized radiation (through a linear accelerator) is used to irradiate the sample and an
analyzing beam (UV-Vis) is delivered perpendicularly (to the electron beam).28 Induced
absorbance change is measured through this fast spectrophotometer and analyzed.22 Hydoxyl
radicals produced from water initially and upon addition of halide such as bromine under saturated
N2O, dibromide radicals are produced in buffer with KBr.20,22 Dibromide radicals oxidize DOPA
to form dopaquinone upon addition of catechol under pulse radiolysis conditions. Rate constants
can be measured and quantified by observing subsequent changes in absorption wavelengths for
different reactions.22 Figure 1-5 details the rate constants of reactions leading to formation of
dopachrome and cysteinyldopaquinone from dopaquinone.
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Figure 1-5 Kinetics of melanogenesis.22,29
In the presence of cysteine dopaquinone is rapidly (k3=3 x 107 M-1s-1) conjugated to cysteinyldopa
with the major isomer being 5-S-CD.22 Redox exchange step to form 5-S-cysteinyldopaquinone
however is the rate determining step with the rate constant of 8.8 x 105 M-1s-1. It also produces
DOPA, which is dearmoatized to dopaquinone. The rate of 5-S-CD formation depends on the rate
of formation of dopaquinone.30 Through stages of pheomelanogenesis, Cysteinyldopaquinone
produces pheomelanin biopolymer. In the absence of the sulphydryl (SH) compound cysteine,
dopaquinone cyclizes to form cyclodopa. This step is very slow (k1=3.8 s-1) and is possible due to
the process being intramolecular at pH 8.6. This cyclization is also pH dependent as the rate is 100
fold slower when pH is reduced to 5.6.29,30 Through redox exchange, (dopaquinone to DOPA)
cyclodopa converts to dopachrome. This reaction is faster compared to the cyclization step with a
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rate constant of 5.3 x 106 M-1s-1. Dopachrome through stages of eumelanogenesis produces
eumelanin biopolymer.
1.2.1.3 Eumelanogenesis
In the absence of cysteine, dopaquinone (DQ) cyclizes to form cyclodopa (CD). Figure 1-6
describes formation of DHI and DHICA quinones from cyclodopa, which with further oxidation
and polymerization form eumelanin. Through redox exchange with dopaquinone, Cyclodopa
converts to dopachrome, which has a half-life of ~30 minutes.

Figure 1-6 Kinetics of Eumelanogenesis: formation of DHI and DHICA quinones.
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Dopachrome undergoes spontaneous decomposition under physiological conditions resulting in
formation of DHICA and as it decarboxylates it forms DHI. This process is non-enzymatic and it
forms decarboxylated DHI as the major product with DHI:DHICA being 70:1.31 Through redox
exchange with dopaquinone, DHI oxidizes to form DHI quinone with a slow reaction rate with
rate constant of 1.4 x 106 M-1s-1 as this reaction does not go to completion.20,27 In the presence of
dopaquinone tautomerase (Dct or Tyrp2), dopachrome is converted to DHICA through this
enzymatic tautomerization where Cu(II) plays a key role.25,31,32 DHICA, through redox exchange
with dopaquinone oxidizes to form DHICA quinone, which has a much slower rate of 1.6 x 10 5
M-1s-1. As this process will not go to completion, involvement of enzymes such as tyrosinase
speeds up oxidation of DHICA to DHICA quinone.27,33 Chemical or enzymatic oxidation of DHI
and DHICA quinones leads to oligomerization and polymerization as rapid deposition of a black
solid is observed leading to formation of eumelanin polymer.34,35 Oxidation of these quinones was
studied by pulse radiolysis, which showed that it tautomerizes to imine and methide form. These
tautomers undergo nucleophilic addition in order to make dimers, trimers and oligomers.29
1.2.1.3.1 Eumelanin structure elucidation:
The structure of eumelanin was elucidated by chemical degradation of this natural polymeric
pigment.36 Through degradation studies using chemical oxidizing agents such as potassium
permanganate, hydrogen peroxide or via reductive hydrolysis using hydroiodic acid. HPLC
methods have been developed to detect the degradation products and the quantification of these
products elucidates composition of Eumelanin.36,37
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Figure 1-7 Oxidative degradation of eumelanin by Alkaline H2O2. (Arrows indicate
conjugation/chain proliferation sites of the polymer)
As shown in Figure 1-7, degradation of different types of melanin using hydrogen peroxide
under alkaline conditions results in simple degradation products, which can be detected and
quantified by HPLC. Eumelanin containing dihydroxyindole (DHI) subunit results in pyrrole2,3,5-tricarboxylic acid (PTCA) and pyrrole-2,3-dicarboxylic acid (PDCA) upon oxidative
degradation. Eumelanin containing dihydroxyindole carboxylic acid (DHICA) results in PTCA
upon oxidative degradation whereas cross-linked eumelanin results in pyrrole-2,3,4,5tetracarboxylic acid (PTeCA). These degradation products are used as bio-markers for analysis
of eumelanin in biological melanin samples.
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1.2.1.4 Pheomelanogenesis
In presence of cysteine formation of cysteinyldopas (5-S-CD and 2-S-CD) and
cysteinyldopaquinones (5-S-CysQ and 2-S-CysQ) from dopaquinone is favored.

Figure 1-8 Nucleophilic addition of cysteine.
Ito and Prota showed (Figure 1-8) that through enzymatic reaction catalyzed by mushroom
tyrosinase producing 5-S-cysteinyldopa as a major (74%) product, and 2,S-cysteinyldopa (14%),
2,5-S,S’-dicysteinyldopa (5%), 6-S-cysteinyldopa (1%) as minor products.21 Due to this reaction
major pheomelanoids observed in nature, in pheomelanin or neuromelanin are functinalized with
Sulphur at 5’ position. As 5-S-CD is the major product it leads to the formation of the key
intermediate 1,4-benzothiazine and other benzothiazine derivatives as described in Figure 1-9.
During the late stage of pheomelanogenesis, 5-S-CD is converted to 5-S-cysteinyldopaquinone (5S-CysQ) with redox exchange with DOPA as it converts to dopaquinone. Cysteinyldopaquinone
cyclizes to form 2H-1,4-benzothiazine-o-quinonimine(QI) as amine nucleophile attacks the
neighboring carbonyl carbon. The rate of this reaction was measured with pulse radiolysis and was
found to be fast with a value of 10 s-1.27 The competing reaction in presence of higher cysteine
11

content is addition of an extra cysteine to the 5-S-CD-Q which forms, 2,5-S,S’-dicysteinyldopa
(2,5-S,S’-diCD). The rate of this reaction is much lower, 1 x 104 M-1s-1 and it only becomes a
competitive process when cysteine concentration is higher than 1 mM in-vivo.17,30

Figure 1-9 Pheomelanogenesis: formation of 1,4-benzothiazines.38
Oxidation of cysteinyldopa and 1,4-benzothiazines was studied by enzymatic and other catalytic
reaction using reagents such as peroxidase/H2O2, tyrosinase, periodate and ferricyanide under
physiological pH.38 2H-1,4-benzothiazine-o-quinonimine (QI) is the key benzothiazine
intermediate which leads to the formation of pheomelanoid monomers. QI undergoes
12

rearrangement with the reaction rate (measured by pulse radiolysis) of 6.0 s-1 in order to form 1,4benzothiazine carboxylic acid (BTZCA) as a major product (85%) and part of it decarboxylates to
form 1,4-benzothiaine (BTZ).20,38–40 QI undergoes redox exchange with 5-S-cysteinyldopa as it is
converted to 5-S-cysteinyldopaquinone resulting in formation of dihydro-1,4-benzothiazine
carboxylic acid (DHBCA).20,41 Reduction of benzothiazine intermediate (BTZ) forms dihydro-1,4benzothiazine (DHB), and hydrolysis of this unstable DHB leads to the formation of dihydroxydihydro-1,4-benzothiazine (DHDHB).38
Cysteinyldopa and its 1,4-BTZ derivatives have shown to chelate strongly with metal ions such as
Zn2+, Fe3+, Cu2+, Al3+, Co2+, and Cd2+. Zinc catalyzes oxidation of BTZCA and forms BTZCAdimers and further oxidation leads to formation of trichochrome C.38 Iron and copper ions chelate
with BTZ and form a complex which assists in decarboxylation and ring contraction resulting in
formation of 1,3-benzothiazole (BTZL) as described in Figure 1-10.38

Figure 1-10 Oxidation of benzothiazine to benzothiazole.38
Cysteinyldopa and its 1,4-BTZ derivatives under enzymatic and metal oxidative conditions form
pheomelanin polymer through oxidative polymerization. Through biomimietic conditions using
enzymatic systems (peroxidase, tyrosinase), chemical agents (H2O2) and aerial oxidation,
oxidative polymerization of cysteinyldopa and its derviatives have been studied.38,42 Different
oligomers were made under different conditions and concentrations of different pheomelanoids,
which implied that the make up of the final pheomelanin polymer is highly dependent on oxidative
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conditions and the nature of polymerization. Degradation studies of natural pheomelanin polymers
discussed below sheds light on the nature of polymerization and conditions in-vivo.
1.2.1.4.1 Pheomelanin structre elucidation:
Structure of Pheomelanin in natural melanin pigment is also determined by degradation
experiments. Oxidative degradation using hydrogen peroxide or reductive hydrolysis by
hydroiodic acid is used. Products are analyzed and quantified by HPLC to study the composition
of pheomelanins. Benzothiazine and its oxidation product benzothiazole are the most commonly
found subunits in natural pheomelanin.36,37,43

Figure 1-11 Pheomelanin degradation by oxidation and reductive hydrolysis.
As shown in Figure 1-11, reductive hydrolysis of pheomelanin with benzothiazine unit using
hydroiodic acid resuls in generation of 4-amino-3-hydroxyphenylalanine (4-AHP). Its isomer, 3AHP is also used as a biomarker for pheomelanin. Oxidative degradation of benzothiazinepheomelanin with alkaline hydrogen peroxide results in Pheomelanin containing benzothiazole
unit results in benzothiazole carboxylic acid (BTCA isomers- BTCA-5 and BTCA-2), which can
further degrade to yield thiazole-4,5-dicarboxylic acid (TDCA) and thiazole -2,4,5-tricarboxylic
14

acid (TTCA). Pheomelanin containing benzothiazole subunit also oxidizes to yield TDCA and
TTCA. These degradation prodcts can be analysed and quantified by HPLC and are used as
biomarkers to understand pheomelanin strcture.36,37,43
1.2.1.5 Mixed melanogenesis
Three step pathway (Figure 1-12) proposed by Ito shows that melnogenesis has three stages of
production, which depend on presence and concentration of cysteine. Initially when tyrosinase
activity is low, dopaquinone is being produced at a low rate. When tyrosinase activity goes up
resulting in increased dopaquinone production, the first stage of melanogenesis occurs as
cysteinyldopas are being produced with presence of cysteine. This production occurs until cysteine
concentration falls below 0.13 μM, after which the second stage begins where cysteinyldopas
oxidize to produced 1,4-benzothiazine intermediates, which further oxidize to produce
pheomelanin polymer. The second stage continues as long as cysteinyldopa concentration is above
9 μM.12,17,19,20 Once cysteine is depleted and cysteinyldopa concentration has lowered,
dopaquinone produces cyclodopa as the third stage begins. At this stage, cyclodopa produces DHI
and DHICA via dopachrome, which further oxidize to form eumelanin polymer.

Figure 1-12 Cysteine dependent mixed melanogenesis. (Adapted with permission from Ito and
Wakamatsu, 2008)20
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This phenomenon of pheomelanin formation followed by eumelanin leads to casing model, which
suggests that pheomelanin polymer forms the core, as its production is favored in the initial stage
when cysteine concentration is high. Once cysteine is depleted, eumelanin production occurs and
eumelanin forms the shell. This model supports structure and formation of neuromelanin, a mixed
melanin polymer.11,44,45 As shown in Figure 1-12 melanogenesis depends on tyrosinase activity,
which dictates dopamine production, as well as presence and concentration of cysteine. When
cysteine levels are low, cysteinyldopaquinone production is low and as a result,
pheomelanogenesis stage is short. In this case, eumelaninogenesis predominates. When cysteine
concentration is high, cysteinyldopa-quinone production is high resulting in longer
pheomelanogenesis and increased pheomelanin production.12,17,19,20
1.2.1.5.1 Neuromelanin structure elucidation:
Neuromelanin is a biopolymer structure consisting of pheomelanin and eumelanin as its major
components. Degradative studies have suggested the benzothiazine and indole structures as
subunits of this biopolymer. However, in contrast to pheomelanin and eumelanin found in skin
and hair pigments, neuromelanin is derived from dopamine. In order to study the structure of
neuromelanin, Ito and coworkers synthesized dopamine-derived eumelanin and cysteinyl
dopamine derived pheomelanin via chemo enzymatic synthesis using mushroom tyrosinase
enzyme.17 Degradation products of synthetic melanin and neuromelanin extracted from
substantia nigra were generated from oxidative degradation and reductive hydrolysis as shown
in Figure 1-13.
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Figure 1-13 Degradation products of dopamine and cys-dopamine derived melanin.
Upon oxidation with alkaline hydrogen peroxide, DHI melanin resulted in PDCA and PTCA
Cysteinyl dopamine derived melanin (benzothiazole and benzothiazine subunit) upon oxidative
degradation generated TDCA and TTCA and upon reductive hydrolysis generated 4-amino-3hydroxyphenylethylamine (4-AHPEA). Comparison of the neuromelanin reductive degradation
products to synthetic melanin degradation products showed that neuromelanin contains nearly
6% of DOPA sidechain compared to dopamine sidechain indicating that neuromelanin is mostly
composed of dopamine derived melanins. Comparison of oxidative degradation products of
neuromelanin with that of synthetic melanin showed that ~25% of melanin content in
neuromelanin is cysteinyl dopamine derived in form of benzothiazine structure.36,46,47
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1.2.2 Sources and synthesis of Melanins:
1.2.2.1 Extraction:
Natural melanin can be extracted from bacterial, fungal, animals or humans (hair, brain tissue).
Method of extraction and purification depend on the source, but the commonality between the
methods is use of alkaline solutions (1 M NaOH or KOH) followed by autoclavation.7 Fungal
melanin can be extracted by incubation with 1 M NaOH at 60 °C followed by precipitation using
HCl. Precipitate is freeze-dried and resolubilized in alkaline solution where the above steps are
repeated several times to purify the melanin.48–51 Extraction of human hair melanin involves
washing with phosphate buffer and DTT (dithiothreitol), followed by incubation with proteinase
K enzyme which is used for keratin digestion as it breaks the peptide bond at carboxyl group
adjacent to alpha amino groups. Repeated treatment with proteinase K and successive washing
with buffer and DTT is utilized to purify human hair melanin.52
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Figure 1-14 (A-D)SEM images (scale bar-200 nm) of neuromelanin from A) putamen B)
premotor cortex C) cerebellum and D) substantia nigra. E) AFM of neuromelanin pigment from
premotor cortex (scale bar-100 nm). F) Wavelength dependent photoelectron emission
microscopy data. (Adapted from Zecca et al., 2008)53
However acid/base extraction changes the molecular structure of melanin by changing
concentration and distribution of metals coordinated to melanoids, as observed by morphology and
spectroscopy.13,51,54 Human neuromelanin is extracted from one of the following organelles:
substantia nigra, putamen, premotor cortex, and cerebellum. The process involves multiple steps
of gradient centrifugation. Figure 1-14 (A-D) shows morphology of the extracted melanins
visualized through electron microscope. Morphology and particle size of neuromelanin differ
based on the source. However, as seen in the plot F in Figure 1-14; of wavelength dependent UV
free electron laser photoelectron emission microscopy, all these melanins have common surface
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oxidation potential.53 This observation provides additional evidence indicating that the process of
melanogenesis involves synthesis of pheomelanins until cysteine is depleted, which forms the core.
Once cysteine is depleted, eumelanins form creating the outer shell of the neuromelanin resulting
in common surface oxidation potential among natural melanin samples.
1.2.2.2 Chemoenzymatic synthesis:
Synthetic melanins are obtained using tyrosinase enzyme to oxidize dopamine in order to get
eumelanin and dopamine in presence of cysteine in order to get pheomelanin as shown in Figure
1-15. Tyrosinase is extracted from plants (e.g. campanulatus) or mushrooms (e.g. Agaricus
Bisporus).10,52,55,56 For pheomelanin synthesis, DOPA or dopamine and cysteine are oxidized using
tyrosinase in sodium phosphate buffer as pheomelanin is precipitated by lowering the pH to 3-4
using acetic acid or hydrochloric acid.13,57

Figure 1-15 Chemoenzymatic synthesis of melanins.
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Eumelanin can be synthesized by following similar procedure without the presence of cysteine,
using DOPA, dopamine, DHI or DHICA, where enzymatic oxidation results in rapid deposition
of black-brown pigment: Eumelanin.34 Enzymes such as peroxidase with H2O2 can also be used
for controlled oligomerization of DHI and DHICA as studied by d’Ischia to synthesize dimers and
tetramers of DHI to study the mechanism behind oxidative polymerization.10,55,58 Horseradish
peroxidase can also be used to yield synthetic melanin from 5,6-dihydroxyindole substrate.59
1.2.2.3 Oxidative polymerization:
Oxidative polymerization or autooxidation of dopamine, DOPA, DHI or DHICA results in
formation of pheomelanin, eumelanin or neuromelanin.60–64 e.g. Melanin can be synthesized via
oxidative polymerization of dopamine hydrochloride in alkaline solution. Nanoparticles of
melanin were synthesized using dopamine hydrochloride through oxidation and selfpolymerization of dopamine in aqueous ammonia in ethanol at room temperature.65

Figure 1-16 Melanin (polydopamine) synthesis via oxidative polymerization (Adapted with
permission from Ju et al., 2011)88
Water-dispersible eumelanin nanoparticles were synthesized (Figure 1-16) by reaction of
dopamine hydrochloride in deionized water with sodium hydroxide, which produced a pale yellow
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basic solution at 50 °C and through spontaneous oxidation nanoparticles of melanin formed as the
color change to dark-brown was observed.66
1.2.2.4 Chemical synthesis of melanin subunits:
1.2.2.4.1 Synthesis of 5,6-dihydroxyindole carboxylate compounds:
Indoles are one of the most commonly studied nitrogen heterocycles, and several synthetic
pathways are available in literature. However, methods to synthesize 5,6-dihydroxyindole (DHI)
and 5,6-dihydroxyindole carboxylate (DHICA) are limited. Figure 1-17 shows commonly used
methods to synthesize 5,6-dimethoxyindole carboxylate (DMIC). Methyl/ethyl azidoacetate
sidechain condensation on aldehyde followed by thermal cyclization following Hemetsberger
indole synthesis is one of the first methods used to synthesize DMIC (Figure 1-17a).67,68

Figure 1-17 Methods to synthesize 5,6-dimethoxyindole carboxylate:(a) Hemetsberger indole
synthesis67 (b) Copper catalyzed domino coupling-cyclization69 (c) Horner-Wadsworth-Emmons
synthesis-Cadogan type cyclization.70
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Copper-catalyzed domino coupling followed by cyclization of aldehyde with isocyanoacetate
(Figure 1-17b) was used by Fang and coworkers to synthesize DMIC and its bromo derivatives in
order to investigate their agonist activity for GRP35 (a G protein coupled receptor involved in
pain, inflammation, cardiovascular diseases).69 Another method to synthesize DMICA was
proposed by Chai, Huleatt and co-workers, where Horner-Wadsworth-Emmons method was used
to more efficiently synthesize cinnamate sidechain from the corresponding nitroveratraldehyde
followed by Cadogen type cyclization. This method used excess of triphenylphosphine in toluene
under microwave conditions to achieve the DMICA product.70
1.2.2.4.2 Synthesis of Eumelanoid oligomers
Chemical synthesis of oligomeric dihydroxyindole (DHI), dihydroxyindole carboxylate
(DHICA), and benzothiazine have been pursued by melanin chemists in last 20 years.35,59,64,71,72
Chemical synthesis of these molecules would help understand complex biosynthesis of
melangenesis. In addition, these oligomers and polymers have shown to be significant in
developing bio-materials with applications in light-harvesting, bio-adhesion, and drug delivery.
One of the synthetic strategy to access 5,6-DHI dimers and trimers is shown in Figure 1-18 using
which dimers and trimers were synthesized from o-ethynylaniline derivatives.71,72 2,3’-biindolyl
and 2,7’-biindolyl were synthesized from 3-iodoindole derivative and 7-iodoindole derivatives
respectively using Pd catalysed Sonogashira coupling with o-ethynylaniline compound followed
by intramolecular cyclization. 2,2-biindolyl compound was synthesized from oxidative
dimerization followed by double concerted intramolecular cyclization of o-ethynylaniline
compound.71
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Figure 1-18 Strategy to synthesize biindolyls.71,72
This work was further extended by synthesizing trimers of 5,6-dihydroxyindoles using the same
strategy. After deprotection, the dimers and trimers compound matched minor intermediates
recovered during 5,6-dihydroxyindole polymerization to eumelanin.72

Figure 1-19 Suzuki coupling to conjugate indole to a 5,6-Dimethoxyindole carboxylate
(DMICA) compound73
Palladium catalyzed couplings are commonly used for indole compounds, however only a few
studies using Pd catalyzed couplings were found for 5,6-dihydroxyindole compounds.68,71,72,74,75
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Recently, palladium catalyzed Suzuki coupling was used to conjugate DMIC to simple indole
compounds in order to synthesize dimers and trimers of eumelanoid type small molecules.
Commercially available DMIC ethyl ester derivatives were mono and dibrominated, and
conjugated with borylated simple aromatic compounds in order to synthsize these derivatives.73
1.2.2.4.3 Synthesis of aminobenzothiazole and 1,4-benzothiazine:
Methods to synthesize benzothiazole include Hoffman method, Jacobson cyclization or oxidation
by bromine under acidic condition or copper/palladium catalyst.76 One of the first methods
utilized to synthesize aminobenzothiazole was to thiocyanate o-aminothiol followed by
cyclization.77 Thiocyanation using potassium thiocyanate or ammonium thiocyanate with
bromine followed by oxidative cyclization are common conditions in order to synthesize
benzothiazoles.76,78 A method to synthesize aminobenzothiazoles from arylthiourea under mild
conditions is by using benzyltrimethylammonium tribromide as bromine source.79

Figure 1-20 Methods for aminobenzothiazole and 1,4-benzothiazine synthesis.
25

Most commonly used method to synthesize benzothiazine compound is alkylate condensation of
dihalogenated alkylating reagent to ortho-aminothiol. ortho-halogenated thiol can also be used as
a substrate with halogenated primary amine alkylating reagent.80–82 Similar to alkylate
condensation, benzothiazine synthesis has also been doen by intramolecular cyclization with
ethylamine tethered to the ring with thioether linkage.83,84 This method is similar to the
conventional method to synthesize 1,4-benzothiazine from 5-S-cysteinyldopa using potassium
ferricyanide as catalyst.40 Cho and coworkers developed a ring expansion reaction of cyclic
ketones and ketoximes using DIBAL-H in order to access five to eight membered heterocycles
one of which was benzothiazine. Reaction proceeds through a reductive rearrangement of oximes
which provide cyclic secondary amines.85,86
1.2.2.4.4 Synthesis of pheomelanoid oligomers:

Figure 1-21 Synthesis of ∆2,2’-bibenzothiazine via oxidative coupling of 2-phenyl-1,4benzothiazine. 87
Trichochromes-present in red hair pigment are consisted of dimeric units of benzothiazines. A
strategy to synthesize ∆2,2’-bibenzothiazine from 3-phenyl-1,4-benzothiazine was done as shown
in Figure 1-21. Oxidative coupling of 3-pheyl-1,4-benothiazine was performed using hydrogen
peroxide in presence of oxygen under strong acidic condition (methanol:36%HCl-3:1). The
reaction goes through a 2,2’-bi(2H-1,4-benzothiazine) intermediate as indicated by DFT
calculations.87
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1.2.3 Properties of Melanins:
1.2.3.1 Physiochemical properties
Melanin pigments exhibit low solubility in water, most common organic solvents such as ethanol,
methanol, chloroform, acetone, benzene, hexane, diethyl ether. Synthetic and natural melanins are
soluble in alkaline solutions such as 1 M sodium or potassium hydroxide and can be precipitated
from alkaline solution at pH below 3 (commonly with 3 M HCl).7,49,61,88 Some common qualitative
chemical tests and extraction protocols are used to identify, extract and analyze melanins.
Precipitated melanin pigment can be decolorized/bleached by oxidizing agents such as KMnO4,
K2Cr2O7, H2O2 and NaClO or by reducing agents such as H2S and Na2S2O4.45,48,49,61,88–90 Melanins
give positive reaction to the polyphenol test as it produces colloidal brown precipitate with FeCl3,
and it produces gray precipitate with ammoniacal silver nitrate solution.7,48,61 Melanin pigment
exhibits high resistance to thermal degradation as observed in the thermogravimetric (TGA) and
derivative thermogravimetricanalysis (DTG).

Figure 1-22 DTG (dashed line) and TGA (solid line) of sepia ink melanin. (Adapted from
Praleaet al., 2019)7
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This analysis was done with synthetic (DOPA-melanin) and natural melanin (from fungal and
bacterial organisms) samples, of which data of melanin extracted from sepia ink has been shown
in Figure 1-22. The first endothermal peak around 71 °C is attributed to evaporation of bound
water. The exothermal peak at 306 °C is attributed to loss of carbon dioxide. Major thermal
decomposition of melanin occurs at a much higher temperature around 998 °C, due to
decarboxylation. It was observed that synthetic melanin are more resistant to decomposition than
natural melanin. Morphology and melanin particle size has been studied with Scanning Electron
Microscopy (SEM)91–100, Transmission Electron Microscopy (TEM)101–103, and Atomic Force
Microscopy (AFM)54,104–107 of synthetic and natural melanins. Elemental analysis is used to
identify and classify the subtype of melanins as the C:N:S, C:N, and S:N ratios differ between
pheomelanin, eumelanin and allomelanin.
1.2.3.2 Spectral and Photophysical properties
Structure of melanin contains highly conjugated network of phenol, benzothiazole,
benzothiazine, indole functionalities, and as a result, they exhibit high UV absorption. The UV
absorption range of melanin in alkaline solution is 196-300 nm and varies between synthetic and
natural melanins. Light absorption in visible region decreases as the wavelength increases. Plot
of logarithmic absorption of melanin with wavelength gives straight line with negative slope, and
is unique to the type of melanin.48,49 This method can be used to characterize and differentiate
between the types of melanins. An example of UV-Vis absorption spectra of synthetic (DOPA)
melanin and sepia melanin along with their logarithmic plots has been shown in Figure 1-23.
Both samples were dissolved in 0.1 M NaOH and sonicated, followed by spectral scan of 220800 nm wavelength range. Both the samples have absorption maxima at 220 nm and show strong
absorption in UV region (plot a). However they product unique absorption pattern as observed in
logarithmic plot (b) with different slopes.
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Figure 1-23 A) UV-vis absorption spectra of sepia ink melanin (blue) and synthetic melanin
(green), B) Linear plot of logarithmic absorbance vs wavelength. (Adapted from Pralea et al.,
2019)7
Spectral analysis of human melanin has been done through in-vitro (400-720 nm) and in-vivo
measurements (620-720 nm).108,109 Melanin quantity can be approximated by slope of the
absorption spectra from the in-vivo experiment results (Figure 1-23).109 Epidermal melanin and
neuromelanin exhibit similar broadband spectrum showing increasing absorbance at higher
energies.53,108–110 Spectral analysis is also useful in differentiating the types of melanin as they
exhibit different behaviors in-vitro and in-vivo. UVA induced absorption of pheomelanin and
eumelanin was studied in-vivo and in-vitro, which showed difference in spectra and dose
dependency on photo-oxidation.111
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Figure 1-24 IR absorption spectra of synthetic melanin and sepia ink melanin. (Adapted from
Pralea et al., 2019)7
Fourier-transform infrared spectroscopy is also used to identify melanin pigment. IR of melanin is
dependent on the source of the melanin and extraction process. An example spectrum of synthetic
melanin and melanin from sepia officinalis has been shown in Figure 1-24.The scan was done on
sample powder (synthetic or sepia) with KBR discs in the range of 400-4000 cm-1. The broad
absorption between 3000 and 3600 cm-1 is characteristic of -OH and -NH stretching vibrations as
melanin contains amine, amide, phenol, carboxylate and aromatic functionalities in indoles,
benzothiazole, benzothiazine core structures as well as different sidechains. C=C and C=O
stretches are observed between 1600-1750 cm-1. Characteristic melanin stretches however are
observed between 1400-1500 cm-1 that are attributed to bending of N-H and stretching modes of
secondary amine (C-N) of indoles, in addition to phenolic stretching between 1100-1150 cm-1.
49,112–114

In addition to UV-Vis and FTIR, NMR (1H and 13C) is also used to characterize melanin

pigments. Proton NMR showed peaks for aromatic hydrogens of phenyl, indole and pyrrole rings,
methylene groups (sidechain), and N-H of indoles, and carbon NMR showed characteristic peaks
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for carbonyl carbons in carboxyl, amide, and carbon atoms linked to heteroatoms such as nitrogen
and sulfur.115–117 Mass spectrometry techniques such as (electrospray ionization) ESI-MS, matrix
assisted laser desoption/ionization (MALDI), secondary ion mass spectrometry (SIMS), electron
impact (EI) have been used to characterize structures of synthetic and natural melanins.50,118,119
1.2.4 Significance and applications:
1.2.4.1 Biological significance:
Melanin has a protective role due to its ability to scatter photons, scavenge free-radicals, and
dissipation of absorbed photons in non-radiative manner.120 It is present in hair and skin in different
forms in humans, and is responsible for the color. Neuromelanin is a dark pigment, which
accumulates in brain primarily in substantia nigra and locus coerleus. Formation of neuromelanin
prevents accumulation of reactive quinones, which are generated from oxidation of catecholamine
neurotransmitters. In addition, it has ability to sequester and bind metal ions, which reduces the
metal toxicity. However, due to its affinity towards iron, it accumulates high level of iron (III) in
form of high-spin, pseudo-octahedral centers with oxo and hydroxo bridges at the binding sites
and its concentration can go up to 10 μg/mg of pigment.47,121,122
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Figure 1-25 MRI images of substantia nigra and locus coeruleus of healthy individual. (NM
present-white) and patient with PD (depleted NM). (Adapted from Isaias et al., 2016)123
This high accumulation of metals may be related to role of neuromelanin in neurodegenerative
diseases such as Parkinson’s Disease (PD). Substantia nigra and locus coeruleus are the most
affected areas in this disorder as shown in MRI of PD patient brain vs healthy brain in Figure
1-25.123 In the affected areas, accumulation and presence of neuromelnain has reduced
significantly in patients with PD whereas significant presence of neuromelanin can be seen in
healthy individual brain. Structural and redox properties of mixed melanin need to be studied in
order to further understand the structure and function of neuromelanin and its role in Parkinson’s
disease.
1.2.4.2 Materials applications:
Despite issues such as insolubility in organic solvents and certain material properties (amorphous
polymer), melanins have been of interest to material chemists due to its desired physiochemical
and photophysical properties.62 Melanins have photoconductivity (UV-Vis) and electrical
conductivity (AC and DC), and have confirmed to be a natural amorphous semiconductor due to
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its ability to do bistable electrical switching.124,125 These properties can be utilized in organic
electronics. Figure 1-26 describes applications (current and potential) of dopamine and
polydopamine derived melanins.62

Figure 1-26 Applications of DOPA and dopamine derived melanins. (Adapted with permission
from d’Ischia et al., 2014)62
Metal and drug binding properties of melanin can be utilized for water purification, and free radical
scavenging property of melanin has applications in polymer stabilization.126,127 UV and
photoprotective properties of melanin has applications in materials for UV screens, and its
adhesion properties can be used in surface coating and bio-adhesion.62,128 Recent applications of
polydopamine type melanin materials include biosensing, nano particle and nanocapsule
preparation for drug delivery, light harvesting and cell interfacing.62,66,125,129–135
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1.3
Viologens
Viologens are redox active, strong electron accepting diquaternary salts of 4,4’-bipyridine
(MV2+). Their photoreduction properties have been known for several years and their common
applications are as herbicides, photocleaving agents, electronic and electrochromic devices.136
Viologens (MV2+) can abstract an electron to generate radical cation (MV+), and if it two
electrons are abstracted it generates neutral species (MV). These species exhibit unique
electronic and photophysical properties.
1.3.1 Viologen Applications:

Figure 1-27 Viologen as (a) electron acceptor (b) electron donor (c) Donor-acceptor tandem.
(Adapted with permission from Kiriya et al., 2014 and Xu et al., 2014)137,138
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Viologens are good electron acceptors in their dicationic (MV2+) state. e.g. Paraquat is a widely
used herbicide which is a dichloride salt of 4,4-bipyridine. During photosynthesis, it abstracts an
electron from mitochondria generated by oxidation of NADH to NAD+. As a result, it oxidizes to
radical cation of paraquat (Figure 1-27a).139 This unstable species abstracts and electron from
oxygen (O2) generating reactive oxygen species (ROS) which leads to degradation of
mitochondria and other organelles. Electron donating property of viologens can be utilized in
conductors as shown in Figure 1-27b. Benzyl viologen (BV) can be used as dopant MoS2
transition metal dichalcogenide semiconductor to form air stable electron transfer complex. It
can also be used as surface dopant at metal junctions in electronic devices which reduces contact
resistance.137 As indicated in Figure 1-27c, triethanolamine (TEOA) donates an electron to the
Ir(III) complex. Photoexcitation of this electron leads to electron transfer to an electron relay
viologen-1,1-ethylene-2,2-bipyridyldiylium (DQ2+). Generated radical cation of this viologen
reduces the acceptor viologen-propyl viologen sulfonate (PVS) by electron transfer through
zeolite solution interface resulting in charge separation. This system works as an artificial
photosynthesis system.138

Figure 1-28 Electochromic switching in tri-cat viologen system. (Adapted with permission from
Sun et al., 2015- https://pubs.acs.org/doi/10.1021/jacs.5b09274, further permissions related to
the material excerpted should be directed to the ACS)140
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Viologens can be used in electrochromic molecular switches. e.g. Cyclobis(paraquatpphenylene) (CBPQT4+) ring can be switched among different units reversibly as shown in Figure
1-28.140 Each unit responds differently to external redox potentials, donating the electrons to the
viologen ring. Each of these oxidation states and bound-unbound states exhibit different colors.
These electrochromic properties can be utilized in electronic and optical devices.
1.3.2 Ion-Pair Charge Transfer (IPCT) complex:
Ion-Pair Charge Transfer (IPCT) metal-viologen complexes are made of dianionic transition
metals and dicationic methyl viologen. These structures exhibit photoinduced electron transfer
between the donor and the acceptor. IPCT complexes with metals such as Au, Ag, Sm, Eu, Fe
have been studied.137,141–145 With donors such as dicyanoaurate, transfer properties of IPCT can
be applied in photochromic and electrochromic devices. Phenyl-viologens such as DNP2+ have
shown desirable optical and electronic properties due to extended π conjugation.146 Their π-π
stacking interactions are being explored in chemistry and biology due to its effect on
photophysical properties of supramolecular complexes.
1.3.2.1 Au(CN)2-DNP viologen complex:
Dicyanoaurate (I) complexes are of interest as they form one of the most stable two-coordinate
complexes due to their high stability constant as well as potential applications in semiconductor
materials and photonic devices147,148. Dicyanoaurate(I) has unique geometric and charge-transfer
properties as d10 Au(I) metal center favors aurophilic interactions and aggregation of [Au(CN)2]n, which would allow tuning of the optical properties149,150 Due to their strong electron accepting
potential, viologens are fluorescence quenchers as they can quench triplet MLCT luminescence
in a complex with metals such as gold (I). {DNP-[Au(CN)2]2}.4H2O exhibit dual luminescence in
visible region as shown in temperature dependent excitation-emission spectra Figure 1-29.150
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DNP2+

Figure 1-29 Temperature dependent luminescence of DNP2+-[Au(CN)2]22-. (Adapted with
permission from Abouelwafa et al., 2012)150
Excitation at 355 nm results in gold-dimer broad emission at 580 nm.As the temperature
increases, the gold dicyanoaurate dimer luminescence (ex-355 nm) is quenched by DNP2+
cations. Oxidative electron transfer results in quenching of the excited state gold-dimer
luminescence at higher temperatures. Viologen luminescence (ex-410 nm) is not quenched at
higher temperatures as oxidation of ground state [Au(CN)2]- is not observed. These observations
have been shown in the energy diagram in Figure 1-30.150
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Figure 1-30 Energy diagram of the {DNP-[Au(CN)2]2} complex. (Adapted with permission
from Abouelwafa et al., 2012)150
At lower temperatures (10 K) fluorescence and phosphorenscence of excited state, ground state
gold-dicyanide, and phosphorescence of excited state DNP2+ are observed as confirmed by the
lifetimes measurements. At higher temperatures (>50 K), after intersystem crossing (ISC) from
singlet to excited state triplet state, luminescence of gold-dicyanide is quenched by the DNPviologen via electron transfer quenching. Findings of the photophysical study of this metalviologen complex indicated that low energy phosphorescence of [Au(CN)2]- and DNP despite
DNP being non-luminescent in its free state. This observation was attributed to heavy atom
effect due to gold resulting in gold-viologen orbital overlap.150
1.3.2.2 Ag(CN)2-DNP viologen complex:
It was observed that DNP, which is non-luminescent in its free state, exhibits phosphorescence
when coupled with dimeric gold-dicyanoaurate, the DNP viologen was complexed with
dicyanoargentate which is known form [Ag(CN)2-]n.146 As shown in Figure 1-31, excitation spectra
at 10 K and 78 K are similar(285 nm and 298 nm respectively). Emission of 412 nm was observed
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at 78 K with excitation at 265 K. Low energy excitation of DNP results in excited singlet state(S1)
of DNP2+ with radiationless decay to triplet excited state (T1) followed by intersystem crossing to
Ag(CN)2- lowest triplet excited state (T1). Phosphorescence is observed due to Ag(CN)2- emission
from T1 to S0. This emission band is high energy due to direct excitation of Ag(CN)2- resulting in
T1 to S0 emission via charge transfer transition.146

Figure 1-31 Luminescence of DNP2+-[Ag(CN)2]22-. (Adapted with permission from Ahern et al.,
2014)146
Luminescence of Ag-DNP complex is different from Au-DNP complex not only due to metal
identity, but due to lack of argentophilic interaction (Ag-Ag) as compared to aurophilic
interactions (Au-Au) observed in Au-DNP complex. Crystallographic analysis along with optical
data suggest that there is little to no interaction between DNP2+ cation and dicyanoargentate as
the excitation-emission spectra of metal-viologen complex is similar to spectra of KAg(CN)2.146
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1.3.3 Helicene viologen
Helicene compounds are nitrogen heterocycles which possess extended armoaticity, chirality,
solid state structures, and ability to form transition metal complexes which can be applied to
development of chemosensers, photovoltaics, and electrochromic devices.151 5,10diaza[5]helicene is one of the helicene compounds which exhbit helical chirality and partially
electron rich and poor molecular regions as indicated by electrostatic potential energy surface in
Figure 1-32.

Figure 1-32 Electrostatic potential energy surface and crystal motif of 5,10-diaza[5]helicene.
(Adapted with permission from Zhang et al., 2016)141
5,10-diaza[5]helicene viologen has C2 symmetry and shows π-π stacking due to extended
aromaticity in the crystal structure, however stacking is not sandwich like due to non-planar
topography as shown in Figure 1-32.141 It shows fluorescence at 504 nm and phosphorescence at
623 nm in its free state. DFT calculations indicate that it exhibits charge transfer character ( S0 to
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S1 electronic transition). This molecule when coupled with anionic metal donors could have
potential applications in electrochromic switches, molecular electronics and sensors.141
1.4
Thesis overview:
Enzymatic and chemical synthesis of melanin from dopamine, DOPA, cysteine, DHI and DHICA
has been widely studied. However, the nature and mechanism of oligomerization and
polymerization have been challenging. Eumelanin has been widely studied ranging from
dimerization, oligomerization (through enzymatic process) to oxidative polymerization involving
development of materials for applications, pheomelanin and its oligomerization mechanisms still
need to be explored. Access to monomeric units of pheomelanin would help bridge this gap. In
addition, it will provide an opportunity for controlled oligomerization using different types of
monomeric units including synthesis of mixed melanoids.
Melanin-based materials have been developed through empirical approaches rather than structureactivity relationships.94 These developments are based on simple eumelanin monomers such as
polydopamine. Due to difficulties in synthesis and properties of pheomelanin, such as
benzothiazine and benzothiazole there is a lack of knowledge in bottom-up synthesis of these
compounds. In addition, materials research related to melanin other than eumelanin is limited. This
research work discusses regioselective synthesis and modification of eumelanoids (eumelanin
monomeric units). Chemical synthesis of pheomelanoids (pheomelanin monomeric units)
benzothiazole

and

benzothiazine

was

accomplished

from

ortho-methoxyaniline

(via

thiocyanation) and o-aminothiol (via alkylate condensation) respectively. Following the synthesis
of monomeric melanoids, mixed melanoids (conjugates of eumelanoid and pheomelanoid) were
synthesized via Miyaura borylation and Suzuki coupling. These melanoids may have applications
in biomaterials, organic electronics, nanomedicine, bioadhesion, and photoprotection. In addition,
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preliminary UV-Vis and Fluorescence spectroscopy analysis of the mixed melanoids material were
performed in order to understand its photophysical properties.

Figure 1-33 Overview of the thesis.
DNP-viologen does not exhibit luminescence in its free state, however when complexed with
gold-dicyanoarate it exhbits phosphorescence due to orbital overlap with dicyanoaurate dimer.
Helicine viologen exhibits luminescence in its free state. In addition it is able to form 2D solidstate architectures due to π-π stacking interactions. These propeties can be harvested by coupling
this ligand with an anionic metal salt. It would be interesting to study the photophysical
properties of a helicene viologen when coupled with dicyanoaurate. As shown in Figure 1-33,
helicene viologen was synthesized from bromoquinoline starting material. This was
accomplished by Pd catalyzed stille coupling or Hiyama-Heck coupling of bromoquinoline,
followed by photocyclization of the resulting stillbene. Product of photocyclization was
methylated and coupled with gold-dicyanoaurate in order to yield the Gold-heli viologen. Crystal
structure of gold-heli viologen was determined and the photophysical properties were studied
and reported.
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2

SYNTHESIS, AND PHOTOPHYSICAL STUDIES OF REGIOSELECTIVELY
FUNCTIONALIZED EUMELANOIDS
2.1
Introduction
Eumelanin is an insoluble black-brown polymeric pigment which is derived from DHI (5,6dihydroxyindole) and DHICA (5,6-dihydroxyindolecarboxylic acid). These polymers possess UV
and photoprotective properties, free radical scavenging, and adhesion; and have applications in
polymer stabilization, photoprotection, organic electronics, biosensing, nanomaterial drug
delivery, and bioadhesion.62,124,133–135,152–154,125–132 In addition, eumelanin has biological
significance due to its presence in human skin, hair and brain. Eumelanin can be synthesized
chemoenzymatically, via oxidative polymerization from monomeric DHI or DHICA units.
Intermediates of DHI and DHICA polymerization are an area of interest due to their structure and
properties. Chemical synthesis of subunits of eumelanin biopolymer has been explored in
literature.67–70,73 5,6-dimethoxyindole carboxylate (DMIC) and its 3’-bromo derivative were
synthesized using Hemetsberger-Knittel indole synthesis.67 Huleatt et al. described synthetic
strategies to access a small library functionalized DHI and DHICA derivatives via expedient routes
using similar methods.68 A more efficient assembly of these functionalized derivatives was done
which involved Cadogen indole synthesis using ortho-nitroveratraldehyde derivatives.70 DHICA
derivatives were synthesized using copper catalyzed domino four component coupling and
cyclization in order to study their GPR35 agonist activity (GPR35- A G-protein coupled receptor
involved in inflammation, pain, metabolic disorders).69
The focus of this research was chemical synthesis of small DMIC eumelanoids and their
regioselective functionalization to utilize these functionalized derivatives for mixed melanoid
synthesis via Miyaura-Suzuki coupling with pheomelanoid subunits (Chapter-3). Figure 2-1 shows
the desired DMIC derivatives functionalized with bromine. Despite Cadogen type indole synthesis
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considered more efficient, Hemetsberger indole synthesis was utilized for this work, as the
Cadogen synthesis requires access to nitroveratraldehydes involving an extra synthetic step, and it
uses a molybdenum catalyst for cyclization, which is not easily accessible. In addition, variety of
reaction conditions are required for cyclization step for different substrates.70

Figure 2-1 Targeted 5,6-dimethoxyindole carboxylate (DMIC) derivatives.
Research goal of this project included synthesis of monomeric 5,6-dimethoxyindole carboxylate
(DMIC) from simple starting material like vanillin or isovanillin. Targeted DMIC derivatives were
a) mono-brominated derivatives-3’-bromo, 4’-bromo and 7’-bromo DMIC; b) dibrminated 3,4’dibromo, 3,7’-dibromo and 4,7’-dibromo DMIC; and c) 3,4,7’-tribromo DMIC. Synthesis of
brominated variants have been explored, however synthesis of multibrominated eumelanoids and
synthesis and stability of brominated DHICA has not been studied. Following the synthesis of the
desired regioselectrively brominated DMIC derivatives, deprotection was done on monobrominated compounds to establish deprotection procedures and synthesize deprotected natural
analogues of DHICA (5,6-dihydroxyindole carboxylic acid).
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2.2
Results and discussion
Expedient pathway suggested by Huleatt et al. was followed for this work for synthesis of monobrominated eumelanoids.18 Regioselective bromination was done at different steps in the
sequence to get brominated indole products at 3’, 4’ and 7’ positions. These bromo DMIC
eumelanoids were synthesized from simple starting material like vanillin or isovanillin.
Experiment procedures were altered and optimized in order to fill the gap in experimental
methods, results and characterization data.

Scheme 2-1 Synthesis of 4’-bromo DMIC (2-8) from isovanillin.
Synthesis of 4’-bromo DHICA has been shown in Scheme 2-1. Isovanillin was brominated using
N-bromosuccinimide (NBS) to get the bromination at the 4’-position of the final indole
compound. Recrystallized product was methylated using methyl iodide and purified with silica
gel flash chromatography. In the following step, methyl azidoacetate was condensed on the
sidechain aldehyde using sodium methoxide (1M in methanol) as base.
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Figure 2-2 Mechanism of methyl azidoacetate condensation over sidechain aldehyde.
This reaction follows Knoevenagel condensation type mechanism as shown in Figure 2-2. Sodium
methoxide activates α-carbon of methylazioacetate, which attacks the electrophilic carbonyl
carbon. Mechanism proceeds via several proton transfer steps, and deprotonation and dehydration
of the final intermediate results in formation of α-azido β-arylacrylate as the condensation
product.155 Condensation product was purified by silica gel flash chromatography and
characterized by NMR as well as IR. As observed in Figure 2-3, the condensation product’s
infrared spectrum shows a strong asymmetric stretch at 2124 cm-1 and symmetric stretch around
1250 cm-1, which are characteristic stretching modes of azides.
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Azide
(N3)

Figure 2-3 Infrared spectrum of azidoacetate condensation product.
The final step to synthesize the 4’-bromo DMICA was cyclization via nitrene insertion. Azide
activation is required to create highly electrophilic nitrene intermediate, which would insert into
the aromatic ring resulting in cyclization and indole formation, which could be a light or heat
induced process. Cyclization via Hemetsberger indole synthesis was utilized as heat was used to
generate nitrene.156–158 A tentative reaction mechanism is described in Figure 2-4. Due to heat
nitrogen is evolved as nitrene is generated. Nitrene forms an unstable tricyclic intermediate with
the neighboring unsaturated carbons. Due to low ring stability electrons of the aromatic phenyl
ring opens the tricyclic intermediate as the phenyl ring is dearomatized and nitrogen attaches to
the electrophilic position at the ring.
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Figure 2-4 Mechanism of cyclization via nitrene insertion.
In alternate mechanism, 1,3-dipolar cycloaddition occurs creating the same intermediate.157 This
final intermediate undergoes [1,5]-H shift to generate the desired indole product. Overall yield of
4’-bromo DMIC (2-8) was 54% over four steps. As described in Scheme 2-2, 7’-bromo DMIC (212) and 3’-bromo DMIC (2-4) can be synthesized from vanillin. Similar reaction conditions,
purification and analytical techniques were used as 4’-bromo DMIC(2-8) synthesis (Scheme 2-1).
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Scheme 2-2 Synthesis of 3’-bromo DMIC and 7’-bromo DMIC. Bromination- NBS, DCM, RT,
8 hrs; Methylation-MeI, K2CO3, Acetone, 60 °C, 12 hrs; Sidechain condensation- Methyl
azidoacetate, NaOMe, MeOH, -15 °C-RT, 18 hrs; Nitrene insertion-Toluene, 110 °C, 24 hrs
3’-bromo DMIC (2-4) was synthesized in four steps by the following reaction sequencemethylation (compound 2-1), sidechain condensation (compound 2-2), nitrene insertion
(compound 2-3) and bromination of vanillin. The overall yield of 3’-bromo DHICA (2-4) from
vanillin was 48% in four steps. Bromination of vanillin results in selective bromination at orthoposition to the phenolic OH.

Figure 2-5 7’-bromo DMIC (2-12) synthesis via Hemetsberger-Knittel indole cyclization.
7’-bromo DMIC (2-12) was synthesized from bromination product (2-9) by methylation
(compound 2-10), sidechain condensation (compound 2-11) and nitrene insertion. The overall
yield for 7’-bromo DMIC (2-12) with the above synthetic sequence from vanillin was ~31%.
Overall yield was lower due to the nitrene insertion step, where significant amount of side product
was recovered (Figure 2-5), which required prep-HPLC purification in addition to silica gel
purification.
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Figure 2-6 Synthesis of 3,4’-dibromo DMIC (2-14) and 3,7’-dibromo DMIC (2-15).
Once monobrominated compounds were accessed, different combinations of brominationselective debromination were utilized to synthesize di and tri-brominated DMIC derivatives.
Figure 2-6 describes synthetic methods to synthesize 3,4’-dibromo (2-14) and 3,7’-dibromo DMIC
(2-15) from 4’-bromo DMIC (2-8) and DMIC (2-3) respectively. Using stoichiometric amount of
N-bromosuccinimide (NBS) to brominate 4’-bromo DMIC (2-8) results in selective bromination
at 3’-position resulting in 3,4’-dibromo DMIC (2-14). 3,7’-dibromo DMIC was synthesized by
controlled double bromination of DMIC with NBS(4 eq.) by heating it at 65 °C for 3 hours. Limited
generation of tribromo DMIC was observed. However, if this reaction is ran for 24 hours at 65
°C, it generates 3,4,7’-tribromo DMIC (2-16), which was recovered in 80% yield as shown in
Figure 2-7.

Figure 2-7 Synthesis of 4,7’-dibromo DMIC (2-17) and 3,4,7’-tribromo DMIC (2-16).
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This tribromo derivative (2-16) undergoes regioselective debromination of 3’-bromo under acidic
conditions in presence of lithium bromide and m-dimethoxybenzene (used as a trapping agent) to
generate 4’, 7’-dibromo eumelanoid compound (methyl 4,7-dibromo-5,6-dimethoxy-1H-indole-2carboxylate).9,10 Reaction was monitored with HPLC and TLC.

Figure 2-8 Analytical HPLC chromatogram of regioselective debromination reaction.
Figure 2-8 shows analytical HPLC (C-18) chromatogram of reaction mixture at 75 minutes into
the reaction where most of the SM has been consumed (retention time-6.08 minutes) and mdimethoxybenzene is present at 3.21 minutes. Products were purified with prep-reverse phase
chromatography and fractions were analyzed with NMR. Desired 4’-7’-dibromo product is the
major trace in the chromatogram at 5.46 minutes. The small traces could be impurities such as
brominated m-dimethoxybenzene.
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Figure 2-9 Mechanism of regioselective debromination of tribromo eumelanoid.
Mechanism of regioselective 3’-debromination is shown in Figure 2-9. Protonation occurs at C3
position resulting in the carbocation intermediate, which is attacked by bromide resulting in
bromine and the desired 4’,7’-dibromo DMIC (2-17). However, this compound can re-brominate
in presence of bromine resulting in the tribromo starting material, which is thermodynamically
more stable.73,159 In order to prevent this, o-methoxybenzene was added as a trapping agent, which
is more nucleophilic than the indole. It reacts with bromine and brominates resulting in bromine
trapping, and as a result 4’,7’-bromo DMIC is recovered as the major product after purification.
Monobrominated DMIC synthetic eumelanoids were deprotected in order to get the natural
analogues of DHICA eumelanoids. Deprotection was done by saponification of respective
monobrominated DMICA by lithium or sodium hydroxide followed by demethylation of methoxy
protecting groups by boron tribromide.
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Figure 2-10 Synthesis of mono-brominated 5,6-dihydroxyindole carboxylic acid (DHICA)- A)
NaOH (5 eq.), ethanol:water(1:1), RT, B) BBr3, DCM, -78 °C-RT, C) LiOH, ethanol:water (1:1),
RT
As shown in Figure 2-10, DHICA and its three-monobrominated derivatives were synthesized by
deprotection of respective DMIC derivatives. DHICA (2-19) was synthesized by saponification
of DMIC with sodium hydroxide followed by demethylation. Following similar conditions, 3’bromo, 4’-bromo and 7’-bromo DMIC were deprotected by saponification with lithium
hydroxide and demethylation with boron tribromide. Final products were purified by prepHPLC. These deprotections were done in order to access DHICA and mono-brominated
derivatives of this natural eumelanin subunit.
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Figure 2-11 UV-Vis spectra of 4’-bromo DMIC (2-8) and 4’-bromo DHICA (2-21).
UV-Vis absorption properties of protected (DMIC) and deprotected (DHICA) monomeric
eumelanoids were studied. As shown in Figure 2-11 λmax of the protected derivative 4’-bromo
DMIC (2-8) and the deprotected derivative 4’-bromo DHICA (2-21) are 320 nm and 325 nm
respectively. Despite this similar UV-absorption behavior, 2-21 exhibits broad absorption (with
exponential fit) compared to 2-8 from ~400-650 nm in the visible region. This behavior is due to
aggregation of 4’-bromo DHICA molecules and is similar to broad band absorption observed in
synthetic eumelanin (derived from non-enzymatic oxidation of DOPA) UV-Vis spectrum where
no chromophore is present.160,161
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Figure 2-12 UV-Vis absorption spectra of 5,6-dihydroxyindole (DHICA) and its bromo
derivatives.
After deprotection of Methyl-5,6-dimethoxyindole carboxylate (DMIC) and its monobrominated
derivatives, UV-Vis spectra of DHICA (2-19), 3’-bromo DHICA (2-23), 4’-bromo DHICA (221), and 7'-bromo DHICA (2-25) were recorded. In literature DHICA has been shown to absorb
in UV region at ~330 nm and it generates violet chromophore as a result of non-enzymatic
oxidation in which shows a broad absorption band in visible 500-550 nm.162 Similar to the
literature, Figure 2-12 shows absorption at 330 nm followed by a broad absorption band around
550 nm indicating aggregation of DHICA molecules. Interestingly, the mono-brominated
DHICA derivatives show absorption at 320 nm in UV region with low intensity broad
absorbance in the visible region. However, the absence of absorption band at 550 nm indicates
inhibition of oxidation in brominated DHICA compounds as the chromophore are not generated.
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Figure 2-13 UV-Vis spectra of DHICA (2-19) and 4’-bromo DHICA (2-21) at t=5 mins, 1 hr,
and 24 hrs.
As shown in Figure 2-13, at 5 mins and 1 hour, the absorbance of 5,6-DHICA does not show
significant change with ~330 nm λmax and absorption ~550 nm due to chromophore generation
due to oxidation of DHICA. UV-Vis of 2-19 at 24 hours show the broaderning of the
chromophore absorbance and scattering due to precipitation which could also be visibly observed
by darkening solution with precipitates present. 4’-bromo DHICA showed similar absorbance
behaviour at 5 minutes, 1 hour and 24 hours with maximum absorbance at 320 nm and weak
broad absorbance attributed to slow aggregation of 4’-bromo DHICA molecules. This solution
was observed to darken very little over the course of 24 hours and showed no precipitation. This
indicates that chromophore generation resulting from DHICA oxidation is may be slow as seen
by lack of absorption peak ~550 nm.
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2.3
Conclusions
Methyl-5,6-dimethoxyindole carboxylate (DMIC) and its regioselectively functionalized
derivatives were synthesized using Hemetsberger-Knittel indole synthesis. Indole synthesis was
done from vanillin or isovanillin by using bromination, methylation, sidechain condensation of
azidoacetate, and nitrene insertion in different orders to access DMIC, 3’-bromo DMIC, 4’bromo DMIC, and 7’-bromo DMIC. These DMIC derivatives were further brominated to access
di and tribromo DMIC derivatives. 4’-bromo DMIC was further brominated to access 3,4’dibromo DMIC. Controlled bromination of DMIC resulted in formation of 3,7’-dibromo DMIC.
Bromination of DMIC with excess NBS was done to synthesize 3,4,7’-tribromo DMIC.
Regioselective debromiation of tribromo DMIC resulted in selective 3’-debromination forming
4,7’-dibromo DMIC. DHICA and Mono-brominated DHICA were synthesized from respective
DMIC derivatives. Deprotection of DMIC, 3’-bromo DMIC, 4’-bromo DMIC, and 7’-bromo
DMIC resulted in formation of DHICA, 3’-bromo-DHICA, 4-bromo DHICA, and 7’-bromo
DHICA respectively. UV-Vis spectra of DHICA and its mono-brominated derivatives indicated
that bromination slows down aggregation and chromophore generation via oxidation of DHICA
molecules as indicated by absence of broad absorption band at 550 nm.
2.4
Synthesis
2.4.1 General information
All reagents were purchased from Sigma-Aldrich and Fisher Scientific and used directly without
further purification. Solvents were dried with activated 4 Å molecular sieves or anhydrous solvents
were dispensed from Solvent system. Reactions were monitored by TLC or analytical HPLC. TLC
analysis was performed with silica gel 60 and visualized with UV light (254 nm and 365 nm). All
products were purified with silica-gel flash chromatography or preparative HPLC. Silica gel flash
chromatography was performed with SiliaFlash® F60 (Silicycle, 40-60 μm). HPLC was
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performed on a Gilson® and Agilent® analytical and Gilson® semi-preparative system with UVVis spectrophotometer, using Kinetex 5 µm EVO C18 100Å 4.6 x 150 mm for analytical and
Kinetex 5 µm EVO C18 100Å 21.1 x 150 mm for preparative purpose. Products were characterized
by 1H and

13

C NMR and mass spectrometry. NMR characterization results and J values were

compared with published results. 1H and 13C NMR spectra were recorded on Agilent/Varian 400
MHz or Bruker Neo 500 MHz and 101 MHz NMR spectrometer respectively. 1H NMR
multiplicities are defined as ‘s’-singlet, ‘d’-doublet, ‘t’-triplet, ‘dd’-doublet of doublets, and ‘m’multiplet. ~1 mg of dried sample was sent out to University of Illinois Mass Spectrometry lab
where Mass spectra were recorded using a Synapt G2 Q-TOF ESI mass spectrometer. UV-Vis
absorption spectra were recorded on the SpectraMax i3x multi-mode detection device.
Abbreviations:

TLC-Thin

layer

chromatography,

HPLC-High

Performance

Liquid

Chromatography, NMR-Nuclear Magnetic Resonance, Q-TOF-Quadrupole time of flight, ESIElectrospray ionization
2.4.2 Synthesis of DMIC(2-3) and 3’-bromo DMIC (2-4)
3,4-dimethoxybenzaldehyde (2-1)

To a stirred solution of vanillin (600 mg, 3.94 mmol) in acetone (15 mL) in a scintillation vial was
added potassium carbonate (1.089 g, 7.88 mmol, 2.0 eq.) followed by addition of methyl iodide
(1.399 g, 9.85 mmol, 2.5 eq.) at RT. The mixture was heated at 60 °C for 12 hrs. The mixture was
cooled to RT and solvent was evaporated under reduced pressure. The crude product was dissolved
in ethyl acetate (100 mL) and washed with water, brine and dried over sodium sulfate. The crude
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product was purified with silica gel flash chromatography (30%:70% EtOAc:Hexanes). Product
was confirmed with 1H NMR. Yield: 583 mg, 89% 1H NMR (400 MHz, CDCl3) δ 9.85 (s, 1H),
7.46 (dd, 1H, J = 2.0 Hz, 8.0 Hz), 7.41 (d, 1H, J = 1.6 Hz), 6.98 (d, 1H, J = 8.0 Hz), 3.97 (s, 3H),
3.95 (s, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 191.05, 154.66, 149.80, 130.31, 127.02, 110.54,
109.11, 56.33, 56.17 ppm. Spectral data matched with those in literature.163
Methyl (Z)-2-azido-3-(3,4-dimethoxyphenyl)acrylate (2-2)

To a solution of 3,4-dimethoxybenzaldehyde (250 mg, 1.5 mmol), and methyl 2-azidoacetate (693
mg, 6 mmol, 4 eq.) in methanol (0.5 mL) was added sodium Methoxide (1M in methanol, 4.25
mL, 2.5 eq.) at -15 °C. The mixture was stirred at -15 °C for 2 hours and RT for 18 hrs. TLC
confirmed the consumption of benzaldehyde and formation of the product. The mixture was
washed with water (25 mL) and extracted with diethyl ether (3x25 mL). Combined organic layers
were washed with brine and dried over sodium sulfate. Solvent was evaporated and crude was
purified with silica gel (10:90 EtOAc:Hex). 328 mg, 83% Yield 1H NMR (400 MHz, CDCl3) δ
7.51 (d, 1H, J = 2.0 Hz), 7.34 (dd, 1H, J = 2.0 Hz, 8.8 Hz), 6.88 (s, 1H), 6.87 (d, 1H, J = 8.8 Hz),
3.92 (s, 3H), 3.91 (s, 3H), 3.90 (s, 3H) ppm.

13C

NMR (125 MHz, CDCl3) δ 164.37, `150.42,

148.75, 126.37, 126.03, 125.06, 123.36, 113.13, 110.90, 56.08, 56.06, 52.94 ppm. Spectral data
matched with those in literature.164
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Methyl 5,6-dimethoxy-1H-indole-2-carboxylate (DMIC) (2-3)

3,4-dimethoxy7-ene azidoacetate (150 mg, 0.57 mmol) was dissolved in toluene (5 mL). The vial
was capped with teflon heat resistant cap and tape, and refluxed for 24 hours. Crude was purified
with p rep-HPLC. Solvent was evaporated under reduced pressure yielding the desired product.
Yield-94 mg, 71% 1H NMR (400 MHz, CDCl3) δ 8.88 (N-H), 7.11 (d, 1H, J=2.4 Hz), 7.04 (s,
1H), 6.85 (s, 1H), 3.93 (s, 3H), 3.92 (s, 6H), ppm. 13C NMR (125 MHz, CDCl3) δ 162.22, 150.17,
146.25, 132.00, 125.63, 120.47, 108.84, 102.59, 93.74, 56.16, 51.78 ppm. Spectral data matched
with those in literature.165
Methyl 3-bromo-5,6-dimethoxy-1H-indole-2-carboxylate (2-4)

To a scintillation vial equipped with a stir bar was added Methyl 5,6-dimethoxy-1H-indole-2carboxylate (86 mg, 0.37 mmol), followed by addition of methylene chloride (1.5 mL), Nbromosuccinimide (66 mg, 0.37 mmol, 1 eq.) at RT. The mixture was stirred at RT for 3 hrs.
Yellow precipitate were filtered and dried to get Methyl 3-bromo-5,6-dimethoxy-1H-indole-2carboxylate. Yield- 106 mg, 92%. 1H NMR (400 MHz, CDCl3) δ 8.91 (N-H), 6.97 (s, 1H), 6.81
(s, 1H), 3.97 (s, 3H), 3.97 (s, 3H), 3.94 (s, 3H) ppm.

13C

NMR (125 MHz, CDCl3) δ 161.43,

151.30, 147.15, 130.50, 122.48, 121.34, 101.05, 98.27, 93.79, 56.35, 56.34, 52.11 ppm. Spectral
data matched with those in literature.70
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2.4.3 Synthesis of 4’-bromo DMIC (2-8)
2-bromo-3-hydroxy-4-methoxybenzaldehyde (2-5)

To a scintillation vial equipped with a stir bar was added 3-hydroxy 4-methoxybenzaldehyde/
isovanillin (500 mg, 3.29 mmol), followed by addition of methylene chloride (8 mL), Nbromosuccinimide (585 mg, 3.29 mmol, 1 eq.) at RT. The mixture was stirred at RT for 8 hrs.
Solvent was evaporated under reduced pressure and product was recrystallized with hot ethanol
(15 mL). Solid product was filtered. Yield- 688 mg, 91%. Product was confirmed with 1H NMR.
1H

NMR (400 MHz, CDCl3) δ 10.25 (s, 1H), 7.56 (d, 1H, J = 8.4 Hz), 6.91 (d, 1H, J = 8.4 Hz),

6.11 (s, 1H), 4.00 (s, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 191.02, 151.85, 143.38, 127.44,
122.91, 113.03, 109.44, 56.75 ppm. Spectral data matched with those in literature.166
2-bromo-3,4-dimethoxybenzaldehyde (2-6)

To a stirred solution of 2-bromo 3-hydroxy 4-methoxybenzaldehyde (200 mg, 0.87 mmol) in
acetone (5 mL) in a scintillation vial was added potassium carbonate (240 mg, 1.74 mmol, 2.0 eq.)
followed by addition of methyl iodide (492 mg, 3.46 mmol, 4.0 eq.) at RT. The mixture was heated
at 60 °C for 16 hrs. The mixture was cooled to RT and solvent was evaporated under reduced
pressure. The crude product was dissolved in ethyl acetate (40 mL), washed with water, brine, and
dried over sodium sulfate. The crude product was purified with silica gel flash chromatography
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(30%:70% EtOAc:Hexanes). Product was confirmed with 1H NMR. Yield: 178 mg, 84% 1H NMR
(400 MHz, CDCl3) δ 10.24 (s, 1H), 7.73 (d, 1H, J = 8.8 Hz), 6.95 (d, 1H, J = 8.4 Hz), 3.95 (s,
3H), 3.87 (s, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 191.12, 158.81, 146.54, 127.54, 126.65,
123.29, 111.08, 60.82, 56.46 ppm. Spectral data matched with those in literature.167
Methyl (Z)-2-azido-3-(2-bromo-3,4-dimethoxyphenyl)acrylate (2-7)

To a solution of 2-bromo 3,4-dimethoxy benzaldehyde (100 mg, 0.41 mmol), and methyl 2azidoacetate (188 mg, 1.63 mmol, 4 eq.) in methanol (0.5 mL) was added sodium Methoxide (1M
in methanol, 1 mL, 2.5 eq.) at -15 °C. The mixture was stirred at -15 °C for 2 hours and RT for 18
hrs. TLC confirmed the consumption of benzaldehyde and formation of the product. The mixture
was washed with water (20 mL) and extracted with diethyl ether (3x20 mL). The combined organic
layers were washed with brine and dried over sodium sulfate. Solvent was evaporated and crude
was purified with silica gel (10:90 EtOAc:Hex). Yield-106 mg, 76% Yield 1H NMR (400 MHz,
CDCl3) δ 7.96 (d, 1H, J = 8.8 Hz), 7.28 (s, 1H), 6.90 (d, 1H, J = 8.8 Hz), 3.93 (s, 3H), 3.92 (s,
3H), 3.85 (s, 3H) ppm.

13C

NMR (125 MHz, CDCl3) δ 164.13, 154.29, 146.79, 127.16, 126.27,

125.73, 123.98, 121.70, 119.89, 60.59, 52.73, 50.45 ppm. Spectral data matched with those in
literature.70
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Methyl 4-bromo-5,6-dimethoxy-1H-indole-2-carboxylate (2-8)

5-bromo 3,4-dimethoxy7-ene azidoacetate (116 mg, 0.34 mmol) was dissolved in toluene (3 mL).
The vial was capped with teflon heat resistant cap and tape, and refluxed for 24 hours. Solvent was
evaporated under reduced pressure yielding the desired product. Yield-98 mg, 93% 1H NMR (400
MHz, CDCl3) δ 8.89 (N-H), 7.19 (s, 1H), 6.82 (s, 1H), 3.94 (s, 3H), 3.92 (s, 3H), 3.87 (s, 3H)
ppm.

13C

NMR (125 MHz, CDCl3) δ 162.22, 153.65, 143.35, 133.45, 126.48, 122.52, 110.44,

109.65, 93.72, 61.15, 56.38, 52.13 ppm. Spectral data matched with those in literature.70
2.4.4 Synthesis of 7’-bromo DMIC (2-12)
3-bromo-4-hydroxy-5-methoxybenzaldehyde (2-9)

In a scintillation vial equipped with a stir bar to a solution of 4-hydroxy 3-methoxybenzaldehyde/
vanillin (500 mg, 3.29 mmol) in acetic acid (11 mL), was added bromine (578 mg, 3.61 mmol, 1.1
eq.) dropwise at RT. The mixture was stirred at RT for 5 hrs. The mixture was poured into icewater resulting in product precipitation. Solid product was filtered and dried under vacuum. Yield677 mg, 89%. 1H NMR (400 MHz, CDCl3) δ 9.79 (s, 1H), 7.64 (d, 1H, J = 2.0Hz), 7.36 (d, 1H,
J = 1.6 Hz), 6.49 (s, 1H), 3.99 (s, 3H) ppm.

13C

NMR (125 MHz, CDCl3) δ 189.79, 149.03,

147.83, 130.24, 130.21, 108.34, 108.18, 56.77 ppm. Spectral data matched with those in
literature.168
63

3-bromo-4,5-dimethoxybenzaldehyde (2-10)

To a stirred solution of 3-bromo-4-hydroxy-5-methoxybenzaldehyde (523 mg, 2.26 mmol) in
acetone (15 mL) in a scintillation vial was added potassium carbonate (626 mg, 4.53 mmol, 2.0
eq.) followed by addition of methyl iodide (1.287 g, 9.06 mmol, 4.0 eq.) at RT. The reaction
mixture was heated at 60 °C for 16 hrs. The mixture was cooled to RT and solvent was evaporated
under reduced pressure. The crude product was dissolved in ethyl acetate (120 mL) and washed
with water, brine and dried over sodium sulfate. The crude product was purified with silica gel
flash chromatography (30%:70% EtOAc:Hexanes)and confirmed with 1H NMR. Yield:439 mg,
79% 1H NMR (400 MHz, CDCl3) δ 9.85 (s, 1H), 7.65 (d, 1H, J = 1.6 Hz), 7.39 (d, 1H, J = 1.6
Hz), 3.95 (s, 3H), 3.94 (s, 3H) ppm.

13C

NMR (125 MHz, CDCl3) δ 190.03, 154.35, 151.97,

133.20, 128.95, 118.09, 110.22, 60.99, 56.40 ppm. Spectral data matched with those in
literature.169
Methyl (Z)-2-azido-3-(3-bromo-4,5-dimethoxyphenyl)acrylate (2-11)

To a solution of 3-bromo-4,5-dimethoxybenzaldehyde (150 mg, 0.61 mmol), and methyl 2azidoacetate (282 mg, 2.45 mmol, 4 eq.) in methanol (0.5 mL) was added sodium methoxide (1M
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in methanol, 1.5 mL, 2.5 eq.) at -15 °C. The mixture was stirred at -15 °C for 2 hours and RT for
18 hrs. TLC confirmed the consumption of benzaldehyde and formation of the product. The
mixture was washed with water (25 mL) and extracted with diethyl ether (3x25 mL). The combined
organic layers were washed with brine and dried over sodium sulfate. Solvent was evaporated and
crude was purified with silica gel (10:90 EtOAc:Hex). Yield- 154 mg, 74% Yield 1H NMR (400
MHz, CDCl3) δ 7.58 (d, 1H, J = 2.0 Hz), 7.39 (d, 1H, J = 1.6 Hz), 6.76 (s, 1H), 3.91 (s, 3H), 3.90
(s, 3H), 3.89 (s, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 163.93, 153.40, 147.53, 127.65, 125.67,
123.81, 117.68, 113.71, 60.88, 56.33, 53.15 ppm. Spectral data matched with those in literature.70
Methyl 7-bromo-5,6-dimethoxy-1H-indole-2-carboxylate (2-12)

Methyl(Z)-2-azido-3-(3-bromo-4,5-dimethoxyphenyl)acrylate(116 mg, 0.34 mmol) was dissolved
in toluene (3 mL). The vial was capped with teflon heat resistant cap and tape, and refluxed for 24
hours. Solvent was evaporated under reduced pressure. The crude product was purified with silica
gel flash chromatography (30:70 EtOAc:Hex) to get the desired product. Desired product: Methyl
7-bromo-5,6-dimethoxy-1H-indole-2-carboxylate.Yield- 63 mg, 60%1H NMR (500 MHz,
CDCl3) δ 8.82 (N-H), 7.18 (d, 1H, J=2.5 Hz), 7.06 (s, 1H), 3.94 (s, 3H), 3.92 (s, 3H), 3.91 (s, 3H)
ppm.

13C

NMR (125 MHz, CDCl3) δ 162.05, 145.92, 139.32, 131.17, 128.17, 125.87, 120.83,

111.93, 108.46, 61.47, 61.21, 52.26 ppm. Side-product: Methyl 5-bromo-6,7-dimethoxy-1Hindole-2-carboxylate. Yield- 31 mg, 30% 1H NMR (500 MHz, CDCl3) δ 9.01 (N-H), 7.61 (s, 1H),
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7.09 (d, 1H, J=2.5 Hz), 3.94 (s, 3H), 3.92 (s, 3H), 3.92 (s, 3H) ppm. Spectral data matched with
those in literature.70
2.4.5 Synthesis of di and tri-brominated DMIC (2-14 to 2-17)
Synthesis of 3’4’-dibromo DMICA (2-14)

To a scintillation vial equipped with a stir bar was added methyl 4-bromo-5,6-dimethoxy-1Hindole-2-carboxylate (40 mg, 0.12 mmol), followed by addition of acetonitrile (1.2 mL), Nbromosuccinimide (66 mg, 0.12 mmol, 1 eq.) at RT. The mixture was stirred at 65 °C for 5 hrs.
Solvent was evaporated and crude was purified by silica gel flash chromatography. Yield-41 mg,
88%. 1H NMR (500 MHz, CDCl3) δ 8.98 (N-H), 6.78 (s, 1H), 3.97 (s, 3H), 3.91 (s, 3H), 3.86 (s,
3H) ppm. 13C NMR (125 MHz, CDCl3) δ 161.23, 154.05, 144.16, 133.33, 124.21, 118.10,
111.06, 98.31, 93.49, 60.90, 56.33, 52.31 ppm. HRMS (TOF MS ES+) m/z calculated for
C12H12NO4Br2 ([M+H]+) 391.9126 Da, found 391.9133 Da.
Synthesis of 3’-7’-dibromo DMICA (2-15)

To a scintillation vial equipped with a stir bar was added methyl 5,6-dimethoxy-1H-indole-2carboxylate (39 mg, 0.16 mmol), followed by addition of acetonitrile (1.5 mL), Nbromosuccinimide (116 mg, 0.64 mmol, 4 eq.) at RT. The mixture was stirred at 65 °C for 3 hrs.
Solvent was evaporated and crude was purified by silica gel flash chromatography. Yield-50 mg,
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81%. 1H NMR (500 MHz, CDCl3) δ 8.91 (N-H), 7.00 (s, 1H), 3.99 (s, 3H), 3.96 (s, 3H), 3.92 (s,
3H) ppm. 13C NMR (125 MHz, CDCl3) δ 160.91, 150.64, 147.84, 129.49, 124.44, 123.83,
101.37, 100.28, 100.28, 98.55, 661.39, 56.57, 52.38 ppm. HRMS (TOF MS ES+) m/z
calculated for C12H12NO4Br2 ([M+H]+) 391.9132 Da, found 391.9133 Da.
Synthesis of 3’-4’-7’-tribromo DMICA (2-16)

To a scintillation vial equipped with a stir bar was added methyl 5,6-dimethoxy-1H-indole-2carboxylate (100 mg, 0.42 mmol), followed by addition of acetonitrile (4 mL), Nbromosuccinimide (303 mg, 1.70 mmol, 4 eq.) at RT. The mixture was stirred at RT for 20 hrs.
Solvent was evaporated under reduced pressure. Crude was purified with silica gel flash
chromatography (30:70-EtOAc:Hex). Yield-158 mg, 80%. Product was confirmed with 1H
NMR. 1H NMR (500 MHz, CDCl3) δ 9.05 (N-H), 4.01 (s, 3H), 3.98 (s, 3H), 3.90 (s, 3H) ppm.
13C

NMR (125 MHz, CDCl3) δ 160.54, 150.87, 147.79, 131.86, 125.93, 120.43, 110.27, 98.99,

98.70, 61.60, 61.15, 52.44 ppm. HRMS (TOF MS ES+) m/z calculated for C12H12NO4Br2
([M+H]+) 469.9295 Da, found 469.9272 Da.
Synthesis of 4’-7’-dibromo dimethoxyindole carboxylate (2-17)
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In a scintillation vial methyl 3,4,7-tribromo-5,6-dimethoxy-1H-indole-2-carboxylate (46 mg,
0.098 mmol) was dissolved in acetic acid (1 mL) followed by addition of lithium bromide (18
mg, 0.21 mmol, 2.1 eq.), m-dimethoxybenzene (29 mg, 0.21 mmol, 2.1 eq.), and sulfuric acid
(20.5 mg, 0.21mmol, 2.1 eq.). The mixture was heated at 65 °C for 1.5 hrs. After cooling, the
solution mixture was added to ice water and resulting precipitate were filtered out. The crude
product was purified with silica gel flash chromatography (30:70-EtOAc:Hex). Yield-26 mg,
68% 1H NMR (500 MHz, CDCl3) δ 8.96 (N-H), 7.27 (d, 1H, J=2.0 Hz), 3.97 (s, 6H), 3.92 (s,
3H) ppm. 13C NMR (125 MHz, CDCl3) δ 161.80, 151.23, 143.67, 134.00, 131.51, 127.17,
123.15, 122.56, 60.53, 56.65, 51.28 ppm. HRMS (TOF MS ES+) m/z calculated for
C12H12NO4Br2 ([M+H]+) 391.9133 Da, found 391.9123 Da.
2.4.6 Synthesis of DHICA (2-19) and its mono-brominated derivatives (2-21, 2-23, 2-25)
5,6-dimethoxy-1H-indole-2-carboxylic acid (2-18)

To a solution of 5,6-dimethoxyindole carboxylate (20 mg, 0.085 mmol) was added sodium
hydroxide (5 eq.) and water:ethanol (1:1, 10 mL). The reaction mixture was stirred at RT for 8
hrs. Solvent was evaporated and pH was adjusted to ~2-3 with 1 N HCl. The crude product was
extracted with ethyl acetate (3 x 10 mL). Organic layer was dried with sodium sulfate and
solvent was evaporated. Yield: 18 mg, 95% 1H NMR (500 MHz, CD3CN) δ 9.70(s, N-H), 7.08
(s, 1H), 7.05(s, 1H), 6.95 (s, 1H), 3.85 (s, 3H), 3.81 (s, 3H) ppm. 13C NMR (125 MHz, CD3OD)
δ 164.92, 151.16, 147.16, 134.25, 127.56, 121.82, 109.59, 104.07, 95.41, 56.71, 56.71 ppm.
HRMS (TOF MS ES+) m/z calculated for C12H12NO4Br2 ([M+H]+) 222.0764 Da, found
222.0766 Da.
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5,6-dihydroxy-1H-indole-2-carboxylic acid (DHICA) (2-19)

To the solution of 5,6-dimethoxyindole carboxylic acid (22 mg, 0.099 mmol) in DCM (0.2 mL)
was added BBr3 (0.29 mL, 0.29 mmol, 3 eq) dropwise at -78 oC. The mixture was stirred for 18
hours at RT. The mixture was quenched with water and precipitate were filtered. The crude
product was purified with prep-HPLC. Yield-12 mg, 62% 1H NMR (500 MHz, CD3CN) δ 9.77
(s, N-H), 7.02 (s, 1H), 6.97 (s, 1H), 6.95 (s, 1H) ppm. 13C NMR (125 MHz, CD3CN) δ 163.44,
146.55, 142.16, 133.72, 126.46, 121.50, 109.04, 105.92, 97.51 ppm. Spectral data matched with
those in literature.70
4-bromo-5,6-dimethoxy-1H-indole-2-carboxylic acid (2-20)

To a solution of 4’-bromo 5,6-dimethoxyindole carboxylate (25 mg, 0.079 mmol) was added
Lithium Hydroxide (9.5 mg, 0.39 mmol, 5 eq.) and water:ethanol (1:1, 8 mL). The reaction
mixture was stirred at 50 oC for 8 hours. Solvent was evaporated and pH was adjusted to ~2-3
with 1N HCl. Product was extracted with ethyl acetate (3 x 10 mL). The combined organic layer
was dried with sodium sulfate and solvent was evaporated. Yield-21 mg, 90% 1H NMR (500
MHz, CD3CN) δ 9.95 (s, N-H), 7.05 (s, 1H), 7.00 (s, 1H), 3.89 (s, 3H), 3.79 (s, 3H) ppm. 13C
NMR (125 MHz, CD3CN) δ 162.26, 154.27, 143.90, 134.78, 127.81, 122.72, 109.90, 109.24,
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95.20, 61.16, 56.79 ppm. HRMS (TOF MS ES+) m/z calculated for C12H12NO4Br2 ([M+H]+)
299.9867 Da, found 299.9871 Da.
4-bromo-5,6-dihydroxy-1H-indole-2-carboxylic acid (2-21)

To the solution of 4’-bromo-5,6-dimethoxyindole carboxylic acid (14 mg, 0.046 mmol) in
DCM (0.2 mL) was added BBr3 (0.14 mL, 0.14 mmol, 3 eq) dropwise at -78 oC. The mixture
was stirred for 20 hours at RT. The mixture was quenched with water followed by filtration of
the precipitate. The product crude was purified with prep-HPLC. Yield-10 mg, 80% 1H NMR
(500 MHz, CD3CN) δ 9.74 (s, N-H), 6.98 (s, 1H), 6.94 (s, 1H) ppm. 13C NMR (125 MHz,
CD3CN) δ 161.92, 146.17, 139.75, 132.50, 126.77, 126.70, 122.41, 108.20, 96.93 ppm. HRMS
(TOF MS ES-) m/z calculated for C12H12NO4Br2 ([M-H]-) 269.9397 Da, found 269.9402 Da.
3-bromo-5,6-dimethoxy-1H-indole-2-carboxylic acid (2-22)

To a solution of 3’-bromo 5,6-dimethoxyindole carboxylate (25 mg, 0.079 mmol) was added
Lithium Hydroxide (9.5 mg, 0.39 mmol, 5 eq.) and water:ethanol (1:1, 8 mL). The reaction
mixture was stirred at 50 oC for 5 hours. Solvent was evaporated and pH was adjusted to ~2-3
with 1N HCl. The crude product was extracted with ethyl acetate (3 x 10 mL). The combined
organic layer was dried with sodium sulfate and solvent was evaporated. Yield-22 mg, 93% 1H
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NMR (500 MHz, CD3CN) δ 9.94 (s, 1H), 6.95 (s, 2H), 3.86 (s, 6H) ppm. 13C NMR (125 MHz,
CD3CN) δ 161.52, 152.11, 148.13, 131.83, 123.14, 121.63, 101.28, 97.80, 95.20, 56.52, 56.48
ppm. HRMS (TOF MS ES+) m/z calculated for C12H12NO4Br2 ([M+H]+) 299.9866 Da, found
299.9871 Da.
3-bromo-5,6-dihydroxy-1H-indole-2-carboxylic acid (2-23)

To the solution of 3’-bromo-5,6-dimethoxyindole carboxylic acid (18 mg, 0.06 mmol) in DCM
(0.25 mL) was added BBr3 (0.18 mL, 0.18 mmol, 3 eq) dropwise at -78 oC. The mixture was
stirred for 20 hours at RT. The mixture was quenched with water and precipitate were filtered.
The crude product was purified with prep-HPLC. Yield-11 mg, 68% 1H NMR (500 MHz,
CD3CN) δ 10.13 (s, N-H), 7.01 (s, 1H), 6.96 (s, 1H) ppm. 13C NMR (125 MHz, CD3CN) δ
163.27, 146.35, 141.96, 133.47, 132.39, 126.31, 121.27, 108.75, 105.66 ppm. HRMS (TOF MS
ES-) m/z calculated for C12H12NO4Br2 ([M-H]-) 269.9401 Da, found 269.9399 Da.
7-bromo-5,6-dimethoxy-1H-indole-2-carboxylic acid (2-24)

To a solution of 7’-bromo 5,6-dimethoxyindole carboxylate (25 mg, 0.079 mmol) was added
Lithium Hydroxide (9.5 mg, 0.39 mmol, 5 eq.) and water:ethanol (1:1, 8 mL). The reaction
mixture was stirred at 50 oC for 6 hours. Solvent was evaporated and pH was adjusted to ~2-3
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with 1N HCl. The crude product was extracted with ethyl acetate (3 x 10 mL). The combined
organic layer was dried with sodium sulfate and solvent was evaporated. Yield-22 mg, 90% 1H
NMR (500 MHz, CD3CN) δ 9.91(s, N-H), 6.99 (s, 1H), 6.96 (s, 1H), 3.85 (s, 3H), 3.82 (s, 3H)
ppm. 13C NMR (125 MHz, CD3CN) δ 160.25, 153.27, 142.80, 133.75, 127.5, 121.62, 109.50,
108.84, 94.70, 60.86, 56.29 ppm. HRMS (TOF MS ES+) m/z calculated for C12H12NO4Br2
([M+H]+) 299.9867 Da, found 299.9871 Da.
7-bromo-5,6-dihydroxy-1H-indole-2-carboxylic acid (2-25)

To the solution of 7’-bromo-5,6-dimethoxyindole carboxylic acid (20 mg, 0.066 mmol) in
DCM (0.3 mL) was added BBr3 (0.2 mL, 0.20 mmol, 3 eq) dropwise at -78 oC. The mixture was
stirred for 20 hours at RT. The mixture was quenched with water and product precipitate were
filtered. The crude product was purified with prep-HPLC. Yield-13 mg, 74% 1H NMR (500
MHz, CD3CN) δ 9.70 (s, N-H), 6.94 (s, 1H), 6.92 (s, 1H) ppm. 13C NMR (125 MHz, CD3CN) δ
160.55, 145.20, 138.25, 131.86, 126.18, 125.50, 121.47, 108.00, 97.56 ppm. HRMS (TOF MS
ES-) m/z calculated for C12H12NO4Br2 ([M-H]-) 269.9398 Da, found 269.9401 Da.

72

3 SYNTHESIS OF PHEOMELANOID MONOMERS- BENZOTHIAZOLES AND
BENZOTHIAZINES
3.1
Introduction
Pheomelanin is red-yellow pigment, commonly found in hair and skin. It is derived from DOPA
or dopamine in presence of cysteine, and as a result, it possesses nitrogen as well as sulfur in its
polymeric structure.10,17,20,55,170 Monomeric eumelanin units (DHI and DHICA) (Chpater-2) have
been widely studied due to scope and applications of eumelanin and polydopamine. Synthesis
and study of pheomelanin has gained significance due to its role in skin cancer and
melanoma.171–174 Pheomelanin is prone to photogdegradation in presence of oxygen and is
potentially phototoxic. Intermediates of pheomelaninogenesis from cyteinyldopa to pheomelanin
need to be further studied in order to understand their biological function and their phototoxic
role in diseases.38

Figure 3-1 Pheomelanin monomeric units.
Pheomelanin found in skin and hair contains DOPA sidechain, whereas pheomelanin found in
brain as part of neuromelanin structure contains dopamine sidechain. Pheomelanin consists of
benzothiazine and its metabolite benzothiazole as shown in Figure 3-1. Synthesis of
benzothiazine with DOPA sidechain was done by Donato and Napolitano from 5,Scysteinyldopa by potassium ferricyanide catalyzed cyclization.38 A unified strategy to synthesize
benzothiazole and benzothiazine with potential access to DOPA and dopamine sidechain still
needs to be explored. In this chapter, synthetic equivalent of natural analogues of pheomelanin
monomeric units benzothiazole and benzothiazine were synthesized with two different
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sidechains-ethyl ester (CO2Et) and methylene nitrile (CH2CN). Ethyl ester sidechain can
potentially be converted to DOPA sidechain by reduction of ester followed by condensationhydroamination.175 Methylene nitrile sidechain can be converted to dopamine sidechain by
hydrogenation with borane-tetrahydrofuran or transition metal catalyzed hydrogenation. This
strategy is advantageous as both types of monomeric units of phenomelanin, benzothiazole and
benzothiazine can be accessed from a simple starting material like ortho-methoxyaniline.

Figure 3-2 Unified strategy to access monomeric pheomelanin subunits.
Benzothiazole were synthesized by thiocyanation of o-methoxyaniline compounds which results
in aminobenzothiazole (X=NH2). Aminobenzothiazole was modified via Sandmeyer reaction to
access benzothiazole (X=H) and bromobenzothiazole (X=Br). Benzothiazine were synthesized
by halogenation followed by Ullman type thiolation at ortho position to amine, followed by
alkylate condensation using different alkylating reagents such as dichloroethane,
bromoacetaldehyde and ethyl bromopyruvate.
3.2

Results and Discussion:

Monomeric pheomelanoids such as benzothiazole (BTZL) and benzothiazine (BTZ) derivatives
were synthesized using commercially available starting material like 3-methoxyphenyl acetonitrile
and 3-methoxy 4-amino benzoic acid. The key intermediate was ortho-methoxyaniline
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(compounds 3-6 and 3-8), which were used to synthesize benzothiazole in one-step. In addition,
ortho-methoxyaniline was also used for synthesis of ortho-aminothiol compounds via
halogenation followed by Ullman coupling.
3.2.1 ortho-methoxyaniline synthesis
One-pot conversion methods to synthesize anilines from phenols via smiles rearrangement are
widely known.176–178 These methods utilize harsher conditions such as use of sodium hydride
base and dimethylacetamide solvent, which produces exothermic reaction. As shown by Xie et
al. anilines can be synthesized from phenols in one-step using smiles rearrangement using milder
conditions.179 Homovanillonitrile was synthesized using vanillin by modifying the sidechain
using TosMIC in 66% yield after purification.

Scheme 3-1 Synthesis of ortho-methoxyaniline (CH2CN sidechain)
Smiles reaction was attempted using two different smiles reagents, 2-chloropropionamide and
bromoacetamide at a few different temperatures (Table 3-1) and reactions were monitored by
TLC. As shown in Scheme 3-2, the mechanism of the reaction involves formation of 3-3 as the
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nucleophilic oxygen attacks the halogenated carbon of the smiles reagent resulting in
nucleophilic substitution.

Scheme 3-2 Smiles rearrangement of homovanillonitrile.
Nitrogen of the terminal amide is activated by deprotonation by base and it attacks the aromatic
carbon. The rearrangement proceeds through an unstable cyclic intermediate, and as a result of
this ring-opening, 3-4 is formed. Upon hydrolysis, 3-4 would be converted to the desired aniline
product. Table 3-1 shows the results of the smiles rearrangement experiments. 3-3 was observed
on TLC and NMR initially when the reaction was being run at higher temperatures (148 or 165
°C) for 5 hours with both the smiles reagents. When the temperature and time were optimized to
180 °C for 18 hours, cyclized 3-4 was observed in NMR along with 3-3.
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Table 3-1 Smiles rearrangement-reaction conditions and results
Smiles reagent

Bromoacetamide

2-chloropropionamide

Base,
solvent,
catalyst
K2CO3
DMF
KI
K2CO3
DMF
KI
K2CO3
DMF
KI
K2CO3
DMF
KI

Conditions
Recovered
(Temp., Time) product
90 oC- 2 hrs
148 oC- 5 hrs

3-3 (Yield- 61%)

100 oC- 2 hrs
165 oC- 5 hrs

3-3 (Yield- 51%)

100 oC- 2 hrs
165 oC- 5 hrs

3-3 (Yield-34%)
& Starting
Material
3-4 (Yield-39%)
3-3 (Yield-12%)

100 oC- 2 hrs
180 oC- 18 hrs

Due to poor conversion after multiple synthesis attempts and difficulty in purification due to
isolation of multiple intermediates, alternate route, which also involved a two-step synthesis of
desired ortho-methoxyaniline compound starting from a simple starting material like 3methoxyphenyl acetonitrile, was used as shown in Scheme 3-1. Nitration was done using
tetrabutylammonium nitrate which gave the desired 2(3-methoxy-4-nitrophenyl)acetonitrile
product (3-5) in 47% yield. Reaction also produced 2,6 dinitro compound as side products. As
described in previous literature, desired product was purified using silica gel flash
chromatography.180,181 This nitro compound undergoes palladium on carbon mediated
hydrogenation in presence of hydrogen gas to yield the desired o-methoxyaniline product (3-6).
Ortho-methoxyaniline variant of CO2Et sidechain (3-8) was synthesized by ethylating 4-amino-3methoxybenzoic acid in ethanol by using sulfuric acid as a catalyst.
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3.2.2 Benzothiazole(BTZL) synthesis
Once ortho-methoxyaniline compounds (3-6 and 3-8) were accessed, the next step was to
synthesize benzothiazole (synthetic analogues of natural phenomelanin subunit BTZL), which
include aminobenzothiazole, benzothiazole, and bromobenzothiazole.

Scheme 3-3 Synthesis of benzothiazoles
Scheme 3-3 was followed in order to access these pheomelanoids. Thiocyanation-cyclization is a
commonly used protocol to synthesize aminobenzothiazole in one-step.7-10 Thiocyanation occurs
at the ortho position to amine, and in presence of bromine in acetic acid nucleophilic nitrogen of
amine cyclizes to form aminobenzothiazole, which is a stable compound. This reaction worked
well for ethyl ester sidechain (3-9, Yield-92%), and methylene nitrile sidechain (3-12, Yield-95%)
and did not require extensive purification steps. Aminobenzothiazole undergoes deamination in
presence of isoamyl nitrite in THF resulting in benzothiazole derivative. Deamination were done
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successfully to synthesize 3-10 (86%) and 3-13 (89%) from 3-9 and 3-12 respectively.
Benzothiazole (3-10 and 3-13) can be brominated using carbon tetrabromide with potassium tertbutoxide to synthesize bromobenzothiazole resulting in 3-11 (83%) and 3-14 (78%). Alternatively,
bromobenzothiazole (3-11 and 3-14) were synthesized directly from aminobenzothiazole via
copper catalyzed sandemeyer reaction in 75% and 67% yield respectively. Deamination to
synthesize benzothiazole and deamination-bromination to synthesize bromobenzothiazole in onestep from aminobenzothiazole follow Sandmeyer mechanism as discussed in Figure 3-3.

Figure 3-3 Sandmeyer reaction mechanism
Sodium nitrite, tert-butyl ammonium nitrite and isoamyl nitrite are used for diazotization of
aromatic amines as they generate nitrosonium, which goes under nucleophilic attack, and generate
diazonium salts.182 In Sandmeyer mechanism, nucleophile can be altered in order to substitute the
aromatic amine with different nucleophilic functional groups. In the case above, when bromination
is done on diazonium salt, nitrogen leaves and bromobenzothiazole is recovered as the product
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whereas if hydrogen adds to the electrophilic carbon of the thiazole, benzothiazole is generated
(Figure 3-3).
3.2.3 Synthesis of key intermediate: ortho-aminothiophenol
The key intermediate to access 1,4-benzothiazine subunits of pheomelanin was orthoaminothiophenol which could later be alkylated to make benzothiazines. Aminobenzothiazole (37, 3-9 and 3-12) could be synthesized from ortho-methoxyaniline compound in one-step.
Aminobenzothiazole could be reduced in alkaline condition at high temperature in order to get
ortho-aminothiophenol. Aminobenzothiazole compound with methyl ester sidechain (3-7) was
used as a model to assess the reaction conditions. Upon reduction with sodium or potassium
hydroxide, the starting material reduced to the dimer of the desired ortho-aminothiophenol
(Scheme 3-4). In addition to challenges in purification, demethylation occurred at the sidechain as
acid product was observed in 1H NMR. Several reaction conditions were attempted by varying
base concentration, temperature, and time, in order to optimize reaction conditions. However, the
same product was observed in each case. The dimer was reduced to the thiol monomer by breaking
the disulfide bond using lithium aluminum hydride, which gave the ortho-aminothiophenol
compound with sidechain acid reduced to primary alcohol. Reduction of ethyl ester (3-9) and
methylene nitrile (3-12) benzothiazole under similar condition did not yield in formation of desired
product due to degradation and purification challenges.
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Scheme 3-4 Reduction of aminobenzothiazole.
Due to undesired modification of sidechain while using harsh reducing conditions with
aminobenzothiazole and challenges in purification, an alternate pathway was explored in order to
get the ortho-aminothiophenol. This pathway involved protection of amine followed by
thiocyanation at the ortho position, and reduction and deprotection to get the nucleophilic
functionalities as shown in Scheme 3-5. Three different protecting groups were used in these
experiments- Boc (di-tert-butyl dicarbonate), Azide (N3), and trityl (triphenylmethyl).

Scheme 3-5 Protection-thiocyanation-reduction scheme for ortho-aminothiophenol synthesis.
(Pg-Protecting group)
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Table 3-2 Thiocyanation of protected ortho-methoxyaniline.

Aromatic amine was protected with the protecting groups mentioned above and the formation of
these products was confirmed with NMR and Infrared spectroscopy. Thiocyanation conditions
were similar to benzothiazole synthesis conditions, except in this case ammonium thiocyanate was
used instead of potassium thiocyanate. Reactions were ran under ice-bath to control thiocyanation
and to prevent cyclization. Table 3-2 shows the results of thiocyanation reactions. With no
protecting group present, under these reaction conditions, benzothiazole formed. With Bocprotected amine, thiocyanation was incomplete and major product recovered was the deprotected
o-methoxyaniline compound. With azide protected amine, thiocyanation did not work as the
starting material was recovered. With trityl protected amine, thiocyanation resulted in deprotection
and thiocyanation at the desired ortho position of amine. However, cyclization occurred resulting
in benzothiazole formation, as it was recovered as the major product.
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Since the pathway discussed above to protect, thiocyanate, and reduce the aniline failed to give the
expected outcomes, thiolation via Ullman type coupling was pursued.

Scheme 3-6 Halogenation-Ullman type thiolation.
ortho-methoxyaniline compound with ethyl ester sidechain (3-8) was iodinated using iodine
monochloride at the ortho position to amine selectively. Following iodination, desired thiol
functionality was installed using copper (II) catalyzed single step aryl thiol synthesis via C-S cross
coupling using 1,2-ethanedithiol as explored by Liu et al.183 The mechanism of this reaction
involves two steps. First step is the catalysis step where halogenated compound undergoes C-S
coupling with 1,2-ethanedithiol via copper catalyzed Ullman type mechanism.183
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Figure 3-4 Mechanism of thiolation via Ullman type C-S coupling.
As shown in Figure 3-4, thiol nucleophile coordinates to the metal, followed by oxidative addition
of aryl halide to the metal complex. Aryl is attached to sulfur of 1,2-ethanedithiol as it reductively
eliminates following C-S coupling, as the intermediate shown in Figure 3-4 is generated. The
second step of this mechanism is intramolecular sulfide cleavage, as the terminal nucleophilic
sulfur of 1,2-dithioethane moiety attacks the neighboring carbon of the aryl attached sulfur forming
tricyclic thioether. This thioether is eliminated, and aromatic thiol is generated upon acid workup.
Ullman type thiol installation was done on iodinated and brominated ortho-methoxy aniline
compounds. Iodination was successfully done to synthesize 3-21 (78%), 3-22 (75%), and 3-23
(60%). Bromination was done with NBS at ortho-position of amine to synthesize 3-24 (84%), 325 (79%), and 3-26 (81%). Thiolation reactions were carried out on methyl ester (CO2Me) 3-21
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and 3-24 to assess conditions. However, Ethyl-ester sidechain was later used to optimize the
reaction condition due to deesterification observed in compounds with methyl-ester sidechain.
Triphenylphosphine and tributylphosphine were used to reduce the dimer to get the o-aminothiol
compound. However, these protocols required an extra purification step and as a result, TCEP was
used to reduce the dimer. Ullman type thiolation was done successfully to synthesize 3-27 in
overall yield of 54% from ortho-methoxyaniline compound (3-8), and 3-29 was synthesized with
overall 47% yield from. 3-6.
3.2.4 Alkylate condensation:
The key intermediate ortho-aminothiophenol was synthesized using Ullman type coupling, which
was followed by alkylate condensation of different alkylating agents to synthesize monomeric
benzothiazines. Synthesis scheme of 1,4-benzothiazine ethyl ester derivatives is shown in Scheme
3-7. Dihydrobenzothiazine (3-30, Yield-71%) was synthesized by condensing dichloroethane on
o-aminothiophenol compound (3-27) in DMF. The aliphatic protons of benzothiazine (CH2-CH2)
and their splitting were characteristic of the desired dihydrobenzothiazine product. Benzothiazine
(3-31, Yield-59%) was synthesized by condensing bromoacetaldehyde on ortho-aminothiophenol
compound (3-27). In the first step, thiophenolate is generated by reaction with sodium hydride.
After addition of bromoacetaldehyde, amino aldehyde is condensed in situ to yield the desired
cyclic imine.184
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Scheme 3-7 Synthesis of benzothiazines by alkylate condensation.
When this reaction was performed with ortho-aminothiophenol compounds with methylene nitrile
sidechain (3-29), isomer of benzothiazine (3-33) was observed in 46% yield. Following similar
reaction mechanism, benzothiazine carboxylate (3-32, Yield-66%) was synthesized by condensing
ethylbromopyruvate on ortho-aminothiophenol (3-27). Crude was purified with prep-HPLC and
products were characterized using NMR. Presence of aliphatic CH2 and proton of ethyl ester
sidechain with relevant chemical shift and integration confirmed the formation of benzothiazine
carboxylate products. Condensation reactions of 3-29 with dibromoethane and ethyl
bromopyruvate were attempted using similar conditions, but product could not be confirmed with
1

H or

13

C NMR. These reactions could be optimized and scaled to yield these benzothiazine

products in a future work. Thus, pheomelanin subunits-benzothiazines (BTZ) and benzothiazloles
(BTZL) were synthesized. Benzothiazoles were synthesized using thiocyanation-cyclization and
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sandmeyer reaction. Benzothiazines were synthesized using Ullman type thiolation and alkylate
condensation reactions. These synthetic pheomelanin subunits could be deprotected to better
represent their natural analogues to extend this work.
3.3 Conclusion and future direction
Synthetic analogues of benzothiazole and benzothiazine (pheomelanin subunits) derivatives were
synthesized from ortho-methoxyaniline derivatives with two different sidechains (CO2Et and
CH2CN) for the first time. Synthesized analogues included aminobenzothiazole compounds with
CO2Et and CH2CN sidechain in 92% and 95% yield, benzothiazole compounds with CO2Et and
CH2CN sidechain in 86% and 89% yield. Bromobenzothiazole compounds with CO2Et and
CH2CN sidechain were synthesized via bromination of benzothiazole with 83% and 78% yield
respectively and via Sandmeyer reaction of aminobenzothiazole compounds with 75% and 67%
yield, respectively. To synthesize benzothiazine compounds, which are synthetic analogues of
1,4-benzothiazine subunit of pheomelanin, ortho-aminothiol compounds with CO2Et and CH2CN
sidechain were synthesized as key intermediates via Ullman type thiolation of ortho-brominated
or ortho-iodinated aniline compounds in 69% and 58% yield. Synthetic analogues of 1,4benzothiazine- dihydrobenzothiazine (71% yield) was synthesized via alkylative condensation of
dichloroethane, benzothiazine with CO2Et and CH2CN sidechain were synthesized via alkylate
condensation of bromo-acetaldehyde in 59% yield 41% respectively; and benzothiazine
dicarboxylate (66% yield) via alkylate condensation of ethyl bromopyruvate.
Ullman type thiolation reaction conditions could be optimized further in future to increase the
yield and efficiency. In addition, it may include modifying sidechains of pheomelanin to access
DOPA sidechain to access natural analogues of 1,4-benzothiazine and benzothiazole which are
key intermediates of pheomelanogenesis. Degradation experiments followed by HPLC analysis
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via reductive hydrolysis or oxidative degradation using HI or H2O2 could be performed on
synthesized natural analogues to analyze degradation products of melanogenesis.
3.4
Synthesis
3.4.1 General synthesis procedure
All reagents were purchased from Sigma-Aldrich and Fisher Scientific and used directly without
further purification. Solvents were dried with activated 4 Å molecular sieves or anhydrous solvents
were dispensed from Solvent system. Reactions were monitored by TLC or analytical HPLC. All
products were purified with silica-gel flash chromatography or preparative HPLC. HPLC was
performed on a Gilson analytical to semi-preparative system using Kinetex 5 µm EVO C18 100Å
4.6 x 150 mm for analytical and Kinetex 5 µm EVO C18 100Å 21.1 x 150 mm for preparative
purpose. Products were characterized by 1H and

13

C NMR and mass spectrometry. NMR

characterization results and J values were compared with published results. 1H and

13

C NMR

spectra were recorded on Agilent/Varian 400 MHz or Bruker Neo 500 MHz and 101 MHz NMR
spectrometer, respectively. 1H NMR multiplicities are defined as ‘s’-singlet, ‘d’-doublet, ‘t’triplet, ‘dd’-doublet of doublets, and ‘m’-multiplet. Mass spectra were recorded using a Synapt G2
Q-TOF ESI mass spectrometer at the Mass Spectrometry Lab at the University of Illinois Urbana
Champagne. Abbreviations: TLC-Thin layer chromatography, HPLC-High Performance Liquid
Chromatography, NMR-Nuclear Magnetic Resonance, Q-TOF-Quadrupole time of flight, ESIElectrospray ionization
3.4.2 Synthesis of ortho-methoxy aniline compound
2-(4-hydroxy-3-methoxyphenyl) acetonitrile (3-1)
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To the mixture of potassium tert-butoxide (2.24 g, 10 mmol) in THF (15 mL), solution of
toluenesulfonylmethyl isocyanide-TosMIC (1.95 g, 10 mmol) in THF (5 mL) was added at -78
°C. Mixture was stirred for 15 minutes followed by addition of vanillin (761 mg, 5 mmol) in
THF (5 mL) dropwise at -78 °C. The mixture was stirred at -78 °C for 2 hours and warmed to rt.
Methanol (5 mL) was added and the mixture was heated at 66 °C for 1.5 hours. Solvent was
evaporated under reduced pressure. Water (20 mL) was added to the crude and the crude product
was extracted with ethyl acetate (3x20 mL). The combined organic layer was dried with sodium
sulfate and evaporated under reduced pressure. The crude product was purified with silica gel
flash chromatography (40:60 EtoAc: Hex). 567 mg, 66%. 1H NMR (400 MHz, CDCl3) δ 6.84
(d, 1H, J=2.0 Hz), 6.82 (d, 1H, J=8.4 Hz), 6.79 (dd, 1H, J=2.0 Hz, 8.4 Hz), 3.85 (s, 3H), 3.62 (s,
2H). 13C NMR (101 MHz, CDCl3) δ 146.63, 146.26, 123.03, 119.76, 118.45, 114.51, 111.29,
56.26, 23.18 ppm. Spectral data matched with those in literature. 185
2-(4-amino-3-methoxyphenyl) acetonitrile synthesis via Smiles rearrangement

General procedure: Cyanovanillin (55 mg, 0.32 mmol) was dissolved in DMF (1.5 mL). Smiles
reagent (1.2 eq.) was added to the solution followed by addition of potassium carbonate (2.5 eq.)
and potassium iodide (0.2 eq.). The mixture was stirred at variable temperature and time (refer to
the Table 3-1-results and discussion). Solvent was evaporated under reduced pressure and crude
was purified with silica gel flash chromatography (70:30 EtOAc:Hex).
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2-(3-methoxy-4-nitrophenyl) acetonitrile (3-5)

To a solution of tetra-n-butyl ammonium nitrate (1.97 g, 6.45 mmol) and 18-crown-6 (27 mg,
0.102 mmol) in dry DCM (40 mL) cooled in ice-bath was added trifluoroacetic anhydride (2.2 mL)
dropwise at 0°C. The solution was stirred in ice bath for 30 minutes and slowly syringed to a
solution of 3-methoxyphenyl acetonitrile (1 g, 6.79 mmol) in DCM (70 mL). The mixture was
stirred at rt overnight. The crude product solution was washed with sodium bicarbonate (100 mL)
and extracted with DCM (3 x 100 mL). The combined organic extracts were dried over sodium
sulfate and solvent was evaporated under reduced pressure. Crude was purified with silica-gel flash
chromatography (30:70 ethyl acetate:hexanes). 613 mg, 47%.1H NMR (500 MHz, CDCl3) δ 7.86
(d, 1H,8 Hz), 7.07 (s,1H), 6.99 (d, 1H, J=8.5 Hz), 3.99 (s, 3H), 3.83 (s, 2H) ppm. 13C NMR (125
MHz, CDCl3) δ 153.62, 136.72, 132.23, 126.74, 120.80, 119.86, 113.13, 56.86, 23.99 ppm.
Spectral data matched with those in literature.180
2-(3-methoxy-4-aminophenyl) acetonitrile (3-6)

To a 20 mL scintillation vial with a septum were added 2-(3-methoxy-4-nitrophenyl) acetonitrile
(150 mg, 0.78 mmol) and palladium on carbon (75 mg). The vial was evacuated and purged with
hydrogen, followed by addition of methanol (3.5 mL). Reaction was stirred under hydrogen for 12
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hours. The catalyst was filtered and solvent was evaporated under reduced pressure to recover 124
mg (98%) 2-(3-methoxy-4-aminophenyl) acetonitrile. 122 mg, 98%. 1H NMR (500 MHz, CDCl3)
δ 6.65 (s,1H), 6.64 (d, 1H,8 Hz), 6.60 (d, 1H, J=7.5 Hz), 3.79 (s, 3H), 3.57 (s, 2H) ppm. 13C NMR
(125 MHz, CDCl3) δ 147.71, 136.13, 121.46, 120.75, 115.07, 110.29, 110.15, 55.72, 23.39 ppm.
Spectral data matched with those in literature.186
3.4.3 Benzothiazole synthesis
Methyl 2-amino-4-methoxybenzo[d]thiazole-6-carboxylate (3-7)

In a 7 mL scintillation vial, potassium thiocyanate (322 mg, 3.31 mmol) and acetic acid (0.5 mL)
were added, followed by addition of methyl 4-amino-3-methooxybenzoate (150 mg, 0.83 mmol)
in acetic acid (1 mL) dropwise at 0 °C. To this mixture was added bromine (146 mg, 0.91 mmol)
in acetic acid (0.5 mL) dropwise at 0 °C. The reaction mixture was stirred at rt for 12 h. The crude
product mixture was diluted with water and potassium carbonate was added to adjust the pH ~8.
Solid precipitate were filtered and dried under vacuum overnight. 177 mg, 89%. 1H NMR (400
MHz, d6-DMSO) δ 7.94 (d, 1H, J=1.2 Hz), 7.84 (s, N-H, 2H), 7.34 (d, 1H, J=1.6 Hz), 3.87
(s, 3H), 3.83 (s, 3H). 13C NMR (101 MHz, d6-DMSO) δ 169.32, 166.91, 149.68, 146.85,
132.25, 123.03, 116.30, 108.83, 56.39, 52.69 ppm. Spectral data matched with those in
literature.187
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Ethyl-4-amino3-methoxybenzoate (3-8)

To a 7 mL scintillation vial with a stir bar was added, 4-amino 3-methoxybenzoic acid (200 mg,
1.20 mmol) followed by addition of ethanol (2.4 mL) and sulfuric acid (0.10 mL). The reaction
mixture was stirred at 81 °C for 10 h. After cooling to room temperature, the solvent was
evaporated under reduced pressure. Saturated sodium bicarbonate (20 mL) was added to the crude
and product was extracted with ethyl acetate (2*20 mL). The organic layer was washed with brine
and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure. 220
mg, 94%. 1H NMR (500 MHz, CDCl3) δ 7.56 (dd, 1H, J=1.6, 6.4 Hz), 7.46 (d, 1H, J=1.2
Hz), 6.66 (d, 1H, J=6.4 Hz), 4.33 (q, 2H, J=6 Hz), 3.90 (s, 3H), 1.37 (t, 3H, J=6 Hz) ppm.
13C

NMR (125 MHz, CDCl3) δ 166.96, 146.20, 141.10, 124.05, 119.90, 113.18, 111.20,

60.48, 55.63, 14.51 ppm. Spectral data matched with those in literature.188
Ethyl 2-amino 4-methoxybenzothiazole 6-carboxylate (3-9)

In a 7 mL scintillation vial, potassium thiocyanate (364 mg, 3.75 mmol) and acetic acid (0.6 mL)
were added, followed by addition of ethyl 4-amino-3-methooxybenzoate (183 mg, 0.94 mmol) in
acetic acid (1 mL) dropwise at 0 °C. To this mixture was added bromine (165 mg, 1.03 mmol) in
acetic acid (0.5 mL) dropwise at 0 °C. The reaction mixture was stirred at rt for 12 h. The crude
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product mixture was diluted with water and potassium carbonate was added to adjust the pH ~8.
Solid precipitate were filtered and dried under vacuum overnight. 220 mg, 92%. 1H NMR (500
MHz, CDCl3) δ 7.97 (d, 1H, J=1.0 Hz), 7.51 (d, 1H, J=1.5 Hz), 5.34 (s, N-H, 2H), 4.40
(q, 2H, J=7.5 Hz), 4.03 (s, 3H), 1.41 (t, 3H, J=7.0 Hz).

13C

NMR (125 MHz, CDCl3) δ

165.94, 146.23, 139.17, 126.88, 119.73, 115.73, 109.73, 106.63, 60.81, 56.06, 14.42 ppm.
Spectral data matched with those in literature.189
Ethyl 4-methoxybenzothiazole 6-carboxylate (3-10)

In a 7 mL scintillation vial, ethyl 2-amino 4-methoxybenzoate 6-carboxylate (25 mg, 0.098 mmol)
and THF (0.5 mL) were added followed by slow addition of isoamyl nitrite (25 mg, 0.21 mmol).
The mixture was stirred at 66 °C for 1 hour. The mixture was cooled and poured into ice-water (8
mL). The aqueous mixture was extracted with ethyl acetate (3 x 8 mL). The organic extracted were
combined and washed with brine, dried over sodium sulfate, and concentrated under reduced
pressure. 20 mg, 86%. 1H NMR (500 MHz, CDCl3) δ 9.05 (s, 1H), 8.29 (d, 1H, J=1.0 Hz), 7.60
(d, 1H, J=1.5 Hz), 4.44 (q, 2H, J=7.5 Hz), 4.12 (s, 3H), 1.43 (t, 3H, J=7.0 Hz). 13C NMR (125
MHz, CDCl3) δ 165.85, 152.43, 145.25, 140.56, 138.59, 129.05, 114.97, 108.01, 61.61,
56.34, 14.36 ppm. Spectral data matched with those in literature.189
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Ethyl 2-bromo 4-methoxybenzothiazole 6-carboxylate (3-11)

To a solution of ethyl4-methoxybenzothiazole 6-carboxylate (20 mg, 0.084 mmol) in DMF (0.2
mL) were added carbon tetrabromide (30.5 mg, 0.092 mmol) and potassium tert-butoxide (38 mg,
0.336 mmol). The mixture was stirred at rt for 1.5 hours. The reaction mixture was poured into
water (5 mL), extracted with DCM (3 x 5 mL), and dried over sodium sulfate. Solvent was
evaporated under reduced pressure to get crude product. The crude product was purified with
silica-gel flash chromatography (40:60 ethyl acetate:hexanes). 22 mg, 83%
Sandmeyer reaction

In a 7 mL scintillation vial, to a stirred solution of 2-amino 4-methoxybenzothiazole 6-carboxylate
(20 mg, 0.079 mmol) and copper (II) bromide (30 mg, 0.134 mmol) in acetonitrile (0.5 mL) was
added isoamyl nitrite (11 mg, 0.095 mmol) dropwise at 0 °C. The mixture was stirred at rt for 3
hours, after which water (4 mL) was added. The precipitate were filtered and dried under vacuum.
19 mg, 75%. 1H NMR (500 MHz, CDCl3) δ 8.13 (d, 1H, J=1.2 Hz), 7.58 (d, 1H, J=1.2 Hz), 4.43
(q, 2H, J=5.6 Hz), 4.09 (s, 3H), 1.43 (t, 3H, J=5.6 Hz). 13C NMR (125 MHz, CDCl3) δ 165.85,
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152.43, 145.25, 140.55, 138.59, 129.05, 114.96, 108.00, 61.61, 56.34, 14.36 ppm. HRMS (TOF
MS ES+) m/z calculated ([M+H]+) 315.9643 Da, found 315.9642 Da.
2-(2-amino-4-methoxybenzothiazol-6-yl) acetonitrile (3-12)

In a 7 mL scintillation vial, potassium thiocyanate (134 mg, 1.38 mmol) and acetic acid (0.2 mL)
were added, followed by addition of 2-(3-methoxy-4-aminophenyl) acetonitrile (56 mg, 0.35
mmol) in acetic acid (0.3 mL) dropwise at 0 °C. To this mixture was added bromine (62 mg, 0.38
mmol) in acetic acid (0.5 mL) dropwise at 0 °C. The reaction mixture was stirred at rt for 12 hours.
The crude product mixture was diluted with water and potassium carbonate was added to adjust
the pH ~8. Solid precipitate were filtered and dried under vacuum overnight. 73 mg, 95%. 1H
NMR (500 MHz, CDCl3) δ 7.01 (d, 1H,1.5 Hz), 6.58 (d, 1H, J=1.5 Hz), 3.76 (s, 2H), 3.61 (s, 3H).
13C

NMR (125 MHz, CDCl3) δ 166.16, 150.14, 141.96, 132.69, 124.74, 119.96, 113.29, 108.89,

56.34, 22.86 ppm. HRMS (TOF MS ES+) m/z calculated ([M+H]+) 220.0545 Da found 220.0542
Da.
2-(4-methoxybenzothiazol-6-yl) acetonitrile (3-13)

In a 7 mL scintillation vial, 2-(2-amino-4-methoxybenzothiazol-6-yl) acetonitrile (40 mg, 0.18
mmol) and THF (0.9 mL) were added followed by slow addition of isoamyl nitrite (47 mg, 0.40
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mmol). The mixture was stirred at 66 °C for 1 hour. Mixture was cooled and poured into ice-water
(15 mL). The aqueous mixture was extracted with ethyl acetate (3 x 15 mL). The organic extracted
were combined and washed with brine, dried over sodium sulfate, and concentrated under reduced
pressure. 33 mg , 89%. 1H NMR (500 MHz, CDCl3) δ 8.93 (s, 1H), 7.53 (d, 1H, J=1.5 Hz), 6.85
(d, 1H, J=1.0 Hz), 4.08 (s, 3H), 3.90 (s, 2H).

13C

NMR (125 MHz, CDCl3) δ 154.24, 153.27,

143.52, 136.33, 128.84, 117.69, 113.20, 106.74, 56.37, 24.20 ppm. HRMS (TOF MS ES+) m/z
calculated ([M+H]+) 205.0436 Da found 205.0433 Da.
2-(2-bromo-4-methoxybenzothiazol-6-yl) acetonitrile (3-14)

To a solution of 2-(4-methoxybenzothiazol-6-yl) acetonitrile (17 mg, 0.084 mmol) in DMF (0.2
mL) were added carbon tetrabromide (30.5 mg, 0.092 mmol) and potassium tert-butoxide (38 mg,
0.336 mmol). Mixture was stirred at rt for 1.5 hours. The reaction mixture was poured into water
(5 mL), extracted with DCM (3 x 5 mL), and dried over sodium sulfate. Solvent was evaporated
under reduced pressure to get crude product. The crude product was purified with silica-gel flash
chromatography (40:60 ethyl acetate: hexanes). 19 mg, 78%

In a 7 mL scintillation vial, to a stirred solution of 2-(2-amino-4-methoxybenzothiazol-6-yl)
acetonitrile (46 mg, 0.208 mmol) and copper (II) bromide (79 mg, 0.35 mmol) in acetonitrile (1.5
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mL) was added isoamyl nitrite (29 mg, 0.25 mmol) dropwise at 0 °C. The mixture was stirred at
rt for 3 hours, after which water (4 mL) was added. The precipitate were filtered and dried under
vacuum. 40 mg, 67%. 1H NMR (500 MHz, CDCl3) δ 7.38 (d, 1H, J=1.5 Hz), 6.83 (d, 1H, J=1.0
Hz), 4.06 (s, 3H), 3.87 (s, 2H) ppm.

13C

NMR (125 MHz, CDCl3) δ 153.13, 142.36, 139.64,

138.14, 129.12, 112.20, 109.10, 107.39, 56.43, 24.17 ppm. HRMS (TOF MS ES+) m/z calculated
([M+H]+) ([M+H]+) 282.9542 Da found 282.9541 Da.
3.4.4 Synthesis of ortho-aminothiophenol intermediate
4-amino-3-mercapto-5-methoxybenzoic acid (3-17)

Methyl 2-amino-4-methoxybenzo[d]thiazole-6-carboxylate (120 mg, 0.50 mmol) was added to a
solution of sodium hydroxide (or potassium hydroxide) (10 mmol, 20 eq.) in water (1.5 mL). The
mixture was heated and stirred at 110-140 °C for 2-4 days (Multiple trials). The mixture was
poured into ice-water (12 mL), acidified with concentrated HCl to pH 4-5 and extracted with ethyl
acetate. The organic layer was washed with water and dried over sodium sulfate. Solvent was
evaporated under reduced pressure. 32 mg, 30%. 1H NMR (400 MHz, DMSO-d6) δ 12.22 (s, 1H),
7.28 (d, 1H, J=1.6 Hz), 7.24 (d, 1H, J=1.6 Hz), 5.86 (s, 2H, N-H), 3.84 (s, 3H) ppm. 13C NMR
(101 MHz, DMSO-d6) δ 167.40, 146.08, 144.50, 130.89, 117.41, 115.08, 112.33, 56.40 ppm.
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To a solution of 5,5'-disulfanediylbis(4-amino-3-methoxybenzoic acid) (28 mg, 0.07 mmol) in
water:acetonitrile (1:1, 5 mL) was added TCEP (tris(2-carboxyethyl)phosphine) (36 mg, 0.126
mmol). Mixture was stirred at room temperature for 3 hours. Solvent was evaporated under
reduced pressure to get the desired thiol. 26 mg, 88%. 1H NMR (400 MHz, CDCl3) δ 7.88 (d, 1H,
J=1.6 Hz), 7.41 (d, 1H, J=1.6 Hz), 4.75 (s, 2H, N-H), 3.92 (s, 3H) ppm.

13C

NMR (101 MHz,

DMSO-d6) δ 167.40, 146.08, 144.50, 130.89, 117.41, 115.08, 112.33, 56.40 ppm. Spectral data
matched with those in literature.190
Methyl 4-amino-3-methoxy-5-thiocyanatobenzoate

To a mixture of methyl 4-amino-3-methoxy benzoate (75 mg, 0.41 mmol) in methanol (2 mL)
were added ammonium thiocyanate (76 mg, 0.99 mmol). The mixture was cooled to 5 °C and
bromine (99 mg, 0.62 mmol) in methanol (1 mL) wad added dropwise. The mixture was stirred at
5 °C for 3 hours and at room temperature for 12 hours. Solid was filtered and washed with water.
Aminobenzothiazole product was observed.77 mg, 79%. 1H NMR (400 MHz, d6-DMSO) δ
7.94 (d, 1H, J=1.2 Hz), 7.84 (s, N-H, 2H), 7.34 (d, 1H, J=1.6 Hz), 3.87 (s, 3H), 3.83 (s,
98

3H).

13C

NMR (101 MHz, d6-DMSO) δ 169.32, 166.91, 149.68, 146.85, 132.25, 123.03,

116.30, 108.83, 56.39, 52.69 ppm. Spectral data matched with those in literature. 187
Methyl 4-((tert-butoxycarbonyl) amino)-3-methoxybenzoate (3-18)

In a 7 mL scintillation vial, to a solution of methyl 4-amino 3-methoxy benzoate (196 mg, 0.82
mmol) in THF (2 mL) was added Boc-anhydride (289 mg, 0.98 mmol, 1.2 eq.). The reaction
mixture was heated and stirred at 66 °C for 24 hours. Reaction was monitored by TLC. The
reaction mixture was cooled, and solvent was evaporated under reduced pressure. Water (10 mL)
was added to the crude and product was extracted with diethyl ether (3x10 mL). The combined
organic layer was washed with brine and dried over sodium sulfate. Solvent was evaporated under
reduced pressure and the crude product was purified using silica gel flash chromatography (20:80
EtOAc:Hex) to get the desired product. 171 mg, 74%. 1H NMR (400 MHz, CDCl3) δ 8.17 (d, 1H,
J= 8.8 Hz), 7.68 (dd, 1H, J=2.0, 8.8 Hz), 7.51 (d, 1H, J=2.0 Hz), 7.28 (s, 1H, N-H), 3.93 (s, 3H),
3.89 (s, 3H), 1.53 (s, 9H) ppm. 13C NMR (125 MHz, CDCl3) δ 167.33, 166.90, 152.31, 146.83,
132.67, 123.47, 116.69, 110.61, 80.96, 55.85, 51.97, 28.28 ppm. Spectral data matched with those
in literature.191
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Methyl 4-azido-3-methoxybenzoate (3-19)

Methyl 4-amino 3-methoxy benzoate (100 mg, 0.55 mmol) and 2N HCl (1.65 mL) were added to
a vial and the solution was cooled to 0 °C. Sodium nitrite (57 mg, 0.83mmol, 1.5 eq.) in water (1.3
mL) was added dropwise to the above solution at 0 °C and the mixture was stirred for 30 minutes.
Sodium azide (142 mg, 2.2 mmol, 4 eq.) in water (2.25 mL) was added to the mixture dropwise
and the vial was stirred for 4 hours at room temperature. The reaction mixture was extracted with
ethyl acetate (3x8 mL). The organic layers were combined and washed with water. Product
solution was dried over sodium sulfate and solvent was evaporated under reduced pressure to get
the desired product. 99 mg, 87%. 1H NMR (400 MHz, CDCl3) δ 7.63 (dd, 1H, J= 2.0, 8.4 Hz),
7.55 (d, 1H, J=2.0 Hz), 7.02 (d, 1H, J=8.4 Hz), 3.93 (s, 3H), 3.91 (s, 3H) ppm. 13C NMR (101
MHz, CDCl3) δ 166.57, 151.82, 133.36, 127.48, 123.27, 120.08, 112.96, 56.32, 52.47 ppm.
Spectral data matched with those in literature.192
Methyl 3-methoxy-4-(tritylamino) benzoate (3-20)

Methyl 4-amino 3-methoxy benzoate (150 mg, 0.83 mmol) was dissolved in dichloromethane (3
mL) in a vial. Triethylamine (168 mg, 1.66 mmol, 2.0 eq.) and trityl chloride (254 mg, 0.91 mmol,
1.1 eq.) were added to the reaction mixture and the vial was stirred at room temperature for 16
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hours. The reaction mixture was diluted with dichloromethane (25 mL) and washed with water
(3x25 mL). The organic layer was dried over sodium sulfate and solvent was evaporated under
reduced pressure to get the desired product. 281 mg, 80%. 1H NMR (400 MHz, CDCl3) δ 7.347.26 (m, 15H), 7.04 (dd, 1H, J=2.0, 8.4 Hz), 6.16 (s, 1H), 5.92 (d, 1H, 8.4 Hz), 5.76 (s, 1H), 3.91(s,
3H), 3.71 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 167.47, 146.25, 144.90, 140.42, 129.06, 128.08,
127.95, 127.02, 123.02, 117.59, 113.53, 109.54, 71.10, 55.78, 51.56 ppm. Spectral data matched
with those in literature.192
Methyl 4-amino-3-iodo-5-methoxybenzoate (3-21)

To a solution of 4-amino 3-methoxy benzene compound (1.65 mmol) and sodium bicarbonate
(279 mg, 3.32 mmol) in DCM (4 mL) was added iodine monochloride (297 mg, 1.83 mmol)
DCM (2.5 mL). Reaction mixture was stirred at room temperature for 24 hours. The mixture was
washed with saturated sodium bicarbonate and extracted with DCM (4x15 mL). The combined
organic fractions were dried over sodium sulfate and solvent was evaporated under reduced
pressure. The crude product was purified with silica gel flash chromatography (30:70
EtOAc:Hex). 395 mg, 78%. 1H NMR (400 MHz, CDCl3) δ 7.99 (d, 1H, J=1.6 Hz), 7.38 (d, 1H,
J=1.6 Hz), 4.59 (s, 2H, N-H), 3.88 (s, 3H), 3.86 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ
166.10, 145.10, 141.82, 133.13, 120.34, 110.55, 80.56, 55.99, 51.95 ppm. Spectral data matched
with those in literature.193
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Ethyl 4-amino-3-iodo-5-methoxybenzoate (3-22)

To a solution of 4-amino 3-methoxy benzene compound (0.80 mmol) and sodium bicarbonate
(134 mg, 1.6 mmol) in DCM (2.5 mL) was added iodine monochloride (143 mg, 0.88 mmol)
DCM (1.5 mL). The reaction mixture was stirred at room temperature for 24 hours. Mixture was
washed with saturated sodium bicarbonate and extracted with DCM (4x10 mL). The combined
organic fractions were dried over sodium sulfate and solvent was evaporated under reduced
pressure. The crude product was purified with silica gel flash chromatography (30:70
EtOAc:Hex). 193 mg, 75%. 1H NMR (400 MHz, CDCl3) δ 7.99 (d, 1H, J=1.6 Hz), 7.40 (d, 1H,
J=1.6 Hz), 4.33 (q, 2H, J=7.2 Hz), 3.90 (s, 3H), 1.37 (t, 3H, J=7.2 Hz) ppm. 13C NMR (101
MHz, CDCl3) δ 165.65, 145.13, 141.72, 133.01, 120.76, 110.58, 80.58, 60.78, 55.99, 14.44
ppm. HRMS (TOF MS ES+) m/z calculated ([M+H]+) 321.9940 Da, found 321.9943 Da.
2-(4-amino-3-iodo-5-methoxyphenyl)acetonitrile (3-23)

To a solution of 4-amino 3-mthoxy benzene compound (0.5 mmol) and sodium bicarbonate (84
mg, 1 mmol) in DCM (1 mL) was added iodine monochloride (89 mg, 0.55 mmol) DCM (1 mL).
Reaction mixture was stirred at room temperature for 24 hours. The reaction mixture was washed
with saturated sodium bicarbonate and extracted with DCM (4x5 mL). The combined organic
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fractions were dried over sodium sulfate and solvent was evaporated under reduced pressure.
Crude was purified with silica gel flash chromatography (30:70 EtOAc:Hex). 86 mg, 60%. 1H
NMR (400 MHz, CDCl3) δ 7.11 (d, 1H, J=2.0 Hz), 6.62 (d, 1H, J=2.0 Hz), 4.22 (s, 2H, N-H),
3.80 (s, 3H), 3.55 (s, 2H) ppm. 13C NMR (101 MHz, CDCl3) δ 146.50, 137.45, 129.60, 120.23,
117.97, 109.59, 82.42, 55.94, 22.64 ppm. HRMS (TOF MS ES+) m/z calculated ([M+H]+)
288.9838 Da, found 288.9835 Da.
Methyl 4-amino-3-bromo-5-methoxybenzoate (3-24)

To a solution of 4-amino 3-mthoxy benzene compound (1.50 mmol) in DCM (5 mL) was added
N-bromosuccinimide (1.50 mmol) at 0 °C. The mixture was stirred at room temperature for 10
hours. The crude was washed with water (40 mL) and extracted with DCM (3x50 mL). The
combined organic layers were dried over sodium sulfate and solvent was evaporated under
reduced pressure. The crude product was purified with silica gel flash chromatography (30:70
EtOAc:Hex). 328 mg, 84%. 1H NMR (400 MHz, CDCl3) δ 7.81 (d, 1H, J=2.0 Hz), 7.38 (d, 1H,
J=2.0 Hz), 4.65 (s, 2H, N-H), 3.91 (s, 3H), 3.87 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ
161.98, 146.24, 139.26, 127.00, 110.56, 109.78, 106.65, 56.06, 51.96. Spectral data matched
with those in literature.194
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2-(4-amino-3-bromo-5-methoxyphenyl)acetonitrile (3-25)

To a solution of 4-amino 3-mthoxy benzene compound (0.6 mmol) in DCM (2 mL) was added Nbromosuccinimide (0.6mmol) at 0 °C. Mixture was stirred at room temperature for 12 hours. The
crude was washed with water (15 mL) and extracted with DCM (3x15 mL). The combined organic
layer was dried over sodium sulfate and solvent was evaporated under reduced pressure. The crude
product was purified with silica gel flash chromatography (30:70 EtOAc:Hex).130 mg, 79%. 1H
NMR (400 MHz, CDCl3) δ 6.99 (d, 1H, J=2.0 Hz), 6.67 (d, 1H, J=2.0 Hz), 3.88 (s, 3H), 3.64 (s,
2H), 3.49 (s, 1H, S-H) ppm.

13C

NMR (125 MHz, CDCl3) δ 147.74, 134.81, 123.80, 119.39,

118.11, 108.80, 108.26, 56.14, 23.04 ppm. Spectral data matched with those in literature.195
2-(4-amino-3-bromo-5-methoxyphenyl)acetonitrile (3-26)

To a solution of 4-amino 3-mthoxy benzene compound (0.35 mmol) in DCM (1.5 mL) was
added N-bromosuccinimide (0.35 mmol) at 0 °C. The mixture was stirred at room temperature
for 10 hours. The crude product was washed with water (10 mL) and extracted with DCM (3x10
mL). The combined organic layers were dried over sodium sulfate and solvent was evaporated
under reduced pressure. The crude product was purified with silica gel flash chromatography
(30:70 EtOAc:Hex). 68 mg, 81%. 1H NMR (400 MHz, CDCl3) δ 6.99 (1H, J=2.0 Hz), 6.66
(1H, J=2.0 Hz), 4.25 (2H, N-H), 3.87 (3H), 3.63 (2H) ppm. 13C NMR (101 MHz, CDCl3) δ
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147.74, 134.81, 123.80, 119.39, 119.12, 108.80, 108.26, 56.14, 23.04 ppm. HRMS (TOF MS
ES+) m/z calculated ([M+H]+) 240.9977 Da, found 240.9976 Da.
Methyl 4-amino-3-mercapto-5-methoxybenzoate

To a 7 mL vial evacuated and purged with N2, methyl-4-amino-3-halo-5-methoxy benzoate (70
mg, 0.27 mmol) was added followed by addition of copper sulfate (2.2 mg, 5 mol%), potassium
hydroxide (76 mg, 1.35 mmol) in DMSO (0.6 mL), water (0.06 mL) were added. 1,2ethanedithiol (51 mg, 0.54 mmol) was added dropwise under N2 to the above mixture. Mixture
was stirred at 90 °C for 36 hours. The reaction mixture was quenched with 5% HCl and extracted
with ethyl acetate. The organic layer was washed with water, brine and dried over sodium
sulfate. Solvent was evaporated under reduced pressure and crude was purified with silica gel
flash chromatography (40:60 EtOAc:Hex). 32 mg, 59%. 1H NMR (400 MHz, CDCl3) δ 7.88 (d,
1H, J=1.6 Hz), 7.41 (d, 1H, J=1.6 Hz), 4.75 (s, 2H, N-H), 3.92 (s, 3H) ppm. 13C NMR (101
MHz, DMSO-d6) δ 167.40, 146.08, 144.50, 130.89, 117.41, 115.08, 112.33, 56.40 ppm. Spectral
data matched with those in literature.190
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Diethyl 5,5'-disulfanediylbis(4-amino-3-methoxybenzoate) (3-28)

To a 7 mL vial evacuated and purged with N2, ethyl-4-amino-3-halo-5-methoxy benzoate (223
mg, 0.69 mmol) was added followed by addition of copper sulfate (11 mg, 10 mol%), cesium
carbonate (1.1 g, 3.45 mmol) in DMSO (3 mL) were added. 1,2-ethanedithiol (98 mg, 1.04 mmol)
was added dropwise under N2 to the above mixture. The mixture was stirred at 110 °C for 20 hours.
The reaction mixture was quenched with 5% HCl and extracted with ethyl acetate. The organic
layer was washed with water, brine and dried over sodium sulfate. Solvent was evaporated under
reduced pressure and the crude product was purified with silica gel flash chromatography (40:60
EtOAc:Hex). 116 mg, 74%. 1H NMR (400 MHz, CDCl3) δ 7.48 (d, 2H, J=1.6 Hz), 7.42 (d, 2H,
J=1.6 Hz), 4.97 (s, 4H, N-H), 4.24 (q, 4H, J=7.2 Hz), 3.90 (s, 6H), 1.30 (t, 6H, J=7.2 Hz). 13C
NMR (125 MHz, CDCl3) δ 166.17, 146.01, 143.48, 131.30, 118.38, 112.11, 107.55, 55.97, 54.48,
25.04 ppm.
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Ethyl 4-amino-3-mercapto-5-methoxybenzoate (3-27)

To a solution of diethyl 5,5’-disulfanediylbis(4-amino-3-methoxybenzoate) (30 mg, 0.06 mmol)
in water:acetonitrile (1:1, 5 mL) was added TCEP (tris(2-carboxyethyl)phosphine) (36 mg, 0.126
mmol). The mixture was stirred at room temperature for 3 hours. Solvent was evaporated under
reduced pressure to get the desired thiol. 28 mg, 93%. 1H NMR (400 MHz, CDCl3) δ 7.78 (d,
1H, J=2.0 Hz), 7.39 (d, 1H, J=2.0 Hz), 4.33 (q, 2H, J=7.2 Hz), 3.90 (s, 3H), 2.96 (s, 1H, S-H),
1.37 (t, 3H, J=7.2 Hz) ppm. 13C NMR (125 MHz, CDCl3) δ 166.17, 146.01, 143.48, 131.30,
118.38, 112.11, 107.55, 60.74, 55.97, 14.30 ppm. HRMS (TOF MS ES+) m/z calculated
([M+H]+) 228.1007 Da, found 228.1005 Da.
2-(4-amino-3-mercapto-5-methoxyphenyl)acetonitrile (3-29)

To a 7 mL vial evacuated and purged with N2, 2-(4-amino-3-halo-5-methoxyphenyl)acetonitrile
(50 mg, 0.21 mmol) was added followed by addition of copper sulfate (4 mg, 10 mol%), cesium
carbonate (367 mg, 1.15 mmol) in DMSO (1 mL) were added. 1,2-ethanedithiol (39 mg, 0.42
mmol) was added dropwise under N2 to the above mixture. The mixture was stirred at 110 °C for
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20 hours. The reaction mixture was quenched with 5% HCl and extracted with ethyl acetate. The
organic layer was washed with water, brine and dried over sodium sulfate. Solvent was
evaporated under reduced pressure and the crude product was purified with silica gel flash
chromatography (40:60 EtOAc:Hex). 24 mg, 58%. 1H NMR (400 MHz, CDCl3) δ 6.94 (d, 1H,
J=2.0 Hz), 6.62 (d, 1H, J=1.6 Hz), 4.26 (s, 2H, N-H), 3.98 (s, 2H), 3.86 (s, 3H), 1.58 (s, 1H, SH). 13C NMR (101 MHz, C3D6O) δ 146.50, 137.45, 129.60, 120.23, 117.97, 109.59, 82.42,
55.94, 22.64 ppm. HRMS (TOF MS ES+) m/z calculated ([M+H]+) 195.0592 Da, found
195.0586 Da.
Ethyl 5-methoxy-3,4-dihydro-2H-benzo[b][1,4]thiazine-7-carboxylate (3-30)

To Ethyl 4-amino-3-mercapto-5-methoxybenzoate (9 mg, 0.04 mmol) and potassium carbonate
(0.02 mmol) in DMF (0.4 mL) was added 1,2-dichloroethane or 1,2-dibromoethane (0.05 mmol).
Mixture was stirred at 60 °C for 10 hours. DMF was evaporated under reduced pressure. The
crude was washed with brine and extracted with ethyl acetate (3x 4 mL). The combined organic
layer was dried over sodium sulfate and solvent was evaporated under reduced pressure. The
crude product was purified with silica gel flash chromatography or HPLC. 7 mg, 71%. 1H NMR
(400 MHz, CDCl3) δ 7.44 (d, 1H, J=2.0 Hz), 7.21 (d, 1H, J=1.6 Hz), 4.98 (s, 1H, N-H), 4.31 (q,
2H), 3.88 (s, 3H), 3.75 (m, 2H), 3.02 (m, 2H), 1.36 (t, 3H). 13C NMR (125 MHz, CDCl3) δ
163.19, 139.16, 130.93, 129.26, 116.91, 111.32, 109.32, 60.59, 55.68, 42.78, 36.90, 14.44 ppm.
HRMS (TOF MS ES+) m/z calculated for ([M+H]+) 254.1006 Da, found 254.1007 Da.
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Ethyl 5-methoxy-2H-benzo[b][1,4]thiazine-7-carboxylate (3-31)

To a solution of sodium hydride (9 mg, 0.04 mmol) in anhydrous THF (0.2 mL) was added 2-(4amino-3-mercapto-5-methoxyphenyl) (0.04 mmol) THF (0.2 mL) was added under N2 at 0 oC.
Reaction mixture was stirred at RT for 2 hours followed by addition of bromoacetaldehyde (0.05
mmol) in THF (0.1 mL) and molecular sieves. The mixture was stirred at RT for 16 hours. The
crude product was filtered through celite and purified with silica gel flash chromatography.6 mg,
59%. 1H NMR (400 MHz, CDCl3) δ 9.06 (s, 1H), 8.30 (d, 1H, J=1.2 Hz), 7.61 (d, 1H, J=1.2
Hz), 4.44-4.42 (m, 4H), 4.12 (s, 3H), 1.42 (t, 3H). 13C NMR (125 MHz, CDCl3) δ 167.95,
143.92, 131.17, 126.02, 116.58, 111.20, 110.85 109.60, 58.47, 56.34, 24.54 ppm. HRMS (TOF
MS ES+) m/z calculated for ([M+H]+) 252.0652, found 252.0654.
2-(5-methoxy-4H-benzo[b][1,4] thiazine-7-yl)acetonitrile

To a solution of sodium hydride (0.035 mmol) in anhydrous THF (0.2 mL) was added 2-(4amino-3-mercapto-5-methoxyphenyl) (0.04 mmol) THF (0.2 mL) was added under N2 at 0 oC.
Reaction mixture was stirred at RT for 2 hours followed by addition of bromoacetaldehyde (0.05
mmol) in THF (0.1 mL) and molecular sieves. The mixture was stirred at RT for 16 hours. The
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crude product was filtered through celite and purified with silica gel flash chromatography. 3 mg,
41%. 1H NMR (400 MHz, CDCl3) δ 7.70 (d, 1H, J=3.2 Hz), 7.21 (d, 1H, J= 3.6 Hz), 7.01 (d,
1H, J=1.6 Hz), 7.68 (d, 1H, J=1.6 Hz), 4.21 (s, 2H), 3.83 (s, 3H). 13C NMR (125 MHz, CDCl3)
δ 143.50, 137.45, 135.91, 129.60, 128.70, 117.97, 113.25, 112.98, 106.59, 55.94, 24.64 ppm.
HRMS (TOF MS ES+) m/z calculated for ([M+H]+) 219.0516, found 219.0512.
Diethyl 5-methoxy-2H-benzo[b][1,4]thiazine-3,7-dicarboxylate (3-32)

To a solution of sodium hydride (8 mg, .035 mmol) in anhydrous THF (0.2 mL) was added 2-(4amino-3-mercapto-5-methoxyphenyl) (0.035 mmol) THF (0.2 mL) was added under N2 at 0 oC.
Reaction mixture was stirred at RT for 2 hours followed by addition of ethyl bromopyruvate
(0.05 mmol) in THF (0.1 mL) and molecular sieves. The mixture was stirred at RT for 16 hours.
The crude product was filtered through celite and purified with silica gel flash chromatography.7
mg, 66%. 1H NMR (400 MHz, CDCl3) δ 8.26 (d, 1H, J=1.2 Hz), 7.60 (d, 1H, J=1.2 Hz), 4.54
(q, 2H), 4.44 (q, 2H), 4.11 (s, 3H), 3.90 (s, 2H), 1.46 (t, 3H), 1.43 (t, 3H). 13C NMR (125 MHz,
CDCl3) δ 166.66, 143.75, 141.40, 139.41, 131.10, 125.70, 117.14, 112.35, 109.45, 60.82, 56.15,
55.91, 31.17, 14.66, 14.50 ppm. HRMS (TOF MS ES+) m/z calculated for ([M+H]+) 324.0890,
found 324.0852.
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4
4.1

SYNTHESIS OF REGIOSELECTIVELY FUNCTIONALIZED EUMELANOIDS
MIXED MELANOIDS AND THEIR PHOTOPHYSICAL STUDIES
Introduction

Mixed melanin such as neuromelanin are melanin biopolymer which contain conjugated
pheomelanin and eumelanin units. Human neuromelanin is extracted from one of the following
organelles: substantia nigra, putamen, premotor cortex, and cerebellum. The process involves
multiple steps of gradient centrifugation.53 Access to these natural melanin have been limited to
extraction and biosynthesis.53,121 Oligomerization of pheomelanin subunits in order to access
intermediates to pheomelanogenesis has been done by D’Ischia.87,196 Similarly, oligomerization
of eumelanin subunits, DHI and DHICA has been developed in order to access polydopamine
based synthetic eumelanin for applications in polymer stabilization126,127, surface coating and
bio-adhesion62,128, biosensing, nano particle and nanocapsule preparation for drug delivery, light
harvesting and cell interfacing.62,66,125,129–135 Eumelanin and pheomelanin have unique
photoprotective and material properties. Conjugation of eumelanin and pheomelanin subunits
would form a synthetic subunit of mixed melanin. Oligomerization of this new type of melanin
could have interesting photophysical and materials properties.
Suzuki coupling has been used to couple brominated DHICA compounds to borylated aromatic
species.73 However, brominated indoles have not been functionalized before in order to
conjugate these species with halogenated aromatics via Suzuki coupling. One of the research
goals of this project was to functionalize regioselectivity brominated eumelanin subunits- DMIC.
This would be followed by coupling of these functionalized DHICA subunits with brominated
pheomelanin subunits (benzothiazole) to access subunits of mixed melanin.
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Figure 4-1 Target synthetic mixed melanoid synthesized from synthetic monomeric subunits of
pheomelanin and eumelanin.
Functionalizing monomeric eumelanin units would be advantageous to couple them selectively
with pheomelanin monomeric units such as benzothiazole and benzothiazine. In this work,
monomeric eumelanin units of mono brominated DMIC were functionalized and coupled with
benzothiazole. Benzothiazole with CO2Et sidechain was used as a model substrate to assess the
coupling reactions which would yield a mixed melanoid. Once Suzuki coupling was shown to be
successful to form the new C-C bond, benzothiazole with CH2CN sidechain was used, which
would allow to access natural analogues of dopamine derived mixed melanin (potential
monomeric subunit of neuromelanin) in future.
4.2

Results and Discussion:

Scheme 4-1 describes the two reaction pathways attempted to functionalize eumelanoid and
conjugate it to benzothiazole. Initially aldehyde was installed at the 4’-position via lithiation of
the 4’-bromo eumelanoid (3-8) using organolithium reagent followed by KI catalyzed coupling
of aldehyde with benzothiazole (ethyl ester sidechain) in aqueous solution in presence of tertbutylhydroperoxide.
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Scheme 4-1 Reaction pathways for mixed melanoid (4-4) synthesis.
After several unsuccessful attempts of KI catalyzed coupling, Miyuara borylation of brominated
DMIC compounds followed by Pd catalyzed Suzuki coupling was successfully used to access two
different types of mixed melanin subunits.
4.2.1 Eumelanoid functionalization
Initial pathway to functionalize bromo-DMIC derivatives included installing aldehyde at the
brominated position via lithiation. 4’-bromo DMIC was used as a model substrate. Using
organolithium reagent n-BuLi followed by reaction with DMF (dimethylformamide) installed
aldehyde at the 4’-position via electrophilic addition. The second step of this pathway was KI
catalyzed coupling of aldehyde of 4’-eumelanoid and benzothiazole (ethyl ester sidechain in this
case) in aqueous solution in presence of tert-butylhydroperoxide.11 I- or I2 would form tertbutylperoxyl radical which would form the product via annulation. The mechanism of this reaction
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was studied by controlled experiments by Gao et al and it has been shown in Figure 4-2 for 4’DMIC aldehyde and benzothiazole.11 Benzothiazole would react with water in presence of tertbutyl hydroperoxide to give the dihydrobenzothiazole.

Figure 4-2 Mechanism of KI catalysed coupling of benzothiazole with aromatic aldehyde.11
Nitrogen of the benzothiazole reacts with benzaldehyde forming aminal (Figure 4-2) after
nucleophilic addition and protonation. In the dehydration step, loss of water results in formation
of Schiff’s base. Tert-butylperoxyl radicals promote formation of intermediate as they are being
reduced. This unstable and reactive intermediate undergoes annulation resulting in formation of
intermediate which after deprotonation results in desired product (Figure 4-2) with extended
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conjugation. Lithiation step was done with 4’ and 7’ bromo DMIC (2-8 and 2-12) successfully,
however the purification of the product was difficult and the yields of both these products were
low (30%-55%). In addition, the 7’-aldehyde DMIC product (4-3) was observed to have butylester
at indole ester position as compared to methylester sidechain in the starting material. The KI
catalyzed coupling step was unsuccessful as significant amount of unreacted starting material was
recovered after up to 24 to 48 hours into the reaction. Using a different organlithium reagent may
have helped with increasing the yield of the first step. However, due to low yields in the lithiation
step, failure to consume starting material in the coupling step and limited substrate scope (limited
to BTZL) of KI-catalyzed coupling, a different reaction pathway was used.
In this alternate pathway-Suzuki-Miyaura coupling was used to synthesize mixed melanoids.
Bromo DMIC derivatives (2-8 ans 2-12) were borylated via Miyaura borylation followed by Pd
catalyzed Suzuki coupling of the functionalized eumelanoid with bromobenzothiazole. 4’-bromo
eumelanoid (2-8) was used as model substrate to assess and optimize the reaction conditions.
Initially, borylation via lithiation was attempted but due to poor conversion of the starting material
different Pd catalysts were utilized. Pd catalysts such as PdCl2(dppf), PdCl2(PPh3)2, Pd2(dba)3, and
Pd(PPh3)4 were assessed to optimize borylation. Reactions were monitored with analytical-HPLC
to observe consumption of starting material (2-8), formation of product (4-5), and formation of
protodeboronated product (2-3) at different time points. Pd(PPh3)4 along with reaction conditions
listed below were observed to be the optimized conditions to maximize conversion of 2-8 to 4-5
and minimize the formation of 2-3. Reaction was monitored with analytical HPLC and mole
fraction data were plotted for comparison. Tetrakistriphenyl palladium- Pd(PPh3)4 in dioxane with
potassium acetate base and bispinacolatodiboron as borylating agent yielded the best results. The
optimum conversion was observed at 36 hours (Figure 4-3).
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Figure 4-3 Mole fractions of 4’-bromo DMIC (2-8) borylation reaction. (Calculated from HPLC
data)
As observed in Figure 4-3, in HPLC chromatograms, in addition to the starting material and
product traces, a trace of Methyl 5,6-dimethoxyindole carboxylate (2-3) was observed. This could
be due to protodeboronation of the starting material. However, this degradation was negligible for
4’-bromo DMIC, it was a significant issue in 3’-bromo DMIC borylation.
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Figure 4-4 Borylation and hydrolysis of pinacol ester monitored by HPLC. (C-18 stationary
phase, Mobile phase gradient 50%:50% water:can to 100% AcN in 10 minutes)
Crude of borylation reaction mixture was purified using C18 prep-HPLC. It was observed that
after purification on C-18 with water:acetonitrile as mobile phase, the 4’-pinacol ester product(45) had partially hydrolyzed into the 4’-boronic acid product(4-6). Figure 4-4 details HPLC
chromatograms of reaction mixture at the beginning containing starting material (2-8) at 3.83
minutes, crude at 36 hours shows pinacol ester product (4-5) at 4.28 minutes, and a mixed trace
after purification which shows 4’-boronic acid product (4-6) at 1.81 minutes with 4’-pinacol ester
product (4-5) at 4.28 minutes. For all of the HPLC traces in Figure 4-4, HPLC conditions including
the C-18 column, temperature (30 ℃), and solvent gradient (50%:50% water AcN to 100% AcN
in 10 minutes) were kept constant. Most of the prep-HPLC fractions contained 4’-boronic acid as
the major product and non-hydrolyzed pincol ester as the minor product. Since boronic acid
functionalized aromatics are known to be more reactive in Suzuki coupling, 4’-pinacol ester
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product (4-5) was hydrolyzed to 4’-bronic acid (4-6) in 50:50 water:AcN at RT in 24 hours. 4-6
was used for Suzuki coupling reactions.

Figure 4-5 Borylation of 7’-bromo DMIC (2-11).
Similar to 4’-bromo DMIC (2-8) borylation to syntheize 4’-boronic acid product (4-6), borylation
of 7’-bromo DMIC (2-11) was performed using Pd catalyst to install pinacol ester (4-8). 7’-pinacol
ester product (4-8) as shown in Figure 4-5, was hydrolyzed using 1:1 water:acetonitrile in 24 hours
to yield 7’-boronic acid product (4-9) in 77% yield over 2 steps. These reactions were monitored
with analytical HPLC (Figure D-1, Appendix D) and showed similar trend as 2-8 borylation, with
starting material (2-11) retention at 4.25 minutes, 7’-pinacol ester product (4-8) retention at 5.01
minutes, and 7’-boronic acid product (4-9) retention at 1.90 minutes. 7’-boronic acid product (49) was used in Suzuki coupling.
Borylation of 3’-bromo DMIC (2-4) was attempted using several reaction conditions as significant
protodeborylation was observed in these reactions. Reactions were monitored with C-18 analytical
HPLC. An example HPLC chromatogram (Figure D-2, Appendix D), which shows HPLC traces
for 3’-bromo DMIC starting material (2-4) at 2.94 minutes, protodeboronated product (2-3) at 2.24
minutes, and desired 3’-borylated product (4-7) at 3.33 minutes. For each reaction, small fractions
were taken out every 4 hours and HPLC conditions including the C-18 column, temperature (30
℃), and solvent gradient (50%:50% water AcN to 100% AcN in 10 minutes) were kept constant.
Mole fractions of the optimization experiments with variable changes have been shown in Table
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4-1. Temperature optimization was done with PdCl2(dppf) catalyst and dioxane as solvent. All
three reactions were running at the same indole concentration (0.28 M) and for the same duration.

Figure 4-6 3’-borylation reaction monitored by analytical HPLC.
Table 4-1 3’-borylation reaction optimization and relevant mole fractions (from HPLC data).

No Temp

Catalyst/
Ligand

Solvent

Time ᵡ (2-3)
(hrs)

ᵡ (4-7)

ᵡ (2-4)

1

RT

PdCl2(dppf)

Dioxane

24

0.048

0.012

0.94

2

50 °C

PdCl2(dppf)

Dioxane

24

0.53

0.04

0.43

3

50 °C

Pd(PPh3)4

Dioxane

24

0.35

0.076

0.57

4

100 °C

PdCl2(dppf)

Dioxane

24

0.93

0.029

0.041

5

100 °C

Pd2(dba)3
X-phos

Dioxane

24

0.28

0.03

0.69

6

100 °C

Pd(PPh3)4

Dioxane

24

0.76

0.03

0.21

7

65 °C

Pd(PPh3)4

THF

24

0.11

0.09

0.80

8

65 C

Pd(PPh3)4

THF

36

0.30

0.12

0.58

o
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As observed by the trend in mole fractions of each compound, the product formation increases as
the temperature is increased initially as the SM conversion is observed to increase, however it
lowers at high temperature (100 °C). Most importantly, the amount of protodeboronated product
increases as the temperature is increased. This indicates that the rate of borylation is much slower
than protodeboronation under the reaction conditions. Consistent catalytical loading (5 mol%) was
done with other Pd catalysts used [Pd(PPh3)4 and Pd2(dba)3 with X-phos] while keeping the
reaction conditions same. Both of these catalysts gave similar yield of the product, however,
Pd(PPh3)4 resulted in higher conversion of SM compared to slower reaction of Pd2(dba)3. Despite
generation of higher debrominated product, following higher conversion of SM and better
borylation yields in previous indole borylation, Pd(PPh3)4 was utilized as the catalyst and
conditions were further optimized. Solvent was changed to THF in order to increase solubility and
reflux temperature (65 °C) was used for these optimizations. Entry 8 in Table 4-1 indicates the
optimized conversion of SM to desired borylated product and recovered yield was ~10%. A
parallel reaction was ran for 60 hours and monitored with HPLC, but it indicated degradation of
product to deboronated compound. Borylation of 3’-bromo DMIC (2-4) needs to be further
optimized in future possibly with different bases or catalysts, and the mechanism of
protodeboronation could be studied.

Figure 4-7 Borylation of bromobenzothiazole (3-14).
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In order to circumvent the protodeboronation problem of 3’-borylation, and to access 3’conjugated mixed melanoid, borylation of bromobenzothiazole was attempted. Borylation of
bromo-BTZL (3-14) was attempted using Pd(PPh3)4 and PdCl2(dppf) as catalyst with similar
reaction conditions to bromo-DMIC borylation. Reactions were monitored with HPLC, and it was
observed that pinacol ester of the BTZL is generated as a minor product (22%) with the major
product (63%) being the protodeboronation product of BTZL (3-13). Pinacol ester could be
converted to boronic acid BTZL (4-13) in 77% yield. Borylation reaction of bromo-BTZL (3-14)
needs to be optimized in a future study to access 3’-DMIC conjugated mixed melanoid.
4.2.2 Mixed melanoid synthesis via Suzuki Coupling:

Figure 4-8 Mechanism of Suzuki coupling.
Mixed melanoid synthesis was carried out with 4’-and 7’-boronic acid compounds as they were
conjgated with pheomelanoids using Suzuki coupling. Bromobenzothiazole (3-11) was used as a
model monomeric pheomelanin substrate due to ease of synthesis and scalability. Mechanism of
Pd catalyzed Suzuki coupling is shown in Figure 4-8. Bromobenzothiazole (3-11) would
121

oxidatively add to Pd(0) as it oxidizes to Pd(II) during oxidative addition. In transmetallation step,
in presence of base-potassium phosphate (tribasic) 4’-boronic acid DMIC (4-6) adds to the metal
complex as the boronic acid halogenates resulting in both the aryl compounds complexed to the
Pd(II) metal. In the reductive elimination step, the new C-C bond is formed between the aryl
compounds (4-6 and 3-11) as the mixed melanoid compound (4-10) is generated resulting in
restoration of Pd oxidation state Pd(0).

Figure 4-9 Suzuki coupling to synthesize mixed melanoids.
Suzuki coupling was done successfully on 4’-boronic acid DMIC, where it was coupled with
bromobenzothiazole (R=CO2Et or CH2CN) in presence of Xphos Pd G2 catalyst with yields of
96% (R=CO2Et) and 88% (R=CH2CN). Products were characterized using combination of NMR
experiments including 1D NMR experiments such as 1H, 13C and 2D NMR experiments such as
COSY, HSQC, and HMBC. 2D HMBC was key in characterizing and confirming the
conjugation of the melanoids. A specific section of HMBC spectra of ethyl 2-(5,6-dimethoxy-2(methoxycarbonyl)-1H-indol-4-yl)-4-methoxybenzo[d]thiazole-6-carboxylate is shown in Figure
4-10.
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Figure 4-10 2D HMBC (Indole proton-focused) of mixed melanoid [ethyl 2-(5,6-dimethoxy-2(methoxycarbonyl)-1H-indol-4-yl)-4-methoxybenzo[d]thiazole-6-carboxylate] (4-4).
Correlation of indole proton(1H shift-7.61 ppm-highlighted red) to the neighboring carbons(13C)
is observed. The correlation and as a result the signal becomes weaker as the bond distance
between the proton and the carbon increases. HMBC does not show one bond correlation, however
two (2JCH) to three bond correlation (3JCH) are commonly observed. Two bond correlation (2JCH)
(highlighted green) were observed between the indole proton and the neighboring aromatic
carbons. Three bond correlation (3JCH) (highlighted blue) were observed between indole proton
and two aromatic carbons as well as the carbonyl carbon of the methyl ester. Four bond
correlations(4JCH) are rare in HMBC, but it was observed (highlighted red) for the indole proton
correlating to the benzothiazole carbon of the conjugated benzothiazole. This analysis along with
the NMR analysis mentioned above confirmed the formation of mixed melanoids. 7’-boronic acid
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DMIC (4-9) was coupled with bromo-BTZL (3-14) via Suzuki coupling resulting in 7’-conugated
mixed melanoid (4-11) in 70% yield. Once the mixed melanoids (4-4, 4-10 and 4-11) were
accessed, initial photophysical properties of these compounds were studied using spectramax i3
spectrophotometer.
4.2.3 UV-Vis and Fluroscence properties of mixed melanoids
Overlayed UV-vis spectra of 5,6-DMIC (2-3), benzothiazole (3-13), and their mixed melanoid
(4-10) has been shown in Figure 4-11. Broad absorption spectra are characteristic of melanin
derivatives. Absorption at 260 nm and 280 nm were observed as λmax for BTZL (3-13) and 5,6DMIC (2-3) respectively. Mixed melanoid (4-10) is a conjugate of 3-13 and 2-3, and it shows
absorbance 280 nm however, the λmax was observed at low energy UV wavelength 360 nm
resulting from extended aromaticity of the conjugated system.

Figure 4-11 UV-Vis absorbance of 5,6-DMIC (2-3), BTZL (3-13), and their mixed melanoid (410)- 50 µM in ethanol.
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Similar UV-Vis absorption spectra were observed for mixed melanoids 4-4 and 4-11. For
compound 4-4 (Figure E-1, Appendix E) absorption peaks were observed at 280 nm and λmax at
350 nm and another absorption peak (shoulder) at 390 nm. For compound 4-11 (Figure E-3,
Appendix-E), which contains the same sidechain (CH2CN) in the pheomelanoid unit as 4-10,
UV-Vis absorption spectrum showed peaks at 280 nm. λmax was observed at low energy UV
wavelength 350 nm and an absorption band (shoulder) at 380 nm similar to 4-10.

Figure 4-12 Fluorescence spectra of 4-10.
Preliminary fluorescence properties of mixed melanoids (4-4, 4-10 and 4-11) were studied. All
three of these mixed melanoid products visibly luminesce under 365 nm light source. As shown
in excitation-emission spectra of compound 4-10 in Figure 4-12, excitation at 280 nm and 360
nm results in emission at 425 nm. Similarly, as described in Figure E-2 (Appendix E), compound
4-4 exhibits luminescence (emission) at 455 nm upon excitation at 280 nm and 354 nm; and
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compound 4-11 (Figure E-4, Appendix E) exhibits luminescence (emission) at 450 nm upon
excitation at 280 nm and 350 nm. These luminescence results of a synthetic mixed melanin
dimer are comparable to those of synthetic eumelanin solution where excitation at 360-380 nm
showed emission at 460-480 nm.160 However, synthetic eumelanin solution exhibited excitation
wavelength dependent emission as it breaks Kasha’s rule, and emission spectra does not mirror
the respective absorption spectra violating the mirror image rule.160,197 As shown in Figure 4-12,
luminescence spectra of 4-10 follows Kasha’s rule where emission is independent of excitation
wavelength as it stays constant (420 nm) for two different excitation wavelengths (280 nm and
360 nm) resulting from photon transfer from lowest excitation state S1 to ground state S0.197 In
addition, it follows the mirror image rule for organic chromophores as the emission spectra (ex280 nm and 360 nm) mirror the absorbance wavelengths. This preliminary data indicates that
these mixed melanoid compounds possess interesting photophysical properties which can be
studied further for materials applications, and these compounds can be studied as organic
chromophores.
4.3 Conclusion and future direction:
Eumelanin subunit (5,6-DMIC) functionalization and conjugation with pheomelanin subunit
(benzothiazole) was attempted using KI catalyzed coupling and Suzuki-Miyaura coupling.
Miyaura borylation was successful in functionalizing 4’-bromo DMIC as it was borylated to
form 4’-boronic acid DMIC in 61% yield over 2 steps. 7’-bromo DMIC was borylated to form
7’-boronic acid DMIC with 77% yield over 2 steps. Functionalized Eumelanin DMIC subunit 46 was coupled with bromobenzothiazole via Pd catalyzed Suzuki coupling to synthesize mixed
melanin subunit with CO2Et and CH2CN sidechain with 96% and 88% yields respectively. 7’boronic acid DMIC was coupled with in similar manner to synthesize 7’-functionalized mixed
melanoid in 70% yield. Structures of these compounds were confirmed with 1D and 2D NMR as
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well as HRMS. Preliminary photophysical data was collected to study UV absorbance and
luminescence behavior. Mixed melanin subunits exhibit broad absorption bands in UV-Vis
absorption spectra with λmax ~360 nm, and luminescence at 425 nm resulting from extended
conjugation of the heteroaromatic system.
This work can be extended further to resolve the limitations regarding the substrate scope by
functionalizing 3’-bromo DMIC and bromobenzothiazole by borylation for it to be used in
Suzuki coupling. In addition, synthesis and functionalization of 5,6-dimethoxyindole (5,6-DMI)
would give access to the 5,6-dihydroxyindole (DHI) mixed melanins. These would give access to
a variety of dimeric, trimeric, and tetrameric mixed melanin subunits. In addition, deprotection
via sidechain hydrogenation of pheomelanin subunit, saponification of methyl ester, and
demethylation of methoxy groups of mixed melanoids would result in formation of natural
analogues of mixed melanin subunits which could be key intermediates in melanogenesis of
neuromelanin. To further explore the applications of these N-heterocycles for as organic
chromophores, the next step should be a detailed study of their photophysical properties.
4.4
Synthesis
4.4.1 General Synthetic procedure:
All reagents were purchased from Sigma-Aldrich and Fisher Scientific and used directly without
further purification. Solvents were dried with activated 4 Ao molecular sieves or anhydrous
solvents were dispensed from Solvent system. Reactions were monitored by TLC or analytical
HPLC. All products were purified with silica-gel flash chromatography or preparative HPLC.
HPLC was performed on a Gilson analytical to semi-preparative system using Kinetex 5 µm EVO
C18 100Å 4.6 x 150 mm for analytical and Kinetex 5 µm EVO C18 100Å 21.1 x 150 mm for
preparative purpose. Products were characterized by 1H and

13

C NMR and mass spectrometry.

NMR characterization results and J values were compared with published results. 1H and 13C NMR
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spectra were recorded on Agilent/Varian 400 MHz or Bruker Neo 500 MHz and 101 MHz NMR
spectrometer, respectively. Mass spectra were recorded using a Synapt G2 Q-TOF ESI mass
spectrometer at the Mass Spectrometry Lab at the University of Illinois Urbana Champagne.
Abbreviations:

TLC-Thin

layer

chromatography,

HPLC-High

Performance

Liquid

Chromatography, NMR-Nuclear Magnetic Resonance, Q-TOF-Quadrupole time of flight, ESIElectrospray ionization
4.4.2 Conjugation via oxidation:
Methyl 4-formyl-5,6-dimethoxy-1H-indole-2-carboxylate

To a stirred solution of methyl 4-bromo-5,6-dimethoxy-1H-indole-2-carboxylate (19 mg, 0.06
mmol) in dry THF (0.6 mL) at -78 °C under N2 was added 2.5 mM n-BuLi (0.30 mmol, 5 eq.)
dropwise. The reaction mixture was stirred at room temperature for 2 hours and
dimethylformamide (0.30 mmol) was added at 0 °C. The reaction mixture was stirred at room
temperature for 5 hours. Ice pieces were added to the reaction mixture followed by 1N HCl (~1
mL) and extracted with ethyl acetate (3x10 mL). The combined organic layer was dried over
sodium sulfate and solvent was evaporated under reduced pressure. The crude product was
purified with silica gel flash chromatography (30:70 EtOAc:Hex). 9 mg, 55%. 1H NMR (400
MHz, CDCl3) δ 10.64 (s, 1H), 8.13 (s, 1H, N-H), 7.22 (d, 1H, 2.0 Hz), 7.15 (s, 1H), 3.97 (s, 3H),
3.93 (s, 3H), 3.91 (s, 3H) ppm. Spectral data matches with those in literature.198
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Methyl 7-formyl-5,6-dimethoxy-1H-indole-2-carboxylate

To a stirred solution of To a stirred solution of To a stirred solution of methyl 7-bromo-5,6dimethoxy-1H-indole-2-carboxylate (15 mg, 0.049 mmol) in dry THF (0.4 mL) at -78 °C under
N2 was added 2.5 mM n-BuLi (0.24 mmol, 5 eq.) dropwise. The reaction mixture was stirred at
room temperature for 2 hours and dimethylformamide (17.5 mg, 0.24 mmol) was added at 0 °C.
Mixture was stirred at room temperature for 5 hours. Ice pieces were added to the reaction
mixture followed by 1N HCl (~1 mL) and extracted with ethyl acetate (3x5 mL). The combined
organic layer was dried over sodium sulfate and solvent was evaporated under reduced pressure.
The crude product was purified with silica gel flash chromatography (20:80 EtOAc:Hex). Yield6 mg, 38%. 1H NMR (500 MHz, CDCl3) δ 10.54 (s, 1H), 10.02 (s, 1H, N-H), 7.40 (s, 1H), 6.18
(d, 1H, 2.0 Hz), 4.02 (s, 3H), 3.93 (s, 3H), 1.31-1.18 (m, 9H) ppm.
Conjugation (Failed)

To a 7 mL scintillation vial were added methyl 4-formyl-5,6-dimethoxy-1H-indole-2-carboxylate
(4 mg, 0.015 mmol), ethyl 4-methoxybenzo[d]thiazole-6-carboxylate (2.5 mg, 0.01 mmol), tert129

butyl hydroperoxide (70% aq., 0.03 mmol), potassium iodide (0.001 mmol, 10 mol%) and water
(0.3 mL). Mixture was heated at 100 °C for 24 hours. Starting material was not consumed as
monitored by TLC and crude NMR. Acetonitrile (0.2 mL) was added and mixture was stirred at
85 °C for 18 hours.
Methyl 5,6-dimethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-2carboxylate

To a mixture of methyl 4-bromo-5,6-dimethoxy-1H-indole-2-carboxylate (70 mg, 0.224 mmol),
tetrakis(triphenylphosphine)palladium(0) (13 mg, 0.0112 mmol, 0.05 eq.), potassium acetate (66
mg, 0.672 mmol, 3 eq.), and bis(pinacolato)diboron (74 mg, 0.291 mmol, 1.3 eq.) evacuated and
purged with N2 was added dry-dioxane (0.4 mL) under N2. The mixture was stirred at 100 oC for
36 hours. Reaction was monitored by HPLC. The catalyst was filtered, and the crude was used
for hydrolysis.
(5,6-dimethoxy-2-(methoxycarbonyl)-1H-indol-4-yl)boronic acid
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The crude mixture from the borylation reaction was stirred in water:acetonitrile (1:1, 5 mL) for
24 hours. Solvent was evaporated and the crude product was purified with prep-reverse phase
HPLC. After purification prep fractions containing product were analyzed using NMR and
analytical HPLC. 38 mg, 61%. 1H NMR (500 MHz, C3D6O) δ 10.66 (s, 1H), 7.71 (s, 1H), 7.51
(s, 2H), 7.21 (s, 2H), 3.92 (s, 3H), 3.89 (s, 3H), 3.86 (s, 3H) ppm. 13C NMR (125 MHz, C3D6O)
δ 162.79, 152.67, 135.71, 127.20, 125.37, 112.66, 108.97, 103.73, 98.47, 61.97, 56.05, 51.72
ppm. HRMS (TOF MS ES+) m/z calculated ([M+H]+) 280.0992 Da, found 280.0986 Da.
Methyl 5,6-dimethoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-2carboxylate

(Reaction conditions are listed in Table 4-1)
General procedure: To a mixture of methyl 3-bromo-5,6-dimethoxy-1H-indole-2-carboxylate (20
mg, 0.064 mmol), Pd(0) catalyst (13 mg, 0.0112 mmol, 0.05 eq.), base (1.7- 3 eq.), and
bis(pinacolato)diboron (19.5 mg, 0.077 mmol, 1.2 eq.) evacuated and purged with N2 was added
dry-dioxane or THF (0.3 mL) under N2. Mixture was stirred at (a temp. between room
temperature-100 oC) for 24-36 hours. Reaction was monitored by HPLC.
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Methyl 5,6-dimethoxy-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-2carboxylate

To a mixture of methyl 7-bromo-5,6-dimethoxy-1H-indole-2-carboxylate (12 mg, 0.038 mmol),
tetrakis(triphenylphosphine)palladium (0) (2.2 mg, 0.0019 mmol, 0.05 eq.), potassium acetate
(11 mg, 0.114 mmol, 3 eq.), and bis(pinacolato)diboron (13 mg, 0.05 mmol, 1.3 eq.) evacuated
and purged with N2 was added dry-dioxane (0.2 mL) under N2. The mixture was stirred at 100 oC
for 36 hours. Reaction was monitored by HPLC. The catalyst was filtered, and the crude was
used for hydrolysis.
(5,6-dimethoxy-2-(methoxycarbonyl)-1H-indol-7-yl)boronic acid

The crude mixture from the borylation reaction was stirred in water:acetonitrile (1:1, 5 mL) for
24 hours. Solvent was evaporated and the crude product was purified with prep-reverse phase
HPLC. After purification prep fractions containing product were analyzed using NMR and
analytical HPLC. 8 mg, 77%. 1H NMR (500 MHz, C3D6O) δ 10.09 (s, 1H), 7.79 (s, 1H), 7.40
(s, 1H), 7.09 (s, 3H), 3.98 (s, 3H), 3.91 (s, 3H), 3.89 (s, 3H) ppm.

13C

NMR (125 MHz, C3D6O)

δ 162.43, 156.46, 149.16, 132.60, 129.42, 127.79, 124.04, 108.72, 108.17, 62.01, 56.38, 52.00
ppm. HRMS (TOF MS ES+) m/z calculated ([M+H]+) 280.0992 Da, found 280.0993 Da.
132

Ethyl 2-(5,6-dimethoxy-2-(methoxycarbonyl)-1H-indol-4-yl)-4-methoxybenzo[d]thiazole-6carboxylate (4-4)

To a 7 mL vial were added XPhosPdG2(4 mol%), (5,6-dimethoxy-2-(methoxycarbonyl)-1Hindol-4-yl) boronic acid (0.021 mmol), ethyl 2-bromo-4-methoxybenzo[d]thiazole-6-carboxylate
(0.0216 mmol, 1.03 eq.). The vial was evacuated and purged with N2 followed by addition of
1,4-dioxane (0.35 mL) and 0.5 M potassium phosphate tribasic (3 eq.). The reaction mixture was
heated at 75 ℃ for 5 hrs. The reaction mixture was quenched with water (4 mL) and extracted
with ethyl acetate (5x4 mL), dried with sodium sulfate and solvent was evaporated under
reduced pressure. The crude product was purified with silica gel flash chromatography (50:50
EtOAc:Hex). 9 mg, 96%. 1H NMR (500 MHz, CDCl3) δ 9.10 (s, 1H, N-H), 8.43 (d, 1H, J=2.0
Hz), 8.29 (d, 1H, J=1.5 Hz), 7.59 (d, 1H, J=1.5 Hz), 7.04 (s, 1H), 4.43 (q, 2H), 4.17 (s, 3H),
3.99 (s, 3H), 3.98 (s, 3H), 3.95 (s, 3H), 1.43 (t, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ
166.52, 164.23, 162.45, 153.23, 152.37, 145.89, 145.52, 137.08, 133.95, 128.10, 127.28, 119.63,
119.17, 115.72, 112.14, 107.34, 97.32, 61.28, 60.96, 56.41, 56.22, 51.92, 14.42 ppm. HRMS
(TOF MS ES+) m/z calculated ([M+H]+) 471.1226 Da, found 471.1226 Da.
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Methyl 4-(6-(cyanomethyl)-4-methoxybenzo[d]thiazol-2-yl)-5,6-dimethoxy-1H-indole-2carboxylate (4-11)

To a 7 mL vial were added XPhosPdG2(4 mol%), (5,6-dimethoxy-2-(methoxycarbonyl)-1Hindol-4-yl) boronic acid (0.021 mmol), 2-(2-bromo-4-methoxybenzo[d]thiazol-6-yl)acetonitrile
(0.0216 mmol, 1.03 eq.). The vial was evacuated and purged with N2 followed by addition of
1,4-dioxane (0.35 mL) and 0.5 M potassium phosphate tribasic (3 eq.). The reaction mixture was
heated at 75 oC for 6 hrs. The reaction mixture was quenched with water (4 mL) and extracted
with ethyl acetate (5x4 mL), dried with sodium sulfate and solvent was evaporated under
reduced pressure. The crude product was purified with silica gel flash chromatography (50:50
EtOAc:Hex). 8 mg, 88%. 1H NMR (500 MHz, CDCl3) δ 8.85 (s, 1H, N-H), 8.41 (d, 1H, J=2.0
Hz), 7.52 (d, 1H, J=1.5 Hz), 7.02 (s, 1H), 6.85 (d, 1H, J=1.5 Hz), 4.16 (s, 3H), 4.00 (s, 3H), 3.99
(s, 3H), 3.96 (s, 3H), 3.91 (s, 2H) ppm. 13C NMR (125 MHz, CDCl3) δ 152.44, 142.72, 128.99,
128.97, 128.77, 128.40, 127.86, 127.19, 126.02, 119.73, 112.53, 112.10, 106.82, 96.90, 61.00,
56.47, 56.20, 51.90, 24.11 ppm. HRMS (TOF MS ES+) m/z calculated ([M+H]+) 438.1124 Da,
found 438.1112 Da.
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Methyl 7-(6-(cyanomethyl)-4-methoxybenzo[d]thiazol-2-yl)-5,6-dimethoxy-1H-indole-2carboxylate (4-11)

To a 7 mL vial were added XPhosPdG2(4 mol%), (5,6-dimethoxy-2-(methoxycarbonyl)-1Hindol-7-yl) boronic acid (0.015 mmol), 2-(2-bromo-4-methoxybenzo[d]thiazol-6-yl) acetonitrile
(0.0155 mmol, 1.03 eq.). The vial was evacuated and purged with N2 followed by addition of
1,4-dioxane (0.35 mL) and 0.5 M potassium phosphate tribasic (3 eq.). The reaction mixture was
heated at 75 ℃ for 6 hrs. The reaction mixture was quenched with water (4 mL) and extracted
with ethyl acetate (5x4 mL), dried with sodium sulfate and solvent was evaporated under
reduced pressure. The crude product was purified with silica gel flash chromatography (50:50
EtOAc:Hex). 5 mg, 70%. 1H NMR (500 MHz, CDCl3) δ 8.83 (s, 1H, N-H), 8.43 (d, 1H, J=2.0
Hz), 7.49 (d, 1H, J=1.5 Hz), 7.06 (s, 1H), 6.90 (d, 1H, J=1.5 Hz), 4.11 (s, 3H), 3.99 (s, 3H), 3.98
(s, 3H), 3.94 (s, 3H), 3.92 (s, 2H) ppm. 13C NMR (125 MHz, CDCl3) δ 153.16, 143.50, 129.79,
129.42, 128.27, 128.05, 126.89, 127.19, 126.51, 118.93, 112.95, 112.50, 107.20, 96.90, 61.49,
56.92, 56.65, 52.15, 24.60 ppm. HRMS (TOF MS ES+) m/z calculated ([M+H]+) 438.1124 Da,
found 438.1112 Da.
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5

SYNTHESIS, STRUCTURE AND PHOTOPHYSICAL PROPERTIES OF METAL
DICYANIDE DONORS COORDINATED TO AZA[5]HELIZENE VIOLOGEN
ACCEPTORS
5.1
Introduction
This chapter describes our collaborative work with HHP group (UMaine) on synthesis and study
of 2D network of gold-heli viologen as published in Dalton Transactions.199 Viologens are redox
active, strong electron accepting diquaternary salts of 4, 4’-bipyridine with the ability to form ionpair charge transfer complexes (IPCT) with donors such as dicyanoaurate. Charge transfer
properties of IPCT can be applied in photochromic and electrochromic devices.200–203 The
photoreduction properties of viologens have been known for several years with applications as
herbicides, photocleaving agents, and electronic devices. However, the photophysical and
photochemical properties of viologens are mostly unexplored.141 Phenylviologens such as 1,1’bis-(2,4-dinitrophenyl)-4,4’-bipyridinium (DNP2+) have shown desirable optical and electronic
properties due to extended π conjugation.150,204 The π–π stacking interactions of phenyl viologens
are being explored in chemistry and biology due to its effect on the photophysical properties of 2D
and 3D networks.205 In conjunction, dicyanoaurate(I) complexes are also of interest as they form
one of the most stable two coordinate complexes, with reports of high stability constants as well
as potential applications in semiconductor materials and photonic devices.147,148 Dicyanoaurate(I)
has also unique geometric and charge-transfer properties as the d10 Au(I) metal center favors
aurophilic interactions and aggregation of [Au(CN)2−]n−, which allow tuning of the optical
properties.149,150 Due to their strong electron accepting potential, viologens are luminescence
quenchers of triplet metal-to-ligand charge transfer (MLCT) luminescence in complexes
containing Au(I).
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Figure 5-1 Previously studied DNP viologen and target Gold-heli viologen (5-13).
In previous studies by HHP group at University of Maine, low energy phosphorescence was
observed from a 3D network consisting of DNP2+ coupled with dicyanoaurate(I) dimers (Figure
5-1).150 These results were surprising given that DNP2+ is non-luminescent in its free state. The
observed luminescence in this complex revealed unique photophysical properties that were
attributed to an IPCT transition arising from the heavy atom effect due to gold-viologen orbital
overlap.150,206 It would be interesting to study the photochemical interaction of other methylated
phenyl viologens which possess extended π conjugation and are luminescent in the free state with
dicyanoaurate(I).
5,10-dimethyl-5,10-diaza[5] helicene bis-tetrafluoroborate viologen was synthesized a few years
ago and the synthetic route has recently been optimized.141,206 In addition, it is one of the few
viologens known which has chirality due to the helical aromatic heterocycle.141,207 It was shown
that this compound has energy holding abilities and is a good electron transfer contender due to its
Ve being greater than Vh (electronic coupling for electron and hole respectively).208 The
conductivity spectra and refractive index of this viologen highlighted its ability of high intra/inter
molecular charge transfer within the crystal and ability to yield significant outputs with low input.
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In this work, we extend the previous work of HHP group on methyl viologen (MV2+) systems by
synthesizing 5,10-dimethyl-5,10-diaza[5]helicene (heli-viologen2+) and coupling it with two
molecules of [Au(CN)2]− to form complex 8 as shown in Figure 5-1. Synthesis and characterization
of the N,N-dimethylaza[5]helicene dicyanoaurate (Au and Ag salts) complex was done using
nuclear magnetic resonance (NMR). The crystal structure of Au heli-viologen was determined by
single crystal X-ray diffraction. Optical properties of this complex were studied using temperature
variable photoluminescence, diffuse reflectance spectroscopy (DRS), and Stern–Volmer analysis.
Density Functional Theory (DFT) calculations were performed to assist with interpretation of the
experimental data.
5.2
Results and Discussion
5.2.1 Synthesis

Scheme 5-1 Retrosynthetic scheme for viologen synthesis.
In order to access the Gold and silver heli-viologens, the key intermediate was quinolyl-E-stilbene,
which can be cyclized to form the aza-helicene structure. As shown in Scheme 5-1, aza-helicene
can be methylated to get MV2+ species of the desired viologen, which can be coupled with gold or
silver anionic species to get the desired metal-heli viologens. The key intermediate, quinolyl-Estilbene was initially synthesized from stepwise wittig route, and the method was improved by
utilizing Pd catalyzed Stille coupling or Hiyama-Heck coupling.
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Scheme 5-2 Step-wise Wittig route to access quinolyl-E-stilbene (5-5).
As shown in Scheme 5-2, stilbene intermediate (5-5) was synthesized in four steps from quinoline3-carbaldehyde (5-1) via Wittig reaction.13 5-1 was reduced with sodium borohydride to yield
primary alcohol of quinoline followed by chlorination using thionyl chloride to access 5-3. In order
to perform Wittig reaction, Wittig salt (5-4) was synthesized from 5-3. Wittig reaction of 5-4 with
aldehyde 5-1 resulted in formation of the new C-C bond resulting in quinolyl-E-stilbene (5-5).
Overall yield of this four-step route was ~20% due to poor yields at Wittig salt synthesis and Wittig
reaction steps. One of the major reasons for product loss was due to difficulty in silica gel
purification of product 5-5 due to presence of triphenylphosphine oxide. To improve the yield and
efficiency of stilbene (5-5) synthesis, Pd catalyzed Stille coupling was explored. To perform Stille
coupling, bis-tributylstannyl ethylene linker (5-8) was required, which was synthesized from
tributylstannyl hydride (5-6) and tributylstannyl acetylene (5-7) in good yield (90%).

139

Table 5-1 Catalyst optimization for Stille coupling.
Pd(0) Catalyst

Ligand

Yield

Tetrakistriphenylphosphine palladium
Pd(PPh3)4

-

20%

Triphenylphosphine PPh3

25%

Tris(dibenzylideneacetone)dipalladium
Pd2(dba)3

Triphenylphosphine PPh3

27%

Tris(o-tolyl)phosphine P(o-tolyl)3

49%

2-dicyclohexylphosphino-2’,4’,6’triisopropylbiphenyl X-phos

57%
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Reaction condition optimizations were done in order to improve the yield of 5-5. Table 5-1 shows
the reaction conditions and catalyst optimization reactions for Stille coupling. Reaction conditions
shown above with Pd2(dba)3 as Pd(0) catalyst and X-phos as the ligand were the optimized
condition resulting in 57% of the desired product. Later, Pd(II) catalyzed Hiyama–Heck crosscoupling was used with triethoxyvinylsilane to get better scalability and higher yield (91%) as
shown by Clennan and coworkers in 2016.141

Figure 5-2 Photocyclization mechanism of 5-5.
Following the synthesis of Stilbene intermediate (5-5), photocyclization was done to synthesize,
5,10-Diaza[5]helicene (5-9). As described by Woodward-Hoffman rules of cyclization, 4n+2
cyclization of 5-5 is conrotatory and as a result is photochemically allowed.209 Figure 5-2
described the mechanism of photocyclization to synthesize 5-9. Several photocyclization
conditions were explored based on UV-Vis absorption spectrum (Figure 5-3).
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Figure 5-3 UV-Vis absorption spectrum of 5-5
Table 5-2 Light source optimization for photocyclization of 5-5
Light Source

Intensity

Time

%Conversion

%Yield(major

(lumens)

(Hours)

Incandescent Lamp

600

48-52

90%

65%

Halogen Flood lamp

5000

55-60

86%

63%

Photo reactor (350 nm)

24000

4-6

100%

73%

product)

Table 5-2 shows different light sources used to optimize photocyclization reaction yields.
Photocyclization generates desired product 5-9 and a side product 5-10. As shown in Table 5-2,
incandescent lamp and halogen flood lamp gave good conversion and yield of the desired
product, however the reaction times were longer, and reproducibility was inconsistent due to low
amount of UV emitted by these light sources. Photocyclization in a photoreactor (350 nm),
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which was equipped with a magnetic stir plate, and cooling fan to minimize the heating resulted
in 100% conversion and 71% yield of the desired product in 4 to 6 hours.

Scheme 5-3 Gold-heli viologen (5-13) synthesis.
Subsequently, Methylation of 5-9 with trimethyloxonium tetrafluoroborate under nitrogen
produced the BF4 salt of heli[5]viologen (5-11) which was purified with preparative HPLC. In
order to couple the heli viologen with gold or silver dicyanide, the reaction needed to be done in
aqueous solution. Due to the limited solubility of 5-11 in aqueous solvents, the tetrafluoroborate
counterion was exchanged for chloride counterions using DOWEX ion-exchange resin. The
chloride heli-viologen (5-12) showed high solubility in aqueous solvents and was further reacted
with potassium dicyanoaurate to produce gold-coupled viologen, 5-13 in powder form. The
powder was dried and used for luminescence experiments. Three crystallization methods were
attempted in order to get single crystals for X-ray crystallography: Slow evaporation, liquid-liquid
diffusion, and vapor diffusion method. Among which vapor diffusion using the solvent
combinations below gave small single crystals for X-ray crystallography.
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Figure 5-4 Single crystal synthesis via vapor-diffusion method.
The crystallization conditions via a vapor diffusion method for Au heli-viologen (5-13) were
optimized and methanol: n-hexane and ethanol: cyclohexane were used as solvent : anti-solvent to
get single crystals for X-ray diffraction analysis.210
5.2.2 Single crystal X-ray diffraction
The solid state structure of Au heli-viologen crystallized in the centrosymmetric monoclinic space
group C2/c and contained one viologen dication and two [Au(CN)2]- anions on general positions
as the elements of the asymmetric unit (Figure 5-5). When looking into the bc-plane of the unit
cell, one of the [Au(CN)2]- anions lies perpendicular to this plane (and parallel to the a-axis) at a
distance of 3.3773(6) Å between the Au(I) atom of the dicyanoaurate anion and the centroid of the
aromatic ring sitting at the turn of the right-handed helical viologen. Typically, dicyanoaurate
anions are linear with N–Au–N angles approaching 180°; however within the structure of Au heliviologen, the [Au(CN)2]- anion lying above the turn of the helicate deviates from linearity, showing
an N–Au–N angle of 174.0(3)°.211 Such a deviation from linearity can be rationalized upon the
application of symmetry to the asymmetric unit. After applying crystallographic symmetry, this
dicyanoaurate anion dimerizes with itself and supports the formation of a bond between the
monovalent gold atoms at a distance of 3.3098(11) Å, a value on par with those published in a
previous report.212
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Figure 5-5 View along the a-axis of Au heli-viologen crystal. The dotted lines show dimer
interactions among adjacent [Au(CN)2]- anions.
As a direct consequence of the binding of the neighboring, symmetry-equivalent [Au(CN)2]anions to one another, their dimerization imparts some structural rigidity as evidenced by the
smaller size of the thermal parameters of the dimer’s constituent gold, carbon and nitrogen atoms.
Projections of the asymmetric unit along the b-axis (Figure 5-5) demonstrated strong onedimensional overlap between the dimerized [Au(CN)2]- anions and the nearly-planar region of the
viologen dications parallel to that axis. Such an orientation of these moieties relative to one another
within the solid-state structure may provide evidence for the onset of interesting spectroscopic
properties. Despite the potential for the dicyanoaurate anion located above the turn of the helical
viologen in concert with its propensity to dimerize upon the application of crystallographic
symmetry to generate interesting spectroscopic features, the second [Au(CN)2]- anion in the
asymmetric unit does not dimerize upon the application of crystallographic symmetry. Unlike the
anion in the asymmetric unit which does dimerize, the second anion has much more linear
geometry as evidenced by its N–Au–N angle of 176.5(5)°. Thermal parameters for the second
dicyanoaurate anion also demonstrate more thermal motion as evidenced by the larger anisotropic
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displacement ellipsoids for its constituent gold, carbon and nitrogen atoms. Between the anion and
the helical viologen, the closest contact occurred between the centroid of the phenyl at the turn in
the helix and N4 from the terminal nitrile at a distance of 3.351(19) Å. This distance suggests the
onset of a potential dipole–dipole interaction given the positioning of the electron-rich nitrile
relative to the electron deficient phenyl ring of the dication.31 Also, given the less intimate
molecular orbital overlap between this latter dicyanoaurate and the planar surface of the viologen,
suggests that unlike the former [Au(CN)2]-, the latter is more spectroscopically innocent. As a
consequence, Au heli-viologen can be described as a 2D network consisting of a series of
noninteracting stacked [Au(CN)2]22-/ heli-viologen2+ slabs.
Analysis of the bond distances within the different [Au(CN)2]- anions as a function of their being
free or dimerized in the solid state also revealed subtle differences. Within the dicyanoaurate anion
that dimerizes, the bond distances between the nitriles and the Au(I) were measured at distances
of 2.007(16) and 2.011(15) Å while those in the free anion were measured at 1.98(2) and 1.94(2)
Å respectively. The nitrile distances from the different anions also revealed differences as those
from the dimerized anion were measured at 1.09(2) and 1.132(19) Å while their analogues from
the free [Au(CN)2]- revealed distances of 1.12(3) and 1.17(3) Å between the constituent carbon
and nitrogen atoms. Such a difference can be hypothesized on the basis of dimerization between
the neighboring dicaynoaurate anions upon the application of symmetry. Electron density is
donated from the nitrile into the corresponding Au–C bond, resulting in a shortening of the former
and a lengthening of the latter. This build-up of electron density on the monovalent Au atom, in
concert with the nearby positioning of a symmetry-related anion, supports bond formation between
the gold atoms. Relevant bond distances within the free dicyanoaurate anion are similar to those
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reported in the literature as no intramolecular donation of electron density to support Au–Au bond
formation occurs.211
5.2.3 Infrared spectroscopy

Figure 5-6 Infrared spectrum of Au heli viologen (5-13).
Au heli-viologen (5-13) is a coordination polymer, where a dominant vibrational feature is the
cyanide stretch. The νs(CN) of the gold(I) dicyanide anions are observed at 2140 cm-1, 2152 cm-1,
2160 cm-1, and 2165 cm-1, indicating that the CN ligands are slightly inequivalent throughout the
crystal motif. This split is in agreement with the structural data which shows the presence of
monomer [Au(CN)2]- and dimer [Au(CN)2]22- units. For oligomer units of metal cyanides, the
νs(CN) vibrational mode moves to lower energies as the oligomer size increases due to the
increased electron density of the CN π* LUMO.213 In keeping with this, we have assigned the
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bands at 2140 cm-1 and 2152 cm-1 to the νs(CN) vibration modes of the dimers and the 2160 cm-1
and 2165 cm-1 bands to the vibrational modes of the monomer subunits.
5.2.4 Photophysical studies
To investigate the absorption of Au heli-viologen, we have performed diffuse reflectance
measurements of solid microcrystalline samples of both Au heli-viologen (5-13) and MV2+ at 298
K (Figure 5-7). Solid samples of gold coordinated MV2+ are yellow in color and absorb strongly
in the UV.
heli[5]viologen
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Figure 5-7 Solid state DRS absorption spectrum of solid samples of Au heli-viologen and MV2+
at 298 K converted via Kubelka-Munk.
As seen in the spectra, the absorption falls off sharply around 475 nm with an optical absorption
edge of 2.39 eV. This edge is slightly more variable for the gold free heli-viologen2+ which slowly
tappers off through the visible range and is identical to previous reports of MV2+ which are
assigned to a π → π* state.141 Introduction of [Au(CN)2]- results in few changes in the DRS spectra
in comparison to heli-viologen2+.
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Figure 5-8 Luminescence spectra of Au heli-viologen between 10 K and 298 K. Excitation
(dashed) and emission (solid).
The appearance of higher energy bands at 268 nm not observed in the gold free heli-viologen2+ are
assigned to a metal to ligand charge transfer (MLCT) localized to the [Au(CN)2]-/[Au(CN)2]22subunits consistent with reports elsewhere.214 The majority of the band remains a π → π* state of
the heli-viologen2+.
As an aromatic cation, heli-viologen2+ is well equipped to accept electrons from the electron rich
gold(I) dicyanide anions as reported for other viologen like molecules. To probe this temperature
variable photoluminescence measurements of microcrystalline samples of Au heli-viologen
between 298 K and 10 K were performed. The spectra are shown in Figure 5-8 and are overlaid to
demonstrate the change in peak shape and relative intensity with respect to temperature. We
observe that the excitation spectrum of Au heli-viologen (5-13) consists of two bands: one high
energy band at 375 nm, and one low energy band at 470 nm. A shift in the relative intensity towards
the high energy band is observed upon temperature change. No significant shift in the position of
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either excitation band is observed at lower temperatures. At room temperature, compound 5-13 in
microcrystalline form shows one broad triplet emission band at 580 nm (τ298 K = 1.01 μs, τ78 K =
1.12 μs). At lower temperatures the relative emission intensity increases and a second, lowerenergy band appears at 608 nm. This band first appears at 129 K and does not shift during cooling.
Time-dependent measurements show much shorter lifetime of this band (τ78

K

= 130 ns) in

comparison to that of the band at 580 nm.

Heli-viologen2+

Figure 5-9 Energy diagram of emission pathways for Au heli-viologen. At higher temperatures
the heli-viologen2+ emission by T1→S0 is favored along with quenching of [Au(CN)2]-2 via the
excited S1 to heli-viologen2+ S1. At low temperatures (<129 K) electron transfer is absent resulting
in [Au(CN)2]-2 S1→S0 emission. S0, ground state; S1, first excited state; T1, first triplet state; NR,
nonradiative decay; ET, electron transfer
Based on previous reports of heli-viologen2+ the data reported here, the 580 nm band is assigned
to a triplet π → π* localized to heli-viologen2+. The emission band observed at 608 nm is a new
feature and was not observed in previous reports of heli-viologen2+. Both the life-time and

150

wavelength of this band are too long for cation S1→S0 emission. Instead, these values better fit
expected values for [Au(CN)2]- emission. We have observed similar behavior in Au(CN)2-/DNP2+
structures where low temperature emission is dominated by [Au(CN)2]- bands but quenched at 298
K.150 The absence of [Au(CN)2]- emission above 129 K indicates quenching by heli-viologen2+ at
high temperatures. It is attributed to an oxidative electron transfer in the excited state at higher
temperatures between [Au(CN)2]- and heli-viologen2+ (Figure 5-9).
5.2.5 Electron transfer analysis
An analysis of this system was performed via Stern–Volmer and a Rehm–Weller to support the
proposed electron transfer. First, a Stern–Volmer analysis was performed in order to examine the
nature of heli-viologen2+ quenching of [Au(CN)2]-, specifically to determine if the observed
quenching is due to electron transfer or resonance.215 First, the ground state absorption spectra of
the components were compared to the combined mixture.
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Figure 5-10 Absorption spectra of potassium dicyanoaurate, heli[5]viologen, and Au heliviologen in methanol (5 x 10-4 M).
Figure 5-10 shows that the absorption spectrum of a mixture of heli-viologen2+ and potassium
dicyanoaurate is the simple sum of the two component absorption spectra. The lack of an additional
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absorption band in the mixed spectrum indicates that no ground state electronic interaction occurs
between the two species. From this observation, we conclude that no static quenching occurs in
this system. While our previous experiment indicates no ground-state quenching, the possibility of
quenching in the excited-state was further investigated. The effect of heli-viologen2+ as a dynamic
quencher of [Au(CN)2]- photoluminescence was investigated by measuring the photoluminescence
of a series of heli-viologen2+/dicyanoaurate solutions. Luminescence intensity associated with
[Au(CN)2]- was observed to decrease as the concentration of heli-viologen2+ was increased. Since
we observe photoluminescence quenching upon addition of heli-viologen2+, this data can be fit to
the Stern–Volmer equation to further analyze the photophysical kinetics of the system.
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Figure 5-11 Stern-Volmer plot for aqueous Au heli-viologen.
Figure 5-11 shows the Stern–Volmer plot constructed for this experiment. From this plot a KSV
value can be determined (KSV = 5170 M-1). The data show that quenching is observed for this
system. This indicates that there is a significant interaction between gold dicyanoaurate species
and heli-viologen2+ during the photophysical excitation and relaxation process. This observation
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provides further support for our assignment of the emission band observed at 608 nm as a
[Au(CN)2]- →heli-viologen2+ electron transfer.
The Rehm–Weller equation35 can be used to support the proposed electron transfer by determining
whether the process is thermodynamically favorable.

In the Rehm–Weller equation shown above, ΔGET is the free energy change associated with the
electron transfer process, Ered and Eox are the reduction potential of the viologen heli-viologen2+
acceptor and oxidation potential of the [Au(CN)2]22- donor respectively. Es represents the energy
of the singlet state energy at 78 K (average of the lowest energy excitation band and highest energy
emission band), and eo2/εa is taken as the attraction that the ion pair experiences.206,216 We have
calculated the Eox (1.74 eV) via DFT by taking the difference in energy between an optimized
structure of [Au(CN)2]22- and [Au(CN)2]-. For the Au heli-viologen, ΔGET is therefore calculated
as: ((1.74 + 0.22)-2.32-0.15) = -0.51 eV, indicating the electron transfer is spontaneous. This
calculated free energy change supports an electron transfer process as a feasible explanation for
the observed quenching system.
5.2.6 Ag-Heli Viologen (5-14)
Chloride-heli viologen (5-12) was coupled with potassium dicyanoargentate in order to synthesize
silver-heli[5] viologen (5-14). Several attempts were made to synthesize and recover 5-14, which
were semi-successful as the powder did not precipitate out of solution as easily. When precipitation
was induced by solvent evaporation, inorganic salts precipitated out along with the desired metal
organic complex and isolation of 5-14 could not be confirmed. As shown in Figure 5-12, potassium
dicyanoargentate showed that νs(CN) vibration mode is observed at 2136 cm-1. Synthesized and
precipitated potential Ag-heli viologen sample showed νs(CN) vibrational mode at 2162 cm-1
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similar to Au-heli viologen. In addition low energy vibrational modes of aza-helicine system are
observed below 1600 cm-1.

Figure 5-12 Infrared spectra of KAg(CN)2 (upper) and potential Ag-Heli viologen (lower)
However, this product could not be confirmed with 1H NMR,

13

C NMR or MS. Single crystal

synthesis was attempted on precipitated powder using vapor-diffusion methods but these attempts
were unsuccessful. Synthesis and photophysical properties of Ag-heli viologen need to be studied
in a future to compare the 2D structure of Ag-heli viologen to the synthesized Au-heli viologen.
5.3 Conclusion and Future direction
Au-heli viologen (5-13) was synthesized from 4-bromoquinoline via Pd catalyzed Stille
coupling/ Pd catalyzed Hiyama-Heck coupling, photocyclization, methylation and metal
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coupling reactions with overall yield of 22%. Single crystals of Au-heli viologen (5-13) were
accessed via vapor-diffusion, and characterized by single crystal X-ray diffraction. The 2D
network was found to consist of [Au(CN)2]− dimers and monomers trapped within heliviologen2+ units. Photophysical studies show that at 298 K this complex emits at 580 nm via a
triplet π → π* transition localized to the heli-viologen2+. Cooling to low temperatures results in a
new emission band at 608 nm. Lifetime measurements and DFT calculations indicate that this
new band is the appearance of [Au(CN)2]22− emission. The lack of this emission at temperatures
higher than 129 K indicates that quenching occur from heli-viologen2+. Stern–Volmer and
Rehm–Weller analysis of this transition supports our assignment by revealing that quenching of
[Au(CN)2]22−by heli-viologen2+ involves the transfer of an electron between ion pairs. Synthesis
of Ag-heli viologen was attempted but crystallization and structure confirmation were
unsuccessful. In a future study 2D/3D networks of Ag-heli viologen involving better electron
donors such as dicyanoargentate would provide insight into the electron-transfer phenomenon
investigated here.
5.4 Experimental
5.4.1 General Information
All reagents were purchased from Sigma-Aldrich and Fisher Scientific and used directly
without further purification. All products were purified with silica-gel flash
chromatography or preparative HPLC. HPLC was performed on a Gilson analytical to
semi-preparative system using Kinetex 5 µm EVO C18 100Å 4.6 x 150 mm for analytical
and Kinetex 5 µm EVO C18 100Å 21.1 x 150 mm for preparative purpose. Products were
characterized by 1H and
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C NMR and mass spectrometry. NMR characterization results

and J values were compared with published results. 1H and 13C NMR spectra were recorded
on Agilent/Varian 400 MHz and 101 MHz NMR spectrometer respectively. Mass spectra
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were recorded using a Synapt G2 Q-TOF ESI mass spectrometer at the Mass Spectrometry
lab at the University of Illinois Urbana Champagne.
5.4.2 Synthesis of (E)-1,2-di(quinoline-3-yl)ethene (5-5)
5.4.2.1 Step-wise Wittig route
Quinolin-3-ylmethanol (5-2)

In a 7 mL scintillation vial, 3-quinolinecarboxaldehyde (150 mg, 0.95 mmol) was dissolved
in ethanol (2 mL) followed by addition of sodium borohydride (50 mg, 1.32 mmol, 1.4 eq.).
Mixture was stirred at rt for 2 hrs. The mixture was diluted with diethy ether (5 mL) and
washed with water (2 x 5 mL). The aqueous phase was extracted with diethyl ether (2 x 5
mL) and combined organic phases were dried with sodium sulfate (Na2SO4) and
concentrated. 132 mg, 87% yield. 1H NMR (400 MHz, CDCl3) δ 8.74 (d, 1H, J=2.0 Hz),
8.06 (s, 1H), 8.00 (d, 1H, J=8.8 Hz), 7.70 (d, 1H, J=8.0 Hz), 7.62 (m,1H), 7.48 (m, 1H),
4.83 (s, 2H) ppm. Spectral data matched with those in literature.207
3-chloromethylquinoline (5-3)

In a 7 mL scintillation vial quinolin-3-ylmethanol (130 mg, 0.82 mmol) in dry methylene
chloride (5 mL) under N2 at 0 °C was added thionyl chloride (1.1 mL, 16.3 mmol, ~20 eq.)
was added dropwise. The mixture was warmed up to rt and stirred for 1 hr. The mixture
was concentrated to dryness under vacuum to give 3-chloromethylquinoline. 140 mg, 96%
156

yield. 1H NMR (400 MHz, CDCl3) δ 9.42 (s, 1H), 9.33 (s, 1H), 8.38 (d, 1H, J=8.4 Hz),
8.33 (d, 1H, J=8.8 Hz), 8.20 (m,1H), 8.01 (m, 1H), 5.12 (s, 2H) ppm. Spectral data matched
with those in literature.207
Triphenyl(quinolin-3-ylmethyl)phosphonium chloride (5-4)

In a 20 mL scintillation vial, 3-chloromethylquinoline (135 mg, 0.76 mmol) was dissolved
in toluene (7 mL) followed by addition of triphenylphosphine (200 mg, 0.76 mmol).
Reaction mixture was refluxed at 110 °C for 6 hrs. Solid was filtered, washed with toluene
and dried to get wittig salt. 187 mg, 56%. 1H NMR (400 MHz, CDCl3) δ 8.28 (s, 1H, J=2.0
Hz), 8.04 (s, 1H), 7.80 (d, 1H, J=8.4 Hz), 7.69 (m, 8H,), 7.66 (d,1H), 7.55 (m, 7H), 7.51
(m, 1H), 7.37 (m, 1H), 5.60 (d, 2H, JH-P=14.8 Hz ) ppm. Spectral data matched with those
in literature.207
Wittig reaction (synthesis of (E)-1,2-di(quinoline-3-yl)ethane) (5-5)

In a 7 mL scintillation vial, to a solution of triphenyl(quinolin-3-ylmethyl)phosphonium
chloride (117 mg, 0.25 mmol) and 3-quinolinecarbaldehyde (40 mg, 0.25 mmol) in
methanol (4 mL) was added sodium methoxide (0.3 mL, 0.3 mmol, 1M in MeOH)
dropwise. Mixture was refluxed at 65 °C for 4 hrs. After cooling the mixture, water (20
mL) was added the mixture was extracted with methylene chloride (4 x 20 mL). Due to
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significant presence of triphenylphosphine oxide, the product was purified with silica gel
flash chromatography (60:40 EtOAc:Hexane). 31 mg, 43%
5.4.2.2 Stille coupling to synthesize 5-5
Bis-1,2-tributylstannyl ethylene synthesis (5-9)

Tributylstannyl acetylene (328 mg, 1 mmol) & tributylstannyl hydride (291 mg, 1 mmol)
were added to a vial with AIBN (3.3 mg, 0.02 mmol). The mixture was heated and stirred
at 100 oC for 6 hrs. Water was added to the reaction mixture and the product was extracted
with four aliquots of methylene chloride and dried over Na2SO4. The solvent was
evaporated under reduced pressure yielding 5-9. This product was used in the following
step without further purification. 549 mg, 90%. 1H NMR (400 MHz, CDCl3) δ 6.89 (s,
2H), 1.46-1.64 (m, 12H), 1.25-1.44 (m, 12H), 0.80-0.98 (m, 30H) ppm. Spectral data
matched with those in literature.217
(E)-1,2-di(quinoline-3-yl)ethane(5-5)

3-Bromoquinoline (131 mg,0.63 mmol) and bis-1,2-tributylstannyl ethylene (194 mg, 0.32
mmol) were added to a vial purged with N2. Pd2(dba)3 catalyst (5 mol%) & X-phos (0.1
eq.) were added to the reaction vial, followed by addition of dry toluene (4 mL) under N 2.
The reaction mixture was heated at 110 oC. The solvent was evaporated under reduced
pressure and the crude product was purified with flash chromatography using 70%:30%
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ethyl acetate:hexane mixture with 1% triethylamine to get (E)-1,2-Di(quinoline-3yl)ethane. 51 mg, 57%. Same procedure was followed for other catalysts and ligands (Table
5-1) during optimizations with catalyst amounts varying from 5-10 mol% and ligand (0.10.2 eq.).
5.4.2.3 Hiyama-Heck Coupling

A mixture of triethoxyvinylsilane (0.43 g, 2.25 mmol) and sodium hydroxide (0.5 M, 18
mL) was added to a 40 mL pressure vial, followed by addition of 3-bromoquinoline (1)
(0.75 g, 3.60 mmol) & palladium acetate (0.5 mol%). The reaction vial was sealed with a
heat resistant teflon resistant screw cap and the mixture was stirred at 140 oC for 6 hrs.
After cooling, the green precipitate was filtered and washed with 10:1 ethyl
acetate:chloroform. The solvent was evaporated under vacuum. 460 mg, 91%. 1H NMR
(400 MHz, CDCl3) δ 9.19 (d, 2H, J=2.1 Hz), 8.25 (d, 2H, J=2.1 Hz), 8.11 (d, 2H, J=8.4
Hz), 7.86 (d, 2H, J=8.0 Hz), 7.72 (ddd, 2H, J=8.3,7.0,0.9 Hz), 7.58 (ddd, 2H, J=8.1, 6.7,
0.9 Hz), 7.47 (s, 2H) ppm.

13C

NMR (101 MHz, DMSO-d6) δ 175.40,

151.16,149.62,145.85, 137.60, 130.34, 130.07, 128.96, 127.61, 116.79 ppm. HRMS (TOF
MS ES+) m/z calculated for C20H15N2 ([M+H]+) 283.1235 Da, found 283.1231Da.
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5.4.3 Photocyclization to synthesize 5,10-diaza[5]helicene (5-9)

(E)-1,2-di(quinoline-3-yl)ethane (0.6 g, 2.1 mmol) was dissolved in ethyl acetate (500 mL)
in a round bottom flask. A condenser was attached to the top and the setup was mounted
inside an RPR-100 photoreactor on a stir-plate.

The mixture was stirred and irradiated at 350 nm for 7 hrs. The crude product was purified
with silica-gel chromatography using 70%:30% ethyl acetate:hexane. 430 mg, 73%. 1H
NMR (400 MHz, CDCl3) δ 9.46 (s, 2H), 8.65 (dd, 2H, J=8.4, 1.2 Hz), 8.29 (dd, 2H, J=8.3,
1.3 Hz), 8.14 (s, 2H), 7.76 (ddd, 2H, J=8.3, 7.0, 1.3 Hz), 7.44 (ddd, 2H, J=8.4, 7.0, 1.3 Hz)
ppm.

13C

NMR (101 MHz, CDCl3) δ 152.53, 145.88, 129.71, 129.48, 129.43, 128.17,

127.32, 127.26, 125.61, 124.38 ppm. HRMS (TOF MS ES+) m/z calculated for C20H13N2
([M+H]+) 281.1079 Da, found 281.1070 Da. Benzo-[b]-1,8-diaza[4]-helicene (6) was
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recovered as a side-product. Yield: 110 mg, 19%. 1H NMR (400 MHz, CDCl3) δ 11.37 (d,
1H), 9.37 (s, 1H), 8.75 (s, 1H), 8.49 (d, 2H, J=8.7 Hz), 8.30 (d, 2H, J=8.1 Hz), 8.09-7.98
(m, 2H), 7.93-7.83 (m, 4H), 7.67 (dd, 1H, J=7.96, 6.92 Hz) ppm.
5.4.4 Synthesis of dimethylaza[5]helicene
Dimethylaza[5]helicene bis-tetrafluoroborate (5-11)

To trimethyl oxonium tetrafluoroborate (Meerwein’s salt, 0.356 g, 2.39 mmol) in a 40 mL
scintillation vial was added anhydrous methylene chloride (100 mL) under N 2. 5,10diaza[5]helicene (5-9) (0.223 g, 0.80 mmol) in anhydrous methylene chloride (20 mL) was
then added to the vial under N2. The vial was stirred under N2 for 24 hrs. Methylene chloride
was removed under vacuum. The dried yellow solid was triturated with warm 90% ethanol.
The crude (5-11) was further purified with preparative HPLC using 5% to 15% acetonitrile
in 10 minutes. Yield: 233 mg (60%). 1H NMR (400 MHz, CD3CN) δ 10.04 (d, 2H, J=2.2
Hz), 8.72 (d, 2H, J=8.5 Hz), 8.67 (d, 2H, J=1.5 Hz), 8.57 (d, 2H, J=8.5 Hz), 8.24 (ddd, 2H,
J=8.7, 7.4, 1.3 Hz), 7.88 (ddd, 2H, J=8.3, 7.3, 1.0 Hz), 4.82 (s, 6H) ppm.

13C

NMR (101

MHz, CD3CN) δ 154.82, 136.93, 135.12, 133.74, 131.78, 131.06, 129.86, 129.32, 127.33,
120.34, 47.60 ppm. HRMS (TOF MS ES+) m/z calculated for C20H15N2 ([M]+2) 155.0735
Da, found 155.0731 Da.
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Dimethylaza[5]helicene dichlorate (5-12)

DOWEX 1×8 200-400 mesh ion-exchange resin (Acros) (11.25 g) was loaded onto a
column and washed with methanol followed by equilibration with 50% aqueous ethanol.
Compound 5-11 (225 mg, 0.46 mmol) dissolved in acetonitrile (0.5 mL) was loaded into
the column. The column was washed with 50% aqueous ethanol. The fractions were
concentrated and reloaded on the column and collected two more times. Combined
fractions were concentrated under reduced pressure to yield the product (5-12). Yield: 167
mg (95%). 1H NMR (400 MHz, CD3OD) δ 10.54 (d, 2H, J=2.2 Hz), 8.86 (d, 2H, J=8.4
Hz), 8.82 (d, 2H, J=1.2 Hz), 8.75 (d, 2H, J=8.7 Hz), 8.28 (ddd, 2H, J=8.6, 7.3, 1.3 Hz),
7.92 (ddd, 2H, J=8.2, 7.3, 1.0 Hz), 4.99 (s, 6H) ppm.

13C

NMR (101 MHz, CD3OD) δ

155.89, 137.21, 135.33, 133.99, 132.12, 130.97, 130.46, 129.73, 127.63, 120.59, 47.12
ppm. HRMS (TOF MS ES+) m/z calculated for C20H15N2 ([M]+2) 155.0735 Da, found
155.0735 Da.
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5.4.5 Synthesis of Au heli-viologen(5-13)

To a solution of N,N-Dimethylaza[5]helicene dichloride (5-12) (40 mg, 0.104 mmol) in
water (30 mL), potassium dicyanoaurate (60 mg,0.21 mmol) in water was added while
stirring. The precipitate was filtered after 10-12 hours and solvent was slowly evaporated
to complete the precipitation of N,N-Dimethylaza[5]helicene dicyanoaurate (5-13). Yellow
solid was dried under reduced pressure and used for crystallization. Yield- 49 mg (58%).
Crystallization. Au-heli viologen (Complex 5-13) (10 mg) was dissolved in ethanol (0.2
mL) in a 2 mL scintillation vial. This vial was covered with porous aluminum foil and
placed in a 20 mL scintillation vial containing cyclohexane (2 mL). This closed system was
kept inside the fume hood for 8 to 9 days. Small crystals formed through slow vapor
diffusion. Results were reproduced with methanol as a solvent and n-hexane as antisolvent.210
1H

NMR (400 MHz, CD3OD) δ 10.49 (d, 2H, J=2.2 Hz), 8.89 (d, 2H, J=8.8 Hz), 8.80 (d,

2H, J=2.1 Hz), 8.75 (d, 2H, J=9.0 Hz), 8.29 (ddd, 2H, J=8.6, 7.5, 1.1 Hz), 7.95 (ddd, 2H,
J=8.6, 7.5, 1.1 Hz), 4.97 (s, 6H) ppm. 13C NMR (101 MHz, D2O) δ 153.67, 135.70, 134.10,
133.08, 130.69, 129.96, 129.93, 128.96, 128.51, 126.43, 119.03 ppm.
5.4.6 Crystallography
A small yellow block-like crystal of Au heliviologen having dimensions 0.057 × 0.063 × 0.092
mm3 was secured to a Mitegen cryomount using Paratone oil. Single crystal reflection data were
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collected on a Rigaku Oxford Diffraction (ROD) Synergy-S X-ray diffractometer equipped with a
HyPix-6000HE hybrid photon counting (HPC) detector. The data were collected at 100 K using
Mo Kα1 radiation from a data collection strategy calculated using CrysAlisPro which was also
responsible for unit cell determination, initial indexing, data collection, frame integration, Lorentzpolarization corrections and final cell parameter calculations.218 A numerical absorption correction
via face indexing was performed using the SCALE3 ABSPACK algorithm integrated into
CrysAlisPro.17. The crystal structure was solved via intrinsic phasing using ShelXT and refined
using olex2. refine within the Olex2 graphical user interface.219–221 The structural model’s space
group was unambiguously verified by PLATON.21
Structural refinement of the reflection data for 8 resulted in the identification of electron density
peaks associated with a highly disordered interstitial CH2Cl2 molecule that could not be
satisfactorily modeled. This minor impurity may have been trapped during screening of solvents
for crystallization. The data were treated using the SQUEEZE routine in PLATON, then refined
on F2 to acceptable levels.222 The final structural refinement included anisotropic temperature
factors on all nonhydrogen atoms and hydrogen atoms were attached via the riding model at
calculated positions using appropriate HFIX commands. The crystallographic and refinement data
for Au heli-viologen is listed in Table 1. Crystallographic data for this paper has been deposited
with the Cambridge Crystallographic Data Centre with the CCDC number 1558366.
5.4.7 Spectroscopy studies
Steady-state photoluminescence scans were collected between 298 K and 10 K. Spectra were taken
with a Model Quantamaster-1046 photoluminescence spectrophotometer from Photon Technology
International using a 75 W xenon arc lamp combined with two excitation monochromators and
one emission monochromator. A photomultiplier tube at 800 V was used as the emission detector.
The solid samples were mounted on a copper plate using non-emitting copper-dust high vacuum
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grease. All scans were collected under vacuum with a Janis ST-100 optical cryostat. Infrared
spectra were collected on solid samples at 298 K using a PerkinElmer FT-IR Spectrum Two
equipped with a Universal Attenuated Total Reflectance (UATR) accessory and a LiTaO3 MIR
detector. Diffuse reflectance spectra were collected on solid samples at 298 K. The light source
was a Mikropack DH-2000 deuterium and halogen light source coupled with an Ocean Optics
USB4000 detector. Scattered light was collected with a fiber optic cable. Spectra was referenced
with polytetrafluoroethylene. Data was processed using SpectraSuite 1.4.2_09.
5.4.8 Stern–Volmer quenching experiments
For quenching experiments, heli-viologen2+ was used as the quencher. After determining proper
quencher concentration ranges, the quenching experiment performed using the [Au(CN)2]- sample
solutions. A stock solution of 5 x 10-4 M K[Au(CN)2]2 was first prepared, and then 1 mL stock
solution was distributed among all quenching vials. The quencher solution was then added to the
quenching vials in increments of 50 μL. The contents of each vial were then transferred to cuvettes
and the emission spectrum of each sample was measured separately. Emission scans were
conducted on a Jobin Yvon Systems Fluorolog 3 Spectrofluorometer. The excitation
monochromator was referenced to a secondary detector, and the emission monochromator was
calibrated to a water Raman peak to ensure the accuracy of scans.
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APPENDIX A
NMR SPECTRA FOR CHAPTER 2

Figure A 1 1H NMR spectrum of 2-1

Figure A 2 13C NMR spectrum of 2-1
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Figure A 3 1H NMR of 2-2

Figure A 4 13C NMR of 2-2
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Figure A 5 1H NMR of 2-3

Figure A 6 13C NMR of 2-3
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Figure A 7 1H NMR of 2-18

Figure A 8 13C NMR of 2-18
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Figure A 9 1H NMR of 2-19

Figure A 10 13C NMR of 2-19
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Figure A 11 1H NMR of 2-4

Figure A 12 13C NMR of 2-4
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Figure A 13 1H NMR of 2-22

Figure A 14 13C NMR of 2-22
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Figure A 15 1H NMR of 2-23

Figure A 16 13C NMR of 2-23
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Figure A 17 1H NMR of 2-5

Figure A 18 13C NMR of 2-5
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Figure A 19 1H NMR of 2-6

Figure A 20 13C NMR of 2-6
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Figure A 21 1H NMR of 2-7

Figure A 22 13C NMR of 2-7
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Figure A 23 1H NMR of 2-8

Figure A 24 13C NMR of 2-8
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Figure A 25 1H NMR of 2-20

Figure A 26 13C NMR of 2-20
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Figure A 27 1H NMR of 2-21

Figure A 28 13C NMR of 2-21
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Figure A 29 1H NMR of 2-9

Figure A 30 13C NMR of 2-9
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Figure A 31 1H NMR of 2-10

Figure A 32 13C NMR of 2-10
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Figure A 33 1H NMR of 2-11

Figure A 34 13C NMR of 2-11
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Figure A 35 1H NMR of 2-12

Figure A 36 13C NMR of 2-12
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Figure A 37 1H NMR of 2-24

Figure A 38 13C NMR of 2-24
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Figure A 39 1H NMR of 2-25

Figure A 40 13C NMR of 2-25
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Figure A 41 1H NMR of 2-14

Figure A 42 13C NMR of 2-14
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Figure A 43 1H NMR of 2-15

Figure A 44 13C NMR of 2-15
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Figure A 45 1H NMR of 2-17

Figure A 46 13C NMR of 2-17
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Figure A 47 1H NMR of 2-16

Figure A 48 13C NMR of 2-16
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APPENDIX B
NMR SPECTRA FOR CHAPTER 3

Figure B 1 1H NMR of 3-5

Figure B 2 13C NMR of 3-5
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Figure B 3 1H NMR of 3-6

Figure B 4 13C NMR of 3-6
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Figure B 5 1H NMR of 3-7

Figure B 6 13C NMR of 3-7
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Figure B 7 1H NMR of 3-8

Figure B 8 13C NMR of 3-8

213

Figure B 9 1H NMR of 3-9

Figure B 10 13C NMR of 3-9
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Figure B 11 1H NMR of 3-10

Figure B 12 13C NMR of 3-10
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Figure B 13 1H NMR of 3-11

Figure B 14 13C NMR of 3-11

216

Figure B 15 1H NMR of 3-12

Figure B 16 13C NMR of 3-12
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Figure B 17 1H NMR of 3-13

Figure B 18 13C NMR of 3-13
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Figure B 19 1H NMR of 3-14

Figure B 20 13C NMR of 3-14
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Figure B 21 1H NMR of 3-17

Figure B 22 13C NMR of 3-17
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Figure B 23 1H NMR of 3-18

Figure B 24 13C NMR of 3-18
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Figure B 25 1H NMR of 3-19

Figure B 26 13C NMR of 3-19
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Figure B 27 1H NMR of 3-20

Figure B 28 13C NMR of 3-20
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Figure B 29 1H NMR of 3-21

Figure B 30 13C NMR of 3-21
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Figure B 31 1H NMR of 3-22

Figure B 32 13C NMR of 3-22
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Figure B 33 1H NMR of 3-23

Figure B 34 13C NMR of 3-23
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Figure B 35 1H NMR of 3-24

Figure B 36 13C NMR of 3-24
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Figure B 37 1H NMR of 3-26

Figure B 38 13C NMR of 3-26
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Figure B 39 1H NMR of 3-27

Figure B 40 13C NMR of 3-27
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Figure B 41 1H NMR of 3-29

Figure B 42 13C NMR of 3-29

230

Figure B 43 1H NMR of 3-30

Figure B 44 13C NMR of 3-30
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Figure B 45 1H NMR of 3-31

Figure B 46 13C NMR of 3-31
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Figure B 47 1H NMR of 3-33

Figure B 48 13C NMR of 3-33
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Figure B 49 1H NMR of 3-32

Figure B 50 13C NMR of 3-32
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APPENDIX C
NMR SPECTRA FOR CHAPTER 4

Figure C 1 1H NMR of 4-1

Figure C 2 1H NMR of 4-3
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Figure C 3 1H NMR of 4-6

Figure C 4 13C NMR of 4-6
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Figure C 5 1H NMR of 4-9

Figure C 6 13C NMR of 4-9
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Figure C 7 1H NMR of 4-4

Figure C 8 13C NMR of 4-4
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Figure C 9 2D (1H-1H) COSY of 4-4
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Figure C 10 2D (1H-13C) HSQC of 4-4

Figure C 11 2D (1H-13C) HMBC of 4-4
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Figure C 12 1H NMR of 4-10

Figure C 13 13C NMR of 4-10
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Figure C 14 2D (1H-1H) COSY of 4-10
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Figure C 15 2D (1H-13C) HSQC of 4-10
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Figure C 16 2D (1H-13C) HMBC of 4-10
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Figure C 17 1H NMR of 4-11

Figure C 18 13C NMR of 4-11
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APPENDIX D
A. HPLC CHROMATOGRAM OF CHAPTER-4

Figure D 1 HPLC chromatogram of 7’-bromo DMIC (2-12) borylation
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Figure D 2 HPLC chromatogram of 3’-bromo DMIC (2-4) borylation optimization reactions
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Normalized absorbance

APPENDIX E
B. PHOTOPHYSICAL DATA FOR CHAPTER-4

5,6-DMICA
Bz(ethyl ester
sidechain)
Dimer-1

230

330

430

530

630

Wavelength(nm)
Figure E 1 UV/Vis spectra of 5,6-DMIC (2-3), Benzothiazole (3-10), and mixed melanoid (4-4)

Normalized intensity

Ex-290 nm
Ex-354 nm
Em-455 nm

200

300

400

500

Wavelength(nm)
Figure E 2 Luminescence spectra of mixed melanoid (4-4)
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600

700

Normalized absorbance
230

330

430

530

630

730

Wavelength (nm)

Normalized intensity

Figure E 3 UV/Vis spectrum of mixed melanoid (4-11)

230

Em-450 nm
Ex-350 nm
Ex-280 nm

330

430

530

Wavelength (nm)
Figure E 4 Luminescence spectra mixed melanoid (4-11)
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630

730

APPENDIX F
NMR SPECTRA FOR CHAPTER 5

Figure F 1 1H NMR of 5-2
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Figure F 2 1H NMR of 5-3
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Figure F 3 1H NMR of 5-4
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Figure F 4 1H NMR of 5-9
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Figure F 5 1H NMR of 5-5

Figure F 6 13C NMR of 5-5
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Figure F 7 1H NMR of 5-9

Figure F 8 13C NMR of 5-9
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Figure F 9 1H NMR of 5-11

Figure F 10 13C NMR of 5-11
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Figure F 11 1H NMR of 5-12

Figure F 12 13C NMR of 5-12
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Figure F 13 1H NMR of 5-13

Figure F 14 13C NMR of 5-13
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%Trans

APPENDIX G
C. IR SPECTRA FOR CHAPTER 5

3,950

3,450

2,950

2,450
1,950
Wavenumber (cm-1)

1,450

950

Figure G 1 Full IR spectrum of microcrystalline Au heli-viologen (5-13) at 298 K
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450

APPENDIX H
D. BOND LENGTHS AND BOND ANGLES OF AU-HELI VIOLOGEN

Au(1)-C(1)

2.0107(1)

C(9)-C(10)

1.4369(1)

Au(1)-C(2)

2.0068(1)

C(10)-C(11)

1.4131(1)

Au(2)-C(4)

1.9837(1)

C(10)-C(19)

1.3644(1)

Au(2)-C(3)

1.9433(1)

C(13)-C(18)

1.4101(1)

N(1)-C(1)

1.1318(1)

C(13)-C(14)

1.4156(1)

N(2)-C(2)

1.0913(1)

C(14)-C(15)

1.3473(1)

N(3)-C(3)

1.1708(1)

C(15)-C(16)

1.3870(1)

N(4)-C(4)

1.1198(1)

C(16)-C(17)

1.3998(1)

N(5)-C(5)

1.4637(1)

C(17)-C(18)

1.3923(1)

N(5)-C(6)

1.2860(1)

C(18)-C(19)

1.4561(1)

N(5)-C(26)

1.4028(1)

C(19)-C(20)

1.4407(1)

N(6)-C(11)

1.3096(1)

C(20)-C(21)

1.4663(1)

N(6)-C(12)

1.4724(1)

C(21)-C(26)

1.4320(1)

N(6)-C(13)

1.4031(1)

C(21)-C(22)

1.4159(1)

C(6)-C(7)

1.4320(1)

C(22)-C(23)

1.3267(1)

C(7)-C(8)

1.4136(1)

C(23)-C(24)

1.4234(1)

C(7)-C(20)

1.4379(1)

C(24)- (C25)

1.3774(1)

C(8)-C(9)

1.3398(1)

C(25)-C(26)

1.3754(1)

Table H 1 Select bond lengths of Au heli-viologen
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C(1)-Au(1)-C(2)

176.62(1)

N(6)-C(13)-C(14)

120.77(1)

C(3)-Au(2)-C(4)

177.67(1)

C(13)-C(14)-C(15)

120.78(1)

Au(1)-C(1)-N(1)

177.15(1)

C(14)-C(15)-C(16)

121.68(1)

Au(1)-C(2)-N(2)

175.42(1)

C(15)-C(16)-C(17)

117.87(1)

Au(2)-C(3)-N(3)

175.29(1)

C(16)-C(17)-C(18)

122.24(1)

Au(2)-C(4)-N(4)

176.96(1)

C(13)-C(18)-C(17)

117.82(1)

C(11)-N(6)-C(13)

119.08(1)

C(13)-C(18)-C(19)

118.40(1)

C(12)-N(6)-C(13)

119.16(1)

C(17)-C(18)-C(19)

118.40(1)

C(11)-N(6)-C(12)

121.62(1)

C(10)-C(19)-C(20)

116.99(1)

C(5)-N(5)-C(26)

118.65(1)

C(10)-C(19)-C(18)

116.94(1)

C(6)-N(5)-C(26)

122.98(1)

C(18)-C(19)-C(20)

125.97(1)

C(5)-N(5)-C(6)

117.87(1)

C(7)-C(20)-C(21)

116.80(1)

N(5)-C(6)-C(7)

123.13(1)

C(19)-C(20)-C(21)

126.22(1)

C(6)-C(7)-C(8)

120.84(1)

C(7)-C(20)-C(19)

116.64(1)

C(8)-C(7)-C(20)

121.99(1)

C(20)-C(21)-C(26)

119.32(1)

C(6)-C(7)-C(20)

117.14(1)

C(22)-C(21)-C(26)

116.97(1)

C(7)-C(8)-C(9)

119.55(1)

C(20)-C(21)-C(22)

122.64(1)

C(8)-C(9)-C(10)

118.18(1)

C(21)-C(22)-C(23)

121.43(1)

C(9)-C(10)-C(19)

124.38(1)

C(22)-C(23)-C(24)

120.64(1)

C(11)-C(10)-C(19)

120.09(1)

C(23)-C(24)-C(25)

119.77(1)

C(9)-C(10)-C(11)

115.47(1)

C(24)-C(25)-C(26)

119.63(1)

N(6)-C(11)-C(10)

122.91(1)

N(5)-C(26)-C(21)

117.72(1)

N(6)-C(13)-C(18)

120.16(1)

C(21)-C(26)-C(25)

120.78(1)

C(14)-C(13)-C(18)

118.99(1)

N(5)-C(26)-C(25)

121.41(1)

Table H 2 Select bond angles of Au heli-viologen
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APPENDIX I
E. COMPUTATIONAL MODELLING
All geometry parameters were determined using Gaussian ‘16 software (Gaussian Inc.) with the
University of Maine Advanced Computing Group.23 All ground state and excited state
calculations were performed using density functional theory (DFT) and time-dependent density
functional theory (TD-DFT) calculations using the M06 metahybrid functional24,25 with the CEP31G(d) basis set employed for all atoms.26,27 XRD structures were used as initial structural input.
From the structural data we have developed a neutral model that is composed of two heliviologen2+ units bridged by a dimer [Au(CN)22- and capped with terminal [Au(CN)2] monomer
units. This model contains all subunits present within the crystal structure. Isodensity
representations of molecular orbitals were generated using GaussView 5.0 software (Gaussian
Inc.). MOs were generated and visualized using the Avogadro 1.2.0 software program.28
DFT calculations were performed to interpret the photophysical changes and emission spectra of
Au heli-viologen upon excitation. A neutral model of gold(I) dicyanide coordinated to heliviologen2+, shown in Fig. 9, was developed containing both [Au(CN)2]- and [Au(CN)2]22- subunits.
Calculated ground state geometry parameters, Table S3 (ESI†), are in good agreement with
experimental values with short Au⋯Au distances supportive of aurophilic interactions.

Figure I 1 DFT M06/CEP-31G(d) calculated ground state of [Au(CN)2]-/[Au(CN)2]2-2 coordinated
heli-viologen2+. Close Au⋯Au distance (3.435 Å) shown

262

Calculations at the [Au(CN)2]22- center accurately predict a short Au⋯Au distance of 3.435 Å
compared to an experimental value of 3.310 Å. The close contact distance between the CN- anion
and the N+ cation of the phenyl (3.155 Å) is slightly shorter than the experimental value of 3.216
Å. We attribute this shortened distance to the lack of surrounding [Au(CN)2]- ions normally
present. The loss of surrounding anions causes our model to overly rely on the central electron rich
[Au(CN)2]22- dimer to balance the cationic viologen ion. TD-DFT calculated UV-vis spectra, Fig.
S14 (ESI†), show agreement of our model with the experimental UV-Vis results with both having
strong absorption bands at energies higher than 500 nm. An excited state at 399 nm is predicted
with a strong oscillator strength of 0.0132. This excited state energy aligns with our experimental
luminescence excitation value of 400 nm. The highest contributing molecular orbital transition
calculations performed for this excited state are shown in Figure I 2.
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Figure I 2 TD-DFT M06/CEP-31G(d) energy diagram calculated for Au heli-viologen at 399 nm
excitation for top 3 transitions. Transition percent contributions are noted.
TD-DFT calculations predict that two general types of electron transitions occur upon excitation
at 399 nm. The first centers on the electron donating MOs (HOMO-9, and HOMO-11) which are
primarily composed of the heli-viologen2+ π* with minor contribution from the neighboring
[Au(CN)2]- anion. The electron accepting MO (LUMO) is composed of the heli-viologen2+ π* and
clearly represents a π → π* transition. In the second case, the electron donating MO (HOMO) is
exclusively composed of the dimerized [Au(CN)2]22- subunit with no contribution from the
neighboring heli-viologen2+ cations. This molecular orbital calculated transition is clearly an
electronic transfer and demonstrates the emissive quenching of [Au(CN)2]- by the viologen in the
solid state observed in the experimental photophysical data.
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Distance (Å) / Angle (o)
Experimental* Calculated*
Au...Au

3.310

3.327

NAu(CN)2...Naza[5]helicene 3.216

3.088

Au-C

2.010

2.029

C-Au-C

176.6

166.8

N-C-Au

177.1

169.6

*Average distances
Figure I 3 TD-DFT M06/CEP-31G(d) energy diagram calculated for Au heli-viologen at 399
nm excitation for top 3 transitions. Transition percent contributions are noted
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Normalized Intensity (a.u.)

APPENDIX J
F. UV-VIS, DFT AND MO FOR CHAPTER 5

250

M06/CEP-31G
Experimental

350

450

550

650

750

Wavelength (nm)

Figure J 1 TD-DFT M06/CEP-31G calculated UV-vis of Au heli-viologen compared to
experimental UV-Vis
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Excited State

Excited State

Excited State

Number

Energy

f-oscillation

7

428 nm

0.0078

8

425 nm

0.0067

9

423 nm

0.0014

10

421 nm

0.0000

11

421 nm

0.0069

12

420 nm

0.0027

13

406 nm

0.0004

14

404 nm

0.0009

15

401 nm

0.0028

16

399 nm

0.0132

17

392 nm

0.0011

18

390 nm

0.0083

Table J 1 TD-DFT calculated excited states of of Au heli-viologen with corresponding energy
and f-oscillation
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Orbital Transition

% Contribution

HOMO-9→LUMO+1

25%

HOMO-11→LUMO

21%

HOMO→LUMO+2

18%

HOMO→LUMO+3

16%

HOMO-9→LUMO

12%

HOMO-11→LUMO+1

8%

Table J 2 Calculated MO transitions of Au heli-viologen for excited state at 399 nm with percent
contribution
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Figure J 2 Isodensity representations of MO transitions of excited state at 399 nm for Au heliviologen with percent contribution
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